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CHAPTER ONE 
SUMMARY 
 
The infectious disease tuberculosis (TB) still represents a global threat due to its 
devastating effect on health and the subsequent high mortality rate.  Previous studies have 
indicated that host genetic factors are implicated in host susceptibility to TB.  Since TB is a 
complex disease, it can be assumed that susceptibility to M. tuberculosis has multiple genetic 
causative factors (as well as environmental causes). 
 
The current study focussed on a number of South African Coloured (SAC) individuals, 
some of whom were TB cases and others controls.  Population substructure was tested in 
the admixed SAC population as it can be a strong confounding factor for association 
studies.  Our results using the programme STRUCTURE indicated no population 
substructure in the SAC population.  We further investigated the population structure of 
the SAC group using Affymetrix 500k SNP chip data which showed that the SAC 
population group has 4 major ancestral components: the Khoesan, European, African and 
Asian (Indian). 
 
A number of candidate polymorphisms in eight genes, previously indicated to play an 
important role in TB susceptibility, were tested in case-control associations studies.  We 
found statistically significant associations between IFNGR1, IL-8, IL-1Ra and NRAMP1 
polymorphisms and TB susceptibility in the SAC population. 
 
It has become increasingly evident that gene-gene interactions play a far more important 
part in an individual’s susceptibility to a complex disease than single polymorphisms would 
on their own.  The importance of epistasis was clearly identifiable in this study with only 
four associations found between the individual variants and TB susceptibility, but eight 
instances of statistically significant gene-gene interactions.  A combined data set consisting 
of 106 variants constructed from our database and also used for gene-gene interaction 
analysis yielded numerous statistically significant interactions.   
 
The interaction between the genotype of the human host and the bacterial strain genotype 
was also investigated and yielded interesting results. 
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CHAPTER ONE 
Owing to various polymorphisms in several cytokine genes, the protein levels of the main 
modulators of the immune system, cytokines and chemokines, are changed in several 
diseases such as infectious diseases and may affect susceptibility or resistance to TB.  The 
functional polymorphisms or haplotype patterns in some of these cytokine genes might be 
vital for protective immune responses and may serve as biomarkers of protection or 
susceptibility to TB.  The present study investigated 18 cytokines including pro-
inflammatory, anti-inflammatory and chemokine factors in healthy (mantoux positive or 
negative) children using the Linco-plex immunoassay, and investigated potential 
interactions.  
 
The basic research will one day contribute to personalised genetics which may benefit 
infectious diseases such as TB.  If individuals can be identified as potentially more 
vulnerable, they may require different vaccination strategies, a higher index of suspicion if 
exposed to TB, and prophylactic treatment.   
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CHAPTER ONE 
OPSOMMING 
 
Die infektiewe siekte tuberkulose (TB) is steeds ‘n gevaar wat die hele wêreld bedreig weens 
die groot impak op gesondheid en die gevolglike hoë mortaliteit.  Vorige studies het bevind 
dat die gasheer se genetiese faktore wel betrokke mag wees by die gasheer se vatbaarheid 
vir TB.  Aangesien TB ‘n komplekse siekte is, kan dit aanvaar word dat vatbaarheid tot M. 
tuberculosis veelvuldige genetiese oorsaaklike faktore (sowel as omgewingsoorsake) het. 
 
Hierdie studie het gefokus op ‘n aantal Suid-Afrikaanse Kleurling (SAC) individue, waarvan 
sommige TB pasiënte en ander kontroles was.  Die gemengde SAC populasie is getoets vir 
populasie-stratifikasie, aangesien stratifikasie ‘n sterk verwarrende invloed op pasiënt-
kontrole studies kan hê.  Ons resultate is verkry met behulp van die program 
STRUCTURE en het aangedui dat daar geen populasie sub-struktuur tussen die pasiënte en 
kontroles was nie.  Ons het ook die populasiesamestelling van die SAC groep ondersoek 
met data verkrygbaar van die Affymetrix 500k enkel nukleotied polimorfisme mikroskyfie.  
Hierdie data het getoon dat die SAC populasie uit 4 hoof voorouerlike komponente 
bestaan naamlik die Khoesan, Europeërs, Afrikane en Asiate (Indiërs). 
 
‘n Aantal kandidaat polimorfismes in agt gene, wat volgens vorige studies ‘n belangrike rol 
in TB vatbaarheid te speel, was in hierdie pasiënt-kontrole assosiasie studie bestudeer.  Ons 
het statistiese beduidende verwantskappe tussen IFNGR1, IL-8, IL-1Ra en NRAMP1 
polimorfismes en TB vatbaarheid in die SAC populasie gevind. 
 
Dit het al hoe meer duidelik geword dat geen-geen interaksies ‘n baie belangriker rol in ‘n 
individu se vatbaarheid vir ‘n komplekse siekte speel as enkel polimorfismes op hul eie.  
Die belang van epistase kon duidelik in hierdie studie geïdentifiseer word met slegs vier 
assosiasies wat tussen die individuele variante en TB vatbaarheid gevind is, in vergelyking 
met agt statisties beduidende geen-geen interaksies.  ‘n Gekombineerde datastel wat uit ons 
databasis saamgestel is en wat 106 variante bevat is ook in ‘n aparte geen-geen interaksie 
analise gebruik, wat verskeie statisties beduidende interaksies getoon het. 
 
Die interaksie tussen die menslike gasheer genotipe en die bakteriese stam genotipe is ook 
in hierdie studie ondersoek en het interessante resultate opgelewer. 
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CHAPTER ONE 
Veranderde proteïen uitdrukking van die hoofmoduleerders van die immuunsisteem, 
sitokine en chemokine, kom voor in verskeie siektes soos infektiewe siektes weens 
verskillende polimorfismes in verskeie sitokien-gene.  Sulke polimorfismes kan ook 
vatbaarheid vir of weerstandigheid teen TB beïnvloed.  Die funksionele polimorfismes of 
haplotipe patrone in sommige van hierdie sitokien-gene mag noodsaaklik wees vir 
beskermende immuunresponse en mag ook as biomerkers vir beskerming teen of 
vatbaarheid vir TB dien.  Hierdie studie het 18 sitokiene (insluitend pro-inflammatoriese-, 
anti-inflammatoriese- en chemokiene faktore), sowel as potensiële interaksies in gesonde 
(mantoux positiewe of negatiewe) kinders, ondersoek met behulp van die Linco-plex 
immuno-analise. 
 
Hierdie basiese navorsing sal eendag in die toekoms bydrae tot persoonlike genetiese 
analises wat tot voordeel kan wees vir infektiewe siektes soos TB.  Indien individue as 
potensieël meer vatbaar vir TB geïdentifiseer kan word, kan sulke persone ander 
vaksineringstrategieë sowel as voorkomende behandeling vereis. 
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1.1 TUBERCULOSIS 
 
Tuberculosis (TB) is an important disease in the recent history of mankind due to its 
devastating effect on health and the subsequent high mortality rate, currently throughout 
the world.  This infectious disease remains a scourge especially in low- and middle - income 
countries and is still responsible for a large number of deaths each year (Styblo, 1988).  In 
1993 TB was declared a global public health emergency by the World Health Organization 
(WHO), the only disease thus far to be singled out.  One third of the world’s population is 
thought to be infected with Mycobacterium tuberculosis (M. tuberculosis) and at risk for 
progression to active TB (Ducati et al., 2006; Dye et al., 1999).  The worldwide estimates of 
TB for 2007 were 9.27 million new cases and between 2 to 3 million deaths (World Health 
Organization, 2009).  TB is responsible for 100 000 deaths in children worldwide and it is 
estimated that by the year 2020, TB will still be one of the 10 leading causes of the global 
disease burden resulting in 1 billion more people being infected (Murray & Salomon, 1998; 
Pasqualoto & Ferreira, 2001).  The estimated incidence of TB can be seen in Fig. 1.1 
(World Health Organization, 2009).  It is estimated that pulmonary TB killed more people 
in the nineteenth century in Britain than the combined total of other diseases (Cartwright, 
1977) and currently this disease still represents a global threat (Ducati et al., 2006).  
 
Fig. 1.1 The worldwide incidence of tuberculosis for 2007 from the WHO Report 2009 Global 
Tuberculosis Control (World Health Organization, 2009). 
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The history of TB is fundamentally linked to changes in demographic, social and 
environmental conditions.  Therefore events such as war, urbanization, immigration and 
colonization play a major role in the course of TB in different population groups (Metcalf, 
1991).   
 
1.1.1 The origin and history of tuberculosis 
When and where TB disease occurred for the first time is still unknown, but evidence 
shows that it has been prevalent for several thousand years.  The M. tuberculosis organism 
was first discovered by Koch in 1882 (Koch, 1882).  M. tuberculosis and M. bovis, which 
cause TB mainly in humans or cattle and other animals respectively, are genetically very 
similar, therefore it has been speculated that tuberculosis infection in humans evolved from 
a mutant form of M. bovis (Coovadia & Benatar, 1991).  A more recent theory is that 
domesticated animals contracted the common mycobacterial ancestor from humans (de la 
Rua-Domenech, 2006).  The earliest evidence of tuberculosis in animals comes from 
elephants in India prior to 2000 BC (Manchester, 1984) and the earliest written evidence of 
human pulmonary TB comes from Asia (Morse, 1967).  The first person to describe the 
contagious nature of TB was Aristotle (384-322 BC) (Leff et al., 1979).  However, no 
definite theory has been established regarding the origin and spread of TB since the 
information is still very fragmented due to absence of data, unreliable statistics, under-
reporting and over-diagnosis. 
 
For the duration of the industrial revolution in the 18th and 19th century, towns began to 
grow rapidly, leading to overcrowding.  Since TB was not thought of as an infectious 
disease, no safety measures were taken to avoid transmission, giving rise to the endemic 
nature of the disease.  European colonialism brought about unfavorable changes in the 
population demographics, way of life and surroundings of many indigenous people in 
certain parts of the world and in Africa making them more susceptible to TB (Roelsgaard et 
al., 1964).  Even in Europeans, where TB has been endemic for centuries, lifestyle changes 
affect TB incidence.  For example during the first and second world war the mortality rate 
of TB increased above the trend due to changes in household conditions but mostly due to 
poor nutrition (Coovadia & Benatar, 1991). 
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The earliest information regarding TB in indigenous people from Australia and Africa 
comes from European travellers and missionaries but its reliability is questionable.  The 
absence of data is a huge problem in determining the history of TB particularly in 
developing countries where the figures are unreliable or unavailable (Metcalf, 1991).  Due 
to the unreliable records there were, prior to the twentieth century, no reliable estimates of 
TB incidence available for any country worldwide.  Therefore the first recorded date for 
TB in the Cape and Natal colonies in South Africa was in 1904 (Bryder, 1988).  TB deaths 
were extensively under-reported due to the stigma surrounding them, and were often 
wrongly ascribed to pneumonia or bronchitis (Fishberg, 1922; Swan, 1985).  Over-
diagnoses started in the twentieth century because of the inability to differentiate between 
diseases with similar clinical features, such as pneumonia, heart conditions and lung cancer. 
 
Much controversy exists regarding susceptibility to TB in specific ethnic groups.  A high 
incidence of TB in a specific group does not necessarily imply that the group as such is 
more susceptible to TB, since ethnic groups are in many instances associated with specific 
socio-economic status which is an important determinant of disease risk.  Several theories 
existed for the ethnic differences, one of these being the theory of “virgin 
soil/populations” that started in the late nineteenth to early twentieth century.  The term 
“virgin soil” refers to populations that have never been exposed to infection and therefore 
have had no chance to acquire resistance against the causative organism, making them 
more susceptible (Metcalf, 1991).  After investigating this theory it was found that it can 
only be applied to infectious diseases such as smallpox, where individuals obtain permanent 
immunity after infection, however this theory does not hold in the case of TB since 
environmental factors can reverse apparent immunity.  Therefore this theory does not 
explain most susceptibility to TB (Metcalf, 1991). 
 
1.1.2 The history of TB in South Africa 
Socio-economic, political and demographic factors played a major role in determining the 
incidence of TB in South Africa.  Information prior to the 1940s and 1950s, regarding the 
prevalence of TB and extent of the disease, is incomplete due to poor data collection.  As 
previously mentioned, the reporting of TB started in 1904 in the Cape and Natal (Union of 
South Africa, 1914) but in 1943 the following was stated about the notification figures: 
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“…cannot be relied upon to find an accurate estimate of the incidence of the disease in South Africa [as] 
notification of tuberculosis … is very poorly observed [and] is often erroneous, being based on purely clinical 
and not radiological or bacteriological grounds.” (Dormer et al., 1943) 
 
It is thought that the initial spread of TB amongst indigenous South Africans is closely 
related to the amount of contact with the Europeans (McVicar, 1932).  TB was first 
described as a severe problem amongst the Khoikhoi people who lived in the south-
western parts of South Africa in the early 19th century, whereas black people were infected 
with TB only later in the century (Metcalf, 1991).  The San people were particularly 
devastated by TB after European contact (McVicar, 1932).  Industrial development in 
South Africa led to rapid urbanization of black and coloured (to be defined later, see 
chapter 2) people in the late nineteenth century, resulting in the simultaneous increase in 
TB mortality rates in Johannesburg, Durban and Cape Town (Packard, 1989).  
 
It has been suggested that the mining conditions in South Africa played a major role in the 
spread of TB.  Very high mortality rates were reported amongst black mine workers in the 
Witwatersrand area in 1912.  Conditions in the mines favoured the spread of TB infection, 
such as poor ventilation and high humidity which was exacerbated by miners working in 
close proximity to one another (Packard, 1989).  After 1912, tuberculin tests were 
conducted in the mines and mine workers who tested positive for TB were sent home.  
The miners had inadequate diets and scurvy was prevalent, increasing their chances of 
contracting TB as vitamin C deficiency can lower resistance to TB (Metcalf, 1991).  In 1924 
Allen reported that poor living conditions contributed significantly to the high TB 
mortality rate (Allen, 1924). 
 
1.2 MYCOBACTERIUM TUBERCULOSIS  
 
TB is a chronic granulomatous disease in humans and other mammals.  Four closely related 
mycobacterial species: M. tuberculosis (mostly human tubercle bacillus), M. bovis (mostly 
bovine and other animals), M. microti (mostly small mammals) and M. africanum (mostly 
human and bovine) together also known as the M. tuberculosis complex, can cause TB 
(Greenwood et al., 1997).  M. tuberculosis is responsible for most human TB cases and is 
characterized as a weakly gram-positive bacterium that is non-motile, non-sporulating, non-
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capsulating, has straight or slightly curved rods and may occur in clumps or individually 
(Casanova & Abel, 2002; Greenwood et al., 1997; Murray et al., 1999).  
 
1.2.1 The M. tuberculosis genome 
The complete genome of M. tuberculosis laboratory strain H37Rv was published in 1998 and 
this led to substantial advances in the field of bacterial genomics (Cole et al., 1998; 
Fleischmann et al., 2002).  The M. tuberculosis genome is highly conserved and consists of 
4000 genes rich in repetitive DNA, coding for enzymes involved in lipolysis and 
lipogenesis (Ducati et al., 2006).  Since then a number of other M. tuberculosis and related 
mycobacterial strains have been sequenced.  Comparative genomic analysis of M. tuberculosis 
revealed DNA conservation between chromosomes.  Therefore nonsynonymous single 
nucleotide polymorphisms (nsSNP) that create an amino acid change and synonymous 
single nucleotide polymorphisms (sSNP) provide genetic information that allow for 
different M. tuberculosis strains to be distinguished from each other.  Both types of SNPs 
have a specific function regarding TB.  The nsSNPs correlate with the resistance to anti-
tuberculosis agents whereas the sSNPs can provide the basis for genetic drift and indicate 
evolutionary relationship between mycobacterial strains (Mathema et al., 2006).  Some of 
the most common typing techniques used to study the epidemiology of TB are IS6110 
RFLP analysis, spoligotyping, MIRU-VNTR and SNP analysis (Mathema et al., 2006). 
 
1.2.2 TB strain families 
A hypothesis suggesting that the modern M. tuberculosis strains underwent an evolutionary 
bottleneck ±  20 000 years ago has been formulated based on the high level of conserved 
DNA in the M. tuberculosis housekeeping genes and on the analysis of rare synonymous 
SNPs (sSNPs) and deletions (Brosch et al., 2002; Kapur et al., 1994; Sreevatsan et al., 1997).  
One of the ways by which M. tuberculosis has evolved is by deletion or duplication of 
genomic segments.  Some of these deletions can be used as phylogenetic markers since 
they occurred only once (Hirsh et al., 2004).  
 
Several strains such as LAM (Latin American and Mediterranean), Haarlem, C strain and X 
strain exist all over the world, and the W-Beijing family of strains has been studied most 
extensively (Malik & Godfrey-Faussett, 2005).  An investigation into 875 strains from 80 
different countries led to the hypothesis that M. tuberculosis originated and drifted together 
6 
 
CHAPTER ONE 
with humans “out of “ Africa (Gagneux et al., 2006).  Other evidence that differs from that 
of Gagneux et al., suggests that six lineages of M.tuberculosis have adapted to specific 
populations (Maartens & Wilkinson, 2007) and Hanekom et al. showed that strains from a 
defined sublineage may have been selected by a human population in a defined 
geographical setting (Hanekom et al., 2007).  This argument is also supported by the fact 
that the HLA allele frequencies, of which the HLA genotype have been associated with 
susceptibility to M. tuberculosis, varies widely between human populations with different 
historical backgrounds, with some alleles completely absent in some populations (Lombard 
et al., 2006) 
 
The Beijing family of strains, most easily recognised by its distinctive spoligotyping pattern 
(Bifani et al., 2002), was first reported in 1995 (van Soolingen et al., 1995).  This is the most 
dominant strain worldwide and has been reported in many countries, such as Vietnam, 
Thailand, Hong Kong, Russia and South Africa (Anh et al., 2000; Chan et al., 2001; 
Drobniewski et al., 2002; Glynn et al., 2006; Prodinger et al., 2001).  It has been suggested 
that Beijing strains are hypermutable and have greater virulence compared to other strains 
(Rad et al., 2003) and have also been associated with a higher frequency of drug resistance 
(Dale et al., 2005; Rad et al., 2003; van der Spuy et al., 2009). 
 
From the Mycobacterial complex, M.tuberculosis has evolved into three principle genetic 
groups (PGG 1, 2 and 3).  Based on the combinations of two polymorphisms at the katG 
codon 463 and gyrA codon 95 site, isolates of M.tuberculosis were assigned to one of these 
three groups (Sreevatsan et al., 1997).  PGG 1, known as the ancestral group, is genetically 
more diverse than PGG 2 and 3 since it is older and therefore has accumulated variation. 
 
Based on the sSNP analysis, strains were also assigned to eight different clusters (I-VIII) of 
genetically related organisms on the basis of phylogenetic analysis of 230 sSNPs.  The 
PGG 1 was assigned to clusters I and II, PGG 2 was assigned to clusters III-VI and PGG 
3 which also contain H37 was assigned to clusters VII and VIII (Fig. 1.2) (Gutacker et al., 
2006). 
 
It has been suggested that strain fitness that refers to the heritable variation among 
members of a given species or phylogenetic lineage can play a major role in transmission 
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(Cohen & Murray, 2004).  However, this is still poorly understood.  Certain factors that 
might enhance the fitness in a population may include the ability of the strains to: (1) 
endure and reproduce within the hostile environment of the host, (2) modulate the host 
response and (3) up or down regulate expression of specific genes to adjust the 
effectiveness of antimycobacterial agents (Mathema et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2 The three PGG assigned to the eight different clusters based on the sSNP analysis.  The 
M.tuberculosis complex includes M. bovis, M. africanum, M. microtti, and M. canettii strains.  
Bootstrapping was used to assess the genetic distances (adapted from (Gutacker et al., 2006). 
 
 
1.3 PATHOGENESIS OF TB 
 
M. tuberculosis is a pathogenic bacterium that is usually transmitted through the coughing of 
a patient with pulmonary TB releasing a droplet of nuclei containing M. tuberculosis particles 
of about 1-5μm in diameter and the inhaling of this droplet by another person.  After 
inhalation, the bacillus usually establishes itself in the lungs, being the initial site of 
infection, where it is phagocytosed by the alveolar macrophages after which a vital host 
cellular immune response involving T helper cells, cytokines and a large number of 
chemokines can either lead to protective immunity or progression to disease (Henderson et 
al., 1997; Roach et al., 2002).  It is also known that a combination of environmental and 
host genetic factors play a major role in the outcome of exposure and infection (Fig. 1.3) 
(Casanova & Abel, 2002).  It is clear that susceptibility to TB is polygenetic therefore it is 
unlikely that dysfunction in only one gene will allow progression to TB after infection 
(Meya & McAdam, 2007).  Currently, it is thought that in 10% of immunocompetent 
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individual,  the infection is not contained and they will develop active TB whereas the other 
90% will never develop disease (Murray et al., 1990). 
 
The tubercle bacillus is a intracellular pathogen that survives in the macrophage 
(Greenwood et al., 1997).  The T lymphocytes attracted to the site release lymphokines 
which activate the macrophages to form a granuloma (cluster). The macrophages in the 
granuloma are active and use oxygen which results in anoxia, which together with acidosis 
in the centre of the lesion, kills most of the tubercle bacilli.  Granuloma formation is in 
most cases sufficient to limit primary infection, however not all bacilli are destroyed.  The 
rest can presumably remain dormant as long as the individual’s immune system prevails.  
The dormant bacilli can be reactivated either spontaneously or due to a impairment in the 
host’s immune system giving rise to post-primary disease (Greenwood et al., 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3 The complex interactions between the host, environment and Mycobacteria (adapted from 
(Casanova & Abel, 2002). 
 
1.3.1 TB and the immune system 
The human immune system acts by mounting either a cellular or humoral response. Both 
of these responses involve T helper lymphocytes (Th) that are produced by Th-1 and Th-2 
maturation pathways (Fig. 1.4).  The T lymphocytes are grouped into CD4 or CD8 
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according to cluster differentiation.  The Th-1 type immune response is responsible for 
granuloma formation, whereas the Th-2 type immune response can cause the secretion of 
cytokines that are responsible for the inactivation of macrophage proliferation (Labidi et al., 
2001).  Macrophage-derived pro-inflammatory cytokines such as interleukin-6 (IL-6), IL-
12, tumor necrosis factor (TNF) and interferon gamma (INF-γ) derived from natural killer 
cells are responsible for sustaining or inhibiting bacterial growth (Ducati et al., 2006).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the knowledge of the Th-1 and Th-2 type immune responses and the desire for  
 
Th-1 type 
CD4+ and CD8+ help
lymphocytes 
er T 
Cellular in nature 
Acts against chronic diseas
through macrophag
activation
es, 
e 
Leads to granuloma 
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Secrete cytokines such as IL
IL-12, IL-15 and INF-γ
-2, 
 
The two types of immune responses 
Susceptibility to  
TB 
Protective immunity 
against TB 
Th-1 type Th-2 type 
Different subsets of CD4+ and 
CD8+ helper T lymphocytes 
Secrete cytokines such as IL-4, IL-
5, IL-6, IL-9, IL-10 and TNF 
Humoral in nature 
May be required to eliminate 
extra-cellular antigens and 
parasites 
Th-2 type
This response can cause tissue 
destruction which represents 
immune response failure in many 
diseases
Fig. 1.4 Diagram explaining the two different types of immune responses (Th-1 and Th-2) (Ducati et 
al., 2006; Meya & McAdam, 2007).  (Note: this is somewhat oversimplified, but the Th1/Th2 
balance is a widely accepted idea). 
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human immunization, the first vaccines that were produced focused on the protection 
against acute infections, where the Th-2 type immune response can be efficient (Grange et 
al., 1995).  However more recent attempts focused on developing single antigens into 
vaccines (Labidi et al., 2001).  For a continuing protective immunity, new vaccines should 
be developed that combine selected antigens with potent adjuvants and stimulate the 
suitable immunological pathway.  Therefore the ideal mycobacterial adjuvant would be one 
that induces an increase in Th-1 type response and a parallel inhibition of Th-2 response 
(Grange et al., 1995) (See section 1.4). 
 
1.3.2 Recurrent TB 
Recently it was reported that the age–adjusted incidence rate of TB due to reinfection 
among patients with successful prior treatment in Cape Town was four times higher than 
the rate of new TB cases (Verver et al., 2005).  Individuals, especially in high incidence 
communities, that had TB previously have a greater chance of developing disease when 
reinfected.  Some confounding factors such as HIV and socioeconomic status might have 
biased the estimates, however this still indicates that a group of individuals may exist with a 
predisposition to TB infection or that TB increases susceptibility to recurrence (Bellamy, 
2006; Casanova et al., 2002; Yew &  Leung, 2005). 
 
 
1.4 VACCINATION 
 
Globally, the vaccine used in fighting the battle against TB is the intradermal BCG (bacilli 
Calmette-Guerin) vaccine.  This vaccine is easy to administer, generally without any serious 
complications and has been administered to more than 2 – 3 billion people since 1948 
(Labidi et al., 2001).  BCG is a living attenuated vaccine derived from a strain of M. bovis 
and selected for its limited virulence in humans.  The protective effect of this vaccination 
varies between populations.  In some cases, BCG had a 78% protection rate while in other 
cases no protection was detected (Greenwood et al., 1997).  This difference might be 
ascribed to the pathogenic population-wide exposure to mycobacteria or the 
ineffectiveness of  the BCG vaccine as demonstrated in a meta-analysis of controlled BCG 
trials (Colditz et al., 1994).  This vaccine in general has been effective in preventing TB 
meningitis (TBM) in children but does not give protection to pulmonary TB (PTB) in 
adults (Colditz et al., 1994; Orme, 2001; Sterne et al., 1998).  Currently there are two major 
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problems with the BCG vaccine: 1) it has been shown that sub-strains are formed as a 
result of genetic modifications therefore complete avirulence acquisition is not unsuspected 
for the vaccine making immunization impractical and 2) after many years of BCG 
vaccination there can be a steady loss of T memory cell population (Orme, 2001).  This,  
together with the increasing number of TB cases worldwide, highlight the necessity for 
developing a better vaccine (Young & Dye, 2006).  It was previously suggested that two 
vaccines are needed; one to prevent infection of the pathogen (that applies to two thirds of 
the world’s population) and another one to eradicate infection already established (that 
applies to one third of the world’s population) (Hess & Kaufmann, 1999). 
 
 
1.5 DIAGNOSIS 
 
The diagnosis of TB is not simple, and is usually algorithm-based, which is a combination 
of several factors, such as clinical symptoms (coughing, fever, night sweats, weight loss), a 
positive tuberculin test (TST), chest x-rays and by microscopy or culture.  Diagnosing TB is 
still based on the long tedious process of detecting the acid-fast bacilli under a microscope 
or by culturing the bacterium.  Therefore a new diagnostic tool with high sensitivity, which 
is rapid and affordable is sorely needed for diagnosing TB.  The deletion that classifies 
BCG includes two antigenic proteins, namely 6-kDa early secretory antigenic target (ESAT-
6) and culture filtrate protein-10 (CFP-10) (Mahairas et al., 1996).  Both these antigens are 
essentially limited to M. tuberculosis therefore many assays that test for the presence of TB 
infection are based on IFN-γ release by the T cells in response to ESAT-6 and CFP-10 
(Connell et al., 2006).   
 
The TST is used worldwide as a diagnostic test to detect infection, irrespective of whether 
the infection is old or recent (Bloom & Murray, 1992).  The TST has some limitations 
regarding the antigens ESAT-6 and CFP-10, active and latent TB and BCG vaccination.  
Cross-reactions from exposure to other mycobacteria may induce low levels of tuberculin 
reactivity (Greenwood et al., 1997).  False positives can be produced as protein derivative 
contains antigens present in BCG and non-pathogenic mycobacteria, or false negatives can 
occur in immunocompromised patients or in early primary TB.  The TST is therefore not 
the best test to use since it cannot differentiate between active or latent TB, but on the 
other hand it can indicate the presence of M. tuberculosis infection (Wilkinson et al., 2005).  
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With molecular techniques, such as PCR, TB can now be diagnosed in 1 day instead of 2 
months.   
 
Diagnosing drug resistant TB can take up to 6-8 weeks.  Resistance to Rifampicin usually 
acts as a marker for multi-drug resistance and this can be detected by rapid molecular 
methods such as the polymerase chain reaction (PCR) (Morgan et al., 2005).  In patients 
infected with both TB and HIV the sputum-smear test for TB is often negative, therefore 
the WHO issued diagnostic guidelines for areas where the HIV incidence is very high 
(World Health Organization, 2006). 
 
 
1.6 TREATMENT 
 
The first treatment that TB patients, including HIV-infected TB patients, would receive 
according to guidelines set by the WHO, consists of the combined administration of 
rifampicin, isoniazid, pyrazinamide and streptomycin/ethambutol for the first 2 months 
followed by a combination of rifampicin and isoniazid for at least another 4 months 
(Jindani et al., 2004; World Health Organization, 2006).  The directly observed treatment 
short course (DOTS) is the internationally recommended strategy to control TB and 
consists of five fundamental elements (Fig. 1.5).   
 
 
Political 
commitment
 Direct 
treatment 
observation
Microscopic 
services 
DOTS 
 
 Surveillance 
systems
Drug 
supplies 
 
 
Fig. 1.5 The five fundamental elements of the DOTS strategy 
The DOTS strategy was responsible for a decrease in the incidence of TB in many areas of 
the world, but is far from complete or ideal for multidrug-resistant TB. Therefore new 
diagnostic tools, better vaccines and new drugs need to be developed. People with latent 
TB can also be treated with only isoniazid for six months, however this usually happens in 
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Table 1.1 Factors responsible for the resumption of TB 
Increase in drug resistance
HIV/AIDS pandemic
Increase of injectable drug users
Social structure
Poor nutrition
Increase amount of immigrants 
Aging of the world population
Transmission amongst environments (prisons, hospitals and shelters)
Social inequality
Degradation of health care systems
first world countries only (Ducati et al., 2006).  Several factors are responsible for the 
resumption of TB (Table 1.1) of which the most important is social inequality as it leads to 
malnutrition, poor living conditions and low education levels (Ducati et al., 2006).   
 
 
 
 
 
 
 
 
 
 
 
1.7 DRUG-RESISTANT TB 
 
Drug-resistant TB can arise from two major sources: (1) acquired resistance due to 
inadequate treatment that leads to the selection of resistant strains in patients and (2) 
primary resistance that develops when an individual is infected or re-infected with a 
resistant strain (Victor et al., 2007).  Previous studies have stated the existence of an 
association between the occurrence of spontaneous mutations in M. tuberculosis and drug 
resistance (David & Newman, 1971).  Since acquired resistance due to antibiotic pressure 
can lead to accumulation of these drug-resistant mutants the use of combination therapy 
(using several antibiotics) to reduce the appearance of drug resistance during therapy 
became prevalent (David, 1971; East African/British Medical Research Council, 1972).  
The long duration of treatment combined with the side effects of TB treatment, irregular 
drug supply, poor adherence and malabsorption are contributing factors to drug resistance 
(Davies, 1998; Singh et al., 2007).  In the early 1990s, multidrug-resistant tuberculosis 
(MDR-TB) emerged as a growing phenomenon globally, whereafter extensively drug-
resistant tuberculosis (XDR-TB) followed (Mathema et al., 2006).  South Africa has been 
identified as one of the high-burden countries for drug-resistant TB with a staggering 
number of more than 10 000 number of cases reported for 2007 (World Health 
Organization, 2009). 
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MDR-TB is by definition the resistance to the two important frontline antibiotics, 
rifampicin and isoniazid (Telenti & Iseman, 2000).  It was identified in the Western Cape, 
South Africa for the first time in 1985 (Weyer et al., 1995).  It is estimated that more than 
4% of TB patients worldwide are MDR and more than 40% of these have previously been 
treated for TB (Zignol et al., 2006).  The WHO estimated that 300 000 – 600 000 new cases 
of MDR-TB may emerge every year (World Health Organization, 2006).  The mortality rate 
for MDR-TB is estimated at 40% – 60% which is equivalent to patients untreated for TB 
(Bloom & Murray, 1992).  It has been suggested that three main factors: 1) easy 
accessibility to anti-TB medication, 2) patient noncompliance towards treatment and 3) 
unsuitable administration of drugs by clinicians, contributed to the development of 
MDR/XDR (Riley, 1993).  MDR represents a global problem.   
 
XDR-TB can be defined as resistance to the important frontline antibiotics (rifampicin and 
izoniazid), second line drugs such as ofloxacin and at least one injectable (kanamycin, 
amikacin, capreomycin) (Maartens & Wilkinson, 2007).  An outbreak of XDR has recently 
been reported in South Africa where 52 of 53 HIV positive patients died within 16 days.  
The M. tuberculosis strain in these XDR patients had the same genetic history indicating 
recent transmission or possibly nosocomial transmission (Gandhi et al., 2006). If MDR-TB 
is not detected when chemotherapy is started, inappropriate antibiotic use will inevitably 
result in the development of XDR-TB as the bacteria may be exposed to fewer active drugs 
than required (van Helden et al., 2006). 
 
 
1.8 TB AND THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) 
 
The first documented proof of a link between TB and HIV was in New York in 1992 
(Bloom & Murray, 1992).  It was estimated that individuals infected with HIV and latent 
TB are predisposed to develop active TB at a rate of 7 - 10% per year compared to 8 - 10% 
per lifetime in HIV-negative individuals (Bloom & Murray, 1992; Selwyn et al., 1989; 
Selwyn et al., 1992). It has been reported that the risk of TB is two fold higher one year 
after HIV infection (Sonnenberg et al., 2005).  The association between TB and HIV in 
sub-Saharan Africa is alarming and distressing (Corbett et al., 2006).  Severe suppression of 
the immune system in individuals increases their risk of active disease and a TB incidence 
rate of as high as 30% has been reported in South African patients with advanced HIV 
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(Wood et al., 2000).  It is also suggested that HIV infection is responsible for the 
transmission of most of the TB between adults in sub-Saharan Africa (Glynn et al., 2005).  
The estimated HIV prevalence in new TB cases is the highest in Africa with more than 
50% of new TB cases in South Africa co-infected with both TB and HIV (Fig. 1.6) (World 
Health Organization, 2009). 
Fig. 1.6 The worldwide estimated HIV prevalence in new TB cases for 2007 from the WHO Report 
2009 Global Tuberculosis Control (World Health Organization, 2009). 
 
 
TB induces AIDS progression in HIV-positive patients by the production of cytokines and 
a decrease in CD4 cells therefore co-infection of HIV and TB represents a major problem 
(Ducati et al., 2006).  Evidence suggesting that a strong association exists between TB and 
HIV was supported in a study done in Africa (Table 1.2) (Ducati et al., 2006).  MDR-TB 
has been called “the most malignant opportunistic infection yet associated with HIV 
infection” (Nolan, 1997). 
Table 1.2  Evidence suggesting a strong association between TB and HIV in Africa
TB is the most important disease associated to HIV/AIDS
TB is the major cause of death amongst HIV patients
The incidence of TB increased with the appearance of AIDS
HIV is more prevelant in people with TB
Active TB is more prevelant in HIV-positive people
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1.9 HOST GENETIC SUSCEPTIBILITY TO TB 
ince it is estimated that only 10% of one third of the world’s population infected with M. 
 will develop active TB, the question arises: what makes them different from the 
question, many approaches have 
ncluding animal models, case-control association and genome-wide linkage 
tion specific (Maartens & Wilkinson, 2007).  
enes may not play a role in the risk of infection upon exposure but they might influence 
erent 
proaches will be discussed below. 
 genome scans, linkage analysis or animal studies to 
entify candidate genes, and secondly by hypothesis, where the known or presumed 
o able cause”  for association with the disease (Fig. 1.7). 
 
S
tuberculosis
other 90%?  In search of a genetic based answer to this 
been used, i
studies (Bellamy, 2006).  Adoption studies (Sorensen et al., 1988), twin studies (Comstock, 
1978) and familial clustering (Fine, 1981) have indicated that host genetic factors play an 
important role in host susceptibility to TB.   
 
The genetic susceptibility component of TB seems to be scattered across many genes as 
well as different genes being implicated in different populations, which corresponds with 
the fact that M. tuberculosis might be popula
G
the risk of disease development and the course of disease (Daniel, 1997).  Many studies 
indicated that M. tuberculosis applies a powerful selective pressure on the human genome 
(Bloom & Small, 1998).  The genetic component of susceptibility to TB has been studied 
extensively in the past few years resulting in a rapid increase in available information. 
 
Since TB is a complex disease, it can be assumed that susceptibility to M. tuberculosis has 
multiple genetic causative factors (as well as environmental causes), therefore a single 
approach would not be able to identify all the genes involved (Bellamy, 2006).  Diff
ap
 
1.9.1 Candidate gene approach 
The selection of a candidate gene for a genetic study can be based on two approaches, one 
being by experiment, using data from
id
functi n of the gene provides “ prob
Linkage analysis and case-control association studies are based on two completely different 
approaches (Table 1.3). 
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 T
1994)  
able 1.3  A comparison between linkage-type studies and association studies (Lander & Schork, 
Linkage studies Association studies
Test whether  they show correlated Test whether a disease and an allele show
 
 
 
 
 transmission within a pedigree
 
correlated occurrence in a population
Focus on concordant inheritance Focus on population frequencies
Can detect linkage without association Can detect association without linkage
 
 
 
 
Fig. 1.7 Strategies for identifying susceptibility genes, adapted from (Alcaïs & Abel, 2004). 
 
inkage studies are used to trace chromosomal regions containing putative susceptibility 
wide scan, which ensures that all major genomic regions 
involved in disease susceptibility are identified, or by concentrating on a candidate region.  
 
1.9.2 Linkage analysis 
L
genes, either by a genome-
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This provides the opportunity to find new genes and pathways that might not previously 
have been suspected to contribute to the disease studied.  The inheritance pattern of 
phenotypes and genotypes observed in a certain pedigree can be explained by linkage 
analysis which proposes a model.  Linkage analysis has successfully mapped hundreds of 
monogenic traits (Lander & Schork, 1994).  This type of analysis is very successful for 
simple Mendelian traits but to find a precise model that adequately explains the inheritance 
pattern of a complex trait such as TB can be difficult or impossible.   
 
Model-based or parametric linkage analysis by the logarithm of odds (lod) score method 
needs a defined model that specifies the relationship between the phenotype and factors 
at may influence its expression.  The model is provided by segregation analysis. Model-
region for another intracellular pathogen 
oberts et al., 1993), was chosen for a TB linkage study (Jamieson et al., 2004).  This 
omic regions on 
5q and Xq27 showed evidence of linkage with TB (Bellamy et al., 2000).  To date six 
th
free or non-parametric linkage studies are used when little is known about the relationship 
between the phenotype and the gene, which is generally the case with complex diseases. 
Once evidence for linkage has been found, fine genetic and physical maps are constructed 
to narrow down the interval on the chromosome and allow gene identification by candidate 
gene selection (when the function of the gene is known) or by positional cloning (when the 
function is unknown) (Abel & Dessein, 1997). 
 
The chromosome 17q11-q21 candidate region, syntenic to mouse chromosome 11 which 
was previously identified as a susceptibility 
(R
indicated that the chromosome 17q11-q21 region contained TB susceptibility genes, and 
further evaluation of this region suggested that four genes contributed separately to 
susceptibility (Jamieson et al., 2004).  A model-based linkage study performed in a Canadian 
pedigree using microsatellite markers flanking the natural resistance associated macrophage 
protein 1 gene (NRAMP1, renamed solute carrier family 11A member 1 (SLC11A1)), 
revealed linkage between TB and the 2q35 loci (Greenwood et al., 2000).   
 
The first model-free genome-wide linkage study for tuberculosis was conducted using 
affected sibling pairs from West and South African families where two gen
1
genome-wide linkage scans have been done in TB genetics (Table 1.4).  The minimal 
overlap between susceptibility regions observed in these studies is probably because linkage 
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of a genotype for a genetic marker with TB may be unique to a specific family or 
population and thus impossible to identify in other studies. These studies are also 
exquisitely sensitive to the phenotype definition.  
 
However, as discussed previously, it is very difficult to find a precise model that adequately 
explains the inheritance pattern of a complex trait such as TB.  Association studies have 
uch greater power for detecting genes of small effect than linkage analysis (Risch & 
region phenotype  
m
Merikangas, 1996), provided that the sample size is adequate.  Therefore association studies 
are the most popular study design for investigating host susceptibility to TB. 
 
 
Population Chromosomal  TB  Reference
Table 1.4 Chromosomal regions identified by genome-wide linkage studies of TB 
South African 15q11-13 TB  et al., 2000)        (BellamyThe Gambia Xq TB
Brazilian 
10q26.13 TB
(M 4) iller et al., 20011q12.3
20p12.1
TB
TB
Moroccans 8q12-q13 TB  (Baghdadi et al., 2006) 
South African 6p21-q23 TB (Cooke et al., 2008) Malawian 20q13.31-33
2q21-2q24 PTST-
 TB
Ugandans (Stein et al., 2008) 5p13-5q22 PTST-
Thais (Mahasirimongkol et al., 
7p22-7p21 TB
20q13 TB
5q23.2-31.3 TB
2009) 17p13.3-13.1  TB, CA
20p13-12.3 TB A, C
 
 
 
 studies where 
e allele frequency of a specific marker is compared between unrelated cases (affected 
u ividuals) when Hardy-Weinberg equilibrium 
TB, current or previous microb confirmed tu ulosis 
PTST-, persistently negative in test 
CA, ord set analysis t on ase as co
iologically berc
 tuberculin sk
ered sub with minimum age a set of dise variate 
1.9.3 Case-control association studies 
Population based case-control association studies are the classic association
th
individ als) and controls (unaffected ind
(HWE) holds (Lander & Schork, 1994).  Case-control association studies can detect weak 
effects and several of these studies replicated or validated associations found in previous 
studies or detected novel pathways that might be involved in pathogenesis (Maartens & 
Wilkinson, 2007).  However, an association can arise for one of three reasons: 1) When the 
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specific allele is the actual cause of the disease, 2) when the allele does not cause the trait 
but is in linkage disequilibrium with the actual cause of the disease, 3) as an artifact of 
population admixture (Lander & Schork, 1994).  It is very important therefore, to address 
population stratification and to replicate association studies to confirm the results. 
 
1.9.4 Population stratification 
Since population stratification can arise when the genetic background of cases and controls 
 different, it is important that both these groups should be sampled from the same area 
d be carefully matched on their ethnic, and by implication, 
t of TB susceptibility seems to be scattered across many genes and it 
as been studied extensively in the past few years resulting in a vast amount of information 
A, VDR, DC-SIGN, NRAMP1, 
n. Genes that are involved in protective immunity 
ow greater variance than other genes (Murphy, 1993). This is also the case for the HLA 
is
and that cases and controls shoul
genetic backgrounds (Reich & Goldstein 2001; Cardon & Palmer 2003).  Case-control 
association studies are valid tests for association, provided that the issue of population 
stratification is addressed (Pritchard & Rosenberg 1999).  The role population stratification 
plays in genetic studies as a whole and in this particular study will be discussed in more 
detail in chapter two. 
 
1.9.5 TB and previous genetic susceptibility studies 
The genetic componen
h
(Fig. 1.8).  Several candidate genes, amongst others HL
IFN-γ and MBL have been associated with TB (Table 1.5) whereas others were not 
associated (Table 1.6).  The genes NRAMP1, IFN-γ and MBL will be discussed in section 
1.9.6 as they formed part of this study.   
 
The human leukocyte antigen (HLA) region consists of approximately 200 genes, many of 
which are involved in antigen presentatio
sh
region, which varies between populations and is highly polymorphic.  It has been 
postulated that this is the effect of different selection pressures, such as infectious disease 
(Lombard et al., 2006).  The HLA class I and class II genes are involved in antigen 
presentation to T cells and each protein binds a different range of peptides (Janeway et al., 
2001).  There are three class I α-chain genes in humans, namely HLA-A, -B and –C.  There 
are four subclasses of genes in the HLA class II region, named HLA-DR, -DP, -DM and –
DQ respectively.  HLA genes have been examined in several TB susceptibility studies and 
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were some of the first genes to be investigated and associated with the disease. The HLA-
DR2 is the most consistently associated with TB in several populations such as India 
(Meyer et al., 1998; Ravikumar et al., 1999), Thai (Vejbaesya et al., 2002), Indonesia (Selvaraj 
et al., 1998) and Russia (Khomenko et al., 1990).  It was found that the HLA-DQB1*0503 
influence the progression of TB in the Cambodian population (Goldfeld et al., 1998) 
whereas the DQB1*0601 was associated with TB in the Thai and South Indian population 
(Ravikumar et al., 1999; Vejbaesya et al., 2002).  DRB1*1302 was associated with TB 
susceptibility in a Venda population (Lombard et al., 2006).  
 
 
 
 
 
Fig. 1.8 Genetic involvement in the TB disease process. 
A simplified representation of different outcomes after M. tuberculosis infection and some of the 
genes that may be involved at various stages. The bacteria enter the respiratory system of the 
host via inhaled droplets and are engulfed by macrophages (MФ) and dendritic cells. There are 
three potential outcomes after inhalation of M. tuberculosis: i) Infection develops into active TB. 
immune system. iii) Infection does not 
 
ii) M. tuberculosis is immediately killed by the pulmonary 
progress to active disease, because the bacteria are contained in granulomas. During active TB, 
M. tuberculosis can disseminate from granulomas. (Adapted from (Kaufmann & McMichael, 
2005). 
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The vitamin D receptor (VDR) gene mediates the effects of the active metabolite of 
itamin D, 1,25-dihydroxyvitamin D3, which suppresses the growth of M. tuberculosis in 
itro (Denis, 1991; Rockett et al., 1998) by stimulating cell-mediated immunity and 
lay an important role in TB susceptibility, were 
hosen as candidate genes for this study and will be discussed in detail in the chapters to 
en associated with TB in a Mexican population (Floros et al., 2000).  
P-D plays a crucial role in the pulmonary innate immune response by interacting with the 
nate immune system and plays an important role in the modulation of inflammation 
v
v
activating monocytes (Rook et al., 1986).  Conflicting results have been found in association 
studies of VDR in TB (Bellamy et al., 1999; Bornman et al., 2004; Selvaraj et al., 2000; 
Wilkinson et al., 2000).  A meta-analysis of studies indicated that results were inconclusive 
and that the studies were underpowered (Lewis et al., 2005).  A recent study in South 
Africans determined that the ApaI “AA” genotype and “T”- containing TaqI genotypes 
predicted a faster response to TB treatment, but did not detect an association with TB in a 
case-control analysis (Babb et al., 2007). 
 
1.9.6 Genes investigated in this study 
Eight genes, previously indicated to p
c
follow (See Fig 1.8).   
 
The gene encoding the collectin surfactant protein D (SP-D) is located on chromosome 10 
and has previously be
S
macrophage cell surface molecules and therefore modulating phagocytosis of M. tuberculosis 
(Ferguson et al., 2002).  SP-D has been used as a biomarker for pulmonary disease states as 
it is present on the extrapulmonary epithelial surfaces and in serum (Sørensen et al., 2006). 
 
The gene encoding the collectin mannose-binding protein (MBP) also known as the 
mannose-binding lectin (MBL) is mapped to chromosome 10.  MBL is a component of the 
in
(Turner, 2003).  It has become more evident that MBL plays a multifaceted role in many 
diseases and that a deficiency of the protein, due to three mutations in exon 1, has been 
shown to be associated with increased susceptibility to infectious disease (Summerfield et 
al., 1997) but equivocal results have been found in the case of TB (Bellamy et al., 1998; 
Selvaraj et al., 1999), where promoting the uptake of bacteria into macrophages may be 
advantageous to the bacterium, and the variant alleles have been associated with protection 
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against TB and particularly tuberculous meningitis in South Africa (Hoal-van Helden et al., 
1999), Denmark (Soborg et al., 2003) and Turkey (Cosar et al., 2008). 
 
An effective response by the host during bacterial infections in the lung (M. tuberculosis 
fection) is the recruitment and activation of inflammatory agents to the lung through 
is one of the most well-known pathways involved 
 TB since it is a flagship Th1 cytokine and plays a vital role in the protective immune 
in
chemokine activity.  Interleukin 8 (IL-8) is a tissue derived peptide and a major chemokine 
that is secreted by several cell types in response to inflammatory stimuli (Ma et al., 2003).  
In tuberculosis patients increased levels of IL-8 have been reported in the bronchoalveolar 
lavage fluid (BALF), pleural exudates or cerebrospinal fluid, compared to the controls 
(Dlugovitzky et al., 1997; Mastroianni et al., 1994; Sadek et al., 1998).  Polymorphisms in the 
IL-8 gene, located on chromosome 4, have been associated with TB in a case-control study 
as well as a TDT study (Ma et al., 2003). 
 
The interferon-gamma (IFN-γ) pathway 
in
response against M. tuberculosis infection (Vidyarani et al., 2006).  Several polymorphisms 
have been indentified in IFN-γ and in the α and β chains of the interferon-gamma receptor 
(IFNGR) gene that were mapped to chromosome 12 and 6 respectively (Papanicolaou et al., 
1997; Zimonjic et al., 1995).  IFN-γ and IFNGR form a vital complex in determining the 
outcome of the biological effects of IFN-γ as the functional IFNGR is extremely important 
for containing M. tuberculosis (Dorman et al., 2004).  A previous study showed that defects in 
either of these two genes influence the availability of IFN-γ and therefore individuals were 
more prone to mycobacterial infections (Ottenhoff et al., 1998).  One of the most studied 
polymorphisms in IFN-γ is located in the first intron (+874 T/A) and have been associated 
with TB susceptibility in several populations such as South Africa where it was found in  
both the case-control and TDT study (Rossouw et al., 2003), Spanish (Lopez-Maderuelo et 
al., 2003) and Chinese (Tso et al., 2005).  A study that summarizes all the different studies is 
the meta-analysis performed on this particular SNP which indicated a significant 
protection, with the T/T genotype, to tuberculosis in different ethnic population groups 
throughout the world. Therefore it was shown that the +874 T/A SNP can be a major 
genetic marker for TB resistance. (Pacheco et al., 2008). 
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he gene encoding the chemokine Regulated upon Activation, Normal T-cell Expressed 
he gene encoding the natural resistance-associated macrophage protein (NRAMP1), also 
he interleukin-1 receptor antagonist (IL-1Ra) gene is located on chromosome 2 in close 
T
and Secreted (RANTES), also known as CCL5, is located on chromosome 17.  Its ligand is 
CCR5.  RANTES recruits several types of inflammatory cells including monycytes and T 
lymphocytes and is induced after M. tuberculosis infection.  In tuberculosis patients, an 
increased level of RANTES has been found in bronchoalveolar lavage fluid and in lung 
alveoli during active pulmonary tuberculosis (Sadek et al., 1998).  It has been hypothesized 
that these polymorphisms have an effect on TB in that RANTES recruits M. tuberculosis-
infected macrophages and suppresses intracellular growth of the bacterium.  
 
T
known as the solute carrier family 11A member 1 (SLC11A1), is located on chromosome 2 
and plays a role in macrophage activation.  NRAMP1 regulates cytoplasmic cation levels by 
specifically regulating the iron metabolism in the macrophages (Wyllie et al., 2002) and 
variants in the NRAMP1 gene may alter the function of this protein.  Genetic variants of 
NRAMP1 have been associated with TB in several studies leading to the meta-analysis of 
NRAMP1 polymorphisms which confirmed its association with tuberculosis susceptibility 
(Li et al., 2006).  The 5’ (GT)n variant has been shown to be of functional importance as it 
influenced NRAMP1 expression in a luciferase reporter assay (Searle & Blackwell, 1999).  
The 118 allele ((GT)9) has been associated with higher expression and resistance to TB 
whereas the 120 allele ((GT)10) has been associated with lower promoter activity and 
susceptibility to TB (Awomoyi et al., 2002; Hoal et al., 2004).  The 3’UTR variant has been 
linked to a significantly increased risk of pulmonary tuberculosis in West Africa (Bellamy et 
al., 1998), Asia (Ryu et al., 2000) and South Africa (Hoal et al., 2004). 
 
T
proximity to the IL-1α and IL-1β genes.  Both these gene products bind to the receptor and 
set off the recruitment and activation of macrophages leading to potent pro-inflammatory 
immune responses (Dinarello, 1988).  IL-1Ra also binds to the receptor but acts as a 
competitive inhibitor of IL-1 biological activity, therefore the interaction between IL-1 and 
IL-1Ra determines the initiation, persistence or termination of the pro-inflammatory 
response (McIntyre et al., 1991).  Polymorphisms in IL-1Ra have previously been associated 
with TB susceptibility (Gomez et al., 2006; Wilkinson et al., 1999). 
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rticles reporting significant linkage or association between susceptibility genes and TB (Burgner et al., 2006).Table 1.5  A
Candidate gene Population Phenotype Sample Size Reported Results Reference 
MHC Class (Region I, II, III) 
A1 Supertype Indian PTB &  Miliary TB TB cases = 235; Controls = 289 
Balamurugan et al., (
OR = 0.43; pc = 0.001 2004) 
 
A10; B8 Indian (South) Smear neg.  PTB 
TB cases = 152; 
Controls = 404 
p < 0.01 (Brahmajothi et al., 1991)
TB cases = 42; A2; B5 Egyptian PTB N/A 
Controls = 156 
(Hafez et al., 1985)  
A26; B17; B27; DR14 Iranian PTB TB cases = 44; 
Controls = 108 
p < 0.05 (pc > 0.05) (Mahmoudzadeh-Niknam et al., 2003) 
(Chandanayingyong et al., TB cases = 35; B12 Thai PTB Decreased Frequency 
Controls = 35? 1988) 
B14 Italian Cavitary  TB 
TB cases = 54; 
Controls = 1089 
RR = 3.9; p = 0.001 (Ruggiero et al., 2004)  
African PTB  TB cases = 60; Bw15 Increased Frequency American with Cavitation Controls = 100 
(Al Arif et al., 1979)  
Bw46 Thai PTB TB cases = 35; 
Controls = 35? 
Increased Frequency (Chandanayingyong et al., 1988)  
(Balamurugan et al., PTB &  TB cases = 235; Cw Allotype 1 Indian OR = 1.69; p = 0.005 Miliary TB Controls = 289 2004) 
Cw Allotype 2 Indian PTB &  Miliary TB 
TB cases = 235; 
Controls = 289 
OR = 2.31; p = 0.000004 (Balamurugan et al., 2004) 
TB cases = 436; DQ B57 (Asp/Asp) Cambodian PTB OR = 3.05; p = 0.001 
Controls = 107 
(Delgado et al., 2006) 
DQA1*0101; DQB1*0501; 
DRB1*1501 Mexican PTB 
TB cases = 65; 
Controls = 95 
OR = 6.16 - 7.92 (Teran-Escandon et al., 1999)  
TB cases = 40; DQA1*0301; DQA1*0501 Iranian PTB OR = 0.25; OR = 0.53 
Controls = 100 
(Amirzargar et al., 2004) 
DQA1*0601, DQB1*0301 Thai PTB TB cases = 82; 
Controls = 160 
OR = 0.4, p < 0.02 (Vejbaesya et al., 2002)  
(Dubaniewicz et al., TB cases = 38; DQB1*02 Polish PTB OR = 0.39; p = 0.01 
Controls = 58 2003)  
DQB1*0402; DR4; DR8 Mexican PTB TB cases = 65; 
Controls = 95 
Decreased Frequency (Teran-Escandon et al., 1999)  
CHAPTER ONE 
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DQB1*05 Polish PTB TB cases = 38; OR = 2.84; pc = 0.002 003)  
Controls = 58 
(Dubaniewicz et al., 2
PTB TB cases = 82; 
Controls = 160 
DQB1*0502 Thai OR = 2.06, p = 0.01 (pc = 0.13) (Vejbae ya et al., 2002)  
DQB1*0503 Cambo P T   
s
dian TB B cases = 126; 
Controls = 88 
p = 0.005 (Goldfeld et al., 1998)
27 
DR2 Indian PTB 25 Families p = 0.001 (Singh et al., 1983)  
DR2 Russian PTB Increased Frequency 1990)  (Khomenko et al., N/A 
Smear pos.  TB cases = 204; 
Controls = 404 
(Brahmajothi et al., 1DR2 Indian (South) Attributable risk = 0.29; p = 0.01 PTB 991)  
DR2 Indi (N ) PT T
C
(Raja t al., 1996)  an orth B B cases = 153; 
ontrols = 289 
RR = 1.8; pc = 0.029 lingam e
DR2; DQ1 Indian PTB TB cases = 209; 
Controls = 122 
RR = 2.3; RR = 2.8 (Selvaraj et al., 1998)  
DR2; DQw1 Ind T Attrib % , 1989)   onesian PTB B cases = 101; 
Controls = 65 
utable risk = 36% & 39 (Bothamley et al.
DR2; DRw53 Tuvinian Russian PTB N/A N/A (Pospelov et al., 1996)  
Mex )  DR3 ican PTB TB cases = 51; 
Controls = 54 
Decreased Frequency (Cox et al., 1988
DR3 Russian PTB N/A Decreased Frequency (Khomenko et al., 1
(Chandanayingyong
1988)
990)  
DR4 Thai  et al.,    PTB 
TB cases = 35; 
Controls = 35? 
Increased Frequency 
DR4 Italian Cavitary  TB 
TB cases = 54; 
ontrols = 1089 
RR = 2.7; p = 0.001 (Ruggiero et al., 20
C
04)  
DR y   (Pospelova et al., 2005)B1 *13 & DRB1*14 Tuvinian Russian PTB 14 Pedigrees Transmitted more frequentl
DRB1*07; DQA1*0101 Iranian PTB TB cases = 40; 
Controls = 100 
OR = 2.7; OR = 2.66 (Amirzargar et al., 2004)  
Kore Drug t  T 7 DRB1*0803 an  ResistanPTB 
B cases = 81; 
Controls = 200 
OR = 2.63; pc = 0.04 (Kim et al., 2005a)  
DRB1*11 Chinese PTB TB cases = 74; 
ontrols = 90 
RR = 0.12; p < 0.05 (Wang et al., 2001)
C
  
P P T
C
  DRB1*13 olish TB B cases = 31; 
ontrols = 58 
RR = 0.04; p < 0.001 (Dubaniewicz et al., 2000)
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DRB1*15 Chinese PTB TB cases = 74; RR = 2.91; p < 0.05 (Wang et al., 2001)  
Controls = 90 
TB cases = 22; 
Controls = 36 
DRB1*1501 Indian PTB p < 0.05 (Sriram et al., 2001)  
DRB1*1501; DQB1*0601 Southern Indian  OR = 2.68; OR = 2.32 (Ravikumar et al., 1999)  Sputum pos. PTB 
TB cases = 126; 
Controls = 87 
DRB1*16 Polish PTB TB cases = 31; RR .01 = 9.7; p < 0
Controls = 58 
(D 00)  
HSP70-1A Indian h) DR .  
ubaniewicz et al., 20
(Nort 15 negPTB N/A (Rajalingam et al., 2000)  RR = 12.6; p = 0.02 
PTB TB cases = 57; 
Controls - 40 
TAP-A/F Indian (North) RR = 4.3; pc = 0.01 (Rajalingam et al., 1997)  
TNF Sicilian PTB p = 0.05 (Scola et al., 2003)  TB cases = 45; 
Controls = 100 
TB cases = 135; 
Controls = 430 
TNF (-308G; -238A) Colombian PTB OR = 1.8; OR = 2.2 (Correa et al., 2005)  
P T
 
OR = 2.5  0.00001 TNF -238 Gambian TB B cases = 206; 
Controls = 229
4; p = (Hill et al., 1996)  
Other candidate genes           
(Gadzhiev et al., 1987)BCHE (c erase)   holinest Russian PTB N/A RR = 6.92 
CCL18 (rs2015086; rs14304) Brazilian PTB 92 Pedigrees (627 
Ind) 
RR = 0.4; RR = 0.38 (Jamieson et al., 2004)  
CCL2 (-2518G) Mexi  (Flores-Villanueva et al., 2005) can PTB TB cases = 445; 
Controls = 334 
OR = 2.43; p = 0.0003 
CCL2 (-2518G) Korean PTB TB cases = 129; 
C  ontrols = 162
OR = 2.63; p = 0.0001 (Fl 005) 
B 9
ores-Villanueva et al., 2
CCL4 (rs1719144) razilian PTB 2 Pedigrees (627 
Ind) 
(Jamieson et al., 2004)  RR = 0.35; p = 0.002 
alawian HIVneg.  PTB 
TB cases = 196; 
Controls = 670 
(Fitness et al., 2004)CR1 (Q1022H) M OR = 3.12; p = 0.03   
ES  Tuvi ian ( 3)  D (Esterase) nian Russ PTB TB cases = 73; 
Controls = 251 
Matrakshin et al., 199N/A 
TB cases = 202; 
Controls = 267 
(Gao et al., 2000)  GT( N n) & D543 Japanese PTB OR = 2.07; p = 0.0003 
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Haptoglobin (2:2) Russian PTB 23; 
67 
Significantly Increased (Kharakter et al., 1990)  TB cases = 2
Controls = 5
29 
IFNG Caucasian Smear pos.  PTB 
TB cases = 113; 
Controls = 207 
(Lopez-Maderuelo et al., 
2003)  OR = 3.75; 0.0017 
IFNG South African 13; 
5 
OR = 1.64; p = 0.0055 (Rossouw et al., 2003)  PTB TB cases = 3
Controls = 23
TB cases = 45; IFNG (874 TT) Sicilian PTB p = 0.02 
Controls = 97 
(Lio et al., 2002) 
IFNG (874T/A) 85; 
 
OR = 2.24; p < 0.001 (Tso et al., 2005) Hong Kong Chinese PTB 
TB cases = 3
Controls = 451
TB  = 190; casesIFNG (874T/A) Colombian TB p = 0.01 
Controls = 135 
(Henao et al., 2006) 
IFNG (T/T 874) Croatian   
54; 
75 
OR = 3.12; p = 0.012 (Etokebe et al., 2006) Microscopy pos. TB
TB cases = 
Controls = 1
TB cases = 120; IFNGR1 Croatian PTB p = 0.02 
Controls = 87 
(Fraser et al., 2003)  
IFNGR1 (-611A, -56C) Caucasian TM &  B 
5; 
 
Increased in Cases; p = 0.004 & 0.03 (Rosenzweig et al., 2004) DNPT
TB cases = 5
Controls= 86
IFNGR1 (FA1 (CA)n) Croatian PTB TB cases = 244; 
Controls = 521 
OR = 0.24; p = 0.0023 (Bulat-Kardum et al., 2006) 
ian B  = 358; 
6 
 = 0.01 )  TB cases OR = 1.84; p (Delgado et al., 2002IL10 (-1082) Cambod PT
Controls = 10
HIVpos.  
PT
TB  = 155; casesIL10 (-1082) Malawian OR = 0.37; p = 0.007 B Controls = 541 
(Fitness et al., 2004)  
IL10 (-1082A) Sicilian PTB 5; 
0 
p = 0.05 (Scola et al., 2003)  TB cases = 4
Controls = 10
TB cases = 122; IL1B (+3953 TT/TC) Columbian PTB OR = 0.3; p = 0.001 
Controls = 166 
(Gomez et al., 2006) 
IL1B (-511C) Gambian TB  = 335; 
8 
OR = 0.58; p = 0.015 (Awomoyi et al., 2005)  casesPTB 
Controls = 29
TB cases = 404; IL1RA Gambian PTB OR = 0.46; p = 0.032 
Controls = 417 
(Bellamy et al., 1998)  
IL8 (-251A) Caucasian PTB 6; 
7 
OR = 3.41; p < 0.006 (Ma et al., 2003)  TB cases = 10
Controls = 10
 
CHAPTER ONE 
Candidate gene Population Phenotype Sample Size Reported Results Reference 
IL8 (-251A) African American PTB ; OR = 3.46; p < 0.01 (Ma et al., 2003)  TB cases = 180
Controls = 167 
(Hoal-van Helden et al., 
1999)  
 et al.
TB  TB cases = 91; 
Controls = 79 
MBP (B) South African p = 0.017 Meningitis 
MBP (B) African American OR = 0.34; p < 0.01 (El Sahly , 2004)  TB cases = 176; 
Controls = 71 
PTB 
TB  MBP (B; C) West African 626 Individuals r = 0.565; t = 2.273 In e cidenc (Mombo et al., 2003)  
MBP (B; C; D & X) PTB p = 0.03 (Soborg et al., 2003)  Danish TB cases = 59; 
Controls = 250 
MBP (B; C; D) Indian 
30 
PTB TB cases = 202; 
Controls = 109 
OR = 0.008  6.5; p = (Selvaraj , 1999) et al.   
MBP (C) Gambian PTB TB cases = 397; 
Controls = 422 
OR = 0.79; p = 0.037 (Bellamy et al., 1998)  
MBP (C) Malawian HIVpos.  TB cases = 154; 
Controls = 546 
OR = 0.034 PTB  1.69; p = (Fitness et al., 2004)  
NOS2A (-1026) Brazilian 9  PTB 2 Pedigrees (627
Ind) 
RR = 3.25; p = 0.021 (Jamieson et al., 2004)  
P2RX7 Gambian TB cases = 646; 
Controls = 694 
OR = 0.70; p = 0.003 (Li et al., 2002)  PTB 
TB cases = 204; 
Controls = ? 
N/A (Papiha et al., 1987)  PG e) M1 (*2+ allel South Indian PTB 
PGM1 (Phosphoglucomutase) Indian PTB Significant Difference N/A (Papiha et al., 1983)  
SLC11A1 (3’ UTR) Korean OR = 1.85; p = 0.02 (Ryu et al., 2000)  PTB TB cases = 192; 
Controls = 192 
SLC11A1 (CAAA+/del) Malawian HIV neg./pos.  T 9; B cases = 239/25Controls = 762 O  PTB R = 0.65; OR = 0.70 (Fitness et al., 2004)  
SLC11A1 (D2S424 (distal to
SLC11A1)) 
 Ca an 
 
L 1 (nadian Indi
1 Family (81 Ind)
OD = 3.81; p = 0.0000 Greenwood et al., 2000) PTB 
SLC11A1 (D5 TGTG+/del) 43N & Cambodian TB cases = 358; 
Controls = 106 
OR = 0.59; p = 0.02 (Delgado et al., 2002)   PTB 
TB cases = 110; 
Controls = 180 
OR = 1.93; OR = 2.22 (Liu et al., 2003)  SLC11A1 ( TG+/  D543N & TG del) Chinese Han PTB 
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SLC11A1 (D543N) Japanese in Cavitary Lesion TB 
TB cases = 95; 
Controls = 90 OR = 5.16 (Abe et al., 2003)  
31 
SLC11A1 (D543N; TGTG+/del) PTB TB cases = 120; Controls = 240 Chinese Han OR = 2.59; OR = 1.89 (Liu   
SLC11A1 (G TG+/del) 
 et al., 2004)
T(9) & TG South African PTB TB cases = 265; Controls = 224 p = 0.002 & p = 0.013 (Hoal et al., 2004)  
SLC11A1 (GT(n) &  
274C/T) 
Pediatric 
TB 184 Nuclear Families Houston (USA) p = 0.04 .01 & OR = 1.75; p = 0 (Malik et al., 2005)  
SLC11A1 (GT(n)) PTB TB cases = 329; Controls = 324 Gambian OR = 0.024 ( 1.40; p = Awomoyi et al., 2002)  
SLC11A1 (GT(n)) PTB TB cases = 135; Controls = 108 OR = 2.02 (Ma et al., 2002)  Caucasian US 
SLC11A1 (GT(n); INT4;  
/d) 
Smear pos. 
D543N & TGTG+ PTB 
TB cases = 410; 
Controls = 417 OR = 4.07; p < 0.001 (Bellamy et al., 1998)  Gambian 
SLC11A1 (INT4 & D543N) Severe Chinese TB 
TB cases = 127; 
Controls = 91 OR = 2.29; OR = 2.27 (Zhang , 2005)  
SLC11A1 (INT4 + D543N) Korean Lun ase 
 et al.
NTM 
g Dise
TB cases = 41; 
Controls = 50 OR = 10.88; p = 0.04 (Koh et al., 2005)  
SLC11A1 (INT4 C/C,  
D543N G/A) Peruvian 
TB cases = 507; 
Controls = 513 PTB OR = 1.72 & 1.40; p < 0.05 (Taype et al., 2006)  
NT4) y 44 d)   SLC11A1 (I Guinea-Conakr PTB  Families (160 In χ2 = 4.14; p = 0.036 (Cervino et al., 2000)
SLC11A1 (INT4) Danish Microscopy pos. TB cases = 104; Controls = 176 RR = 1.9; p 0.013 TB   = (Soborg et al., 2002)  
SLC11A1 (region) Brazilian 87 PTB 37 Pedigrees (2Ind) LOD = 0.51; p = 0.025 (Shaw et al., 1997)  
SLC11A1 (TGTG+/del) Chinese Han TB cases = 147; (Duan et al., 2003)  PTB χ2 = 7.79; p < 0.01 Controls = 145 
Republic of 
Guinea SP110 PTB 99 Families p < 0.015 (Tosh et al., 2006)  
SP110 Guinea-Bissau PTB 102 Families p = 0.002 (Tosh et al., 2006)
219 FamiliesSP110 Gambian PTB p < 0.02 (Tosh et al., 2006)
SP-A1 Mexican TB cases = 107; Controls = 101 (Floros et al., 2000)  PTB OR = 4.51, p = 0.008 
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SP-A1 (307A, 776T) Ethiopian 1  p < 0.019 (Malik et al., 2006)  PTB 8 6
TB cases) 
1 Pedigrees (22
Mexican PTB TB cases = 107; 
Controls = 102 
OR = 9.57, p = 0.38 (Floros et al., 2000)  SP-A2 
Ethiopian PTB 181 Pedigrees (226 
TB cases) 
p < 0.042 (Malik et al., 2006)  SP-A2 (355C, 751C) 
Indian PTB TB cases = 17; 
Controls = 19 
OR = 16.3; p< 0.001 (Madan et al., 2002)  SP- 9C) A2 (A1660G; G164
Mexican PTB TB cases = 107; 
Controls = 103 
OR = 2.36; OR = 0.12  (Floros et al., 2000) SP-B (B1012_A, AAGG_1) 
Brazilian PTB 92 Pedigrees (627 
Ind) 
RR = 0.36; p = 0.038 (Jamieson et al., 2004)  STAT5B (rs2230097) 
TLR2 (Arg753Gln) Turkish 1.60 - 6.04 Fold Increase (Ogus et al., 2004)  PTB TB cases = 151; 
Controls = 116 
PTB TB cases = 33; 
Controls = 33 
32 
TLR2 (C2029T) Tunisian p < 0.0001 (Ben Ali et al., 2004)  
African PTB χ2 = 4.17; p = 0.03 (Cervino et al., 2002)  UBE3A 180 Pedigrees 
Spinal  
TB 
TB cases = 64; 
Controls = 103 
VDR (BsmI; FokI) Indian OR = 2.2; OR = 2.4 (Selvaraj et al., 2004)  
VDR (ff) Gujarati Asian Extra-p lmonary OR = 2.8 (Wilkinson et al., 2000)  uTB 
TB cases = 52; 
Controls = 116 
Chinese Han PTB TB cases = 76; 
Controls = 171 
OR = 3.67 (Liu et al., 2003)  VDR (ff) 
T 0; 
 
OR 0.03 B cases = 12
Controls = 240
= 2.35; p = (Liu et al., 2004)  VDR (-ff) Chinese Han PTB 
W n est Africa PTB 382 Trios VDR smI;  (FokI; BApaI; TaqI) χ
2 =  0.009 22.11; p = ( 4)  
FokI) Treatment 
Bornman et al., 200
Peruvian TB  TB cases = 103; 
Controls = 206 
RR = 5.6; RR = 9.6 (Roth et al., 2004)  VDR (TaqI; 
TB cases = 408; (Bellamy et al., 1999)  VDR (tt) Gambian PTB OR = 0.53; p = 0.01 
Controls = 414 
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33 
Candidate Gene Population Phenotype Sample Size Reported Results Reference 
MHC Region (Class I, II & III) 
Aw30; Aw33; B7; B15; B17  Mexican PTB  TB cases = 100;  Controls = 100American    ns  (Cox et al., 1982) 
HLA-A, -B, -C  rn Indian       Northe PTB
TB cases = 124; 
Controls = 109 ns  (Singh et al., 1983) 
DR2  Northern Indian  PTB  TB cases = 124;  Controls = 109 ns ( ion)  after correct  (S
dian  B  (
ingh et al., 1983) 
HLA  In PT 21 Families  No Linkage  Singh et al., 1984) 
HLA-A & -B  Hong Kong  Chinese  
TB cases = 256;  
Controls = 100  PTB  ns  (Hawkins et al., 1988) 
DRB; DQA, DQB  South Indian  PTB  No association; No linkage  (Sanjeevi et al., 1992) 
TB cases = 38;  
Controls = 36;  
12 families  
TNF  Brazilian  PTB  37 pedi 87 Ind)  grees (2 LOD = 0.01  (Shaw et al., 1997) 
dian      TNF  Cambo PTB
TB cases = 126; 
Controls = 88 ns  (Goldfeld et al., 1998) 
HLA  Brazilian  PTB  98 nd)   Pedigrees (704 I ns  (Blackwell, 2001) 
TNF -238; -308  dian  B  ;  0  (SIn PT
TB cases = 210
Controls = 12 ns  elvaraj et al., 2001) 
LT  Indian  PTB  TB cases = 210;  Controls = 120  ns  (S
2; -856; -307  ian  ;    (
elvaraj et al., 2001) 
TNF -1030; -86 Cambod PTB  TB cases = 358Controls = 106 p > 0.05  Delgado et al., 2002) 
HLA -A; -B; -C  Italian  TB cases = 68;  Controls = 108Current TB  ns  9  (Ruggiero et al., 2004) 
TAP1  Korean  PTB  ;  ns  (Roh et al., 2004) TB cases = 219Controls = 210  
DQB1*0501  Iranian  TB cases = 40;  PTB  ns  Controls = 100  (Amirzargar et al., 2004) 
8; -376; -893)   PTB  
TB /144;  
  TNF (-238; -30 Malawian 
HIV neg./ 
pos. 
cases ~ 181
Controls = 417 ns  (Fitness et al., 2004) 
LTA (5' UTR m/sat)  Malawian  HIV neg./ pos. PTB 
T 7;  B cases = 198/23
Controls = 707  ns  (Fitness et al., 2004)  
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TB cases = 190;  TNF (-308)  Colombian  TB  ns  (Henao et al., 2006) Controls = 135  
34 
TAP1*0101; TAP2*0101  Columbian  PTB  TB cases = 122;  ntrols = 166  ns  (Go  et al. 06) mez , 20Co
Other Candidates: 
CCL3 (-906 promoter m/sat)  Malawian  HIV neg./ TB cases = 147/206;  pos. PTB  Controls = 580  ns  (  
C P TC n
(Flores-Villanueva et al., 
Fitness et al., 2004)
CL3 (-459)  Mexican  TB  B cases = 445;  ontrols = 518  s  2005) 
CCL5 (-471)  Mexican  PTB  TB cases = 445;  Controls = 518  ns  
(Flores-Villanueva et al., 
2005) 
CD14 Colu P TB C ((-159CT)  mbian  TB  
cases = 267;  
ontrols = 112  ns  Pacheco et al., 2004) 
CD14 (-159)  Polish  PTB  Not Given  Abstract Only  ns  
(Druszczynska et al., 
2006) 
Ca P TCCXCR1  ucasian US  TB  
B cases = 106;  
ontrols = 107  ns  (Ma et al., 2003) 
CXCR1  African American PTB  TB cases = 180;  Controls = 167  ns  (Ma et al., 2003) 
CXC Cau P T nR2  casian US  TB  B cases = 106;  Controls = 107  s  (Ma et al., 2003) 
CXCR2  African  American PTB  TB cases = 180;  (Ma et al., 2003) ns  Controls = 167  
Haptoglobin (HP)  Zimb P T  (abwean  TB  B cases = 98;  Controls = 98  p = 0.50 Kasvosve et al., 2000) 
ICAM1 (179A/T)  Malawian  HIV neg./ TB cases = 209/217;  pos. PTB  ontrols = 596  ns  C (  
IFN Japa TC  
Fitness et al., 2004)Fit4
A17 (551T/G)  nese  PTB  B cases = 114,  ontrols = 110  p = 0.155 (Akahoshi et al., 2004) 
IFNB (153C/T)  Japanese  TB cases = 114,  PTB  ontrols = 110  p = 0.137 C  (A ) 
IFNG Jap P TC  
kahoshi et al., 2004
 (1348T/A)  anese  TB  B cases = 114,  ontrols = 110  p = 0.55 (Akahoshi et al., 2004) 
IFNG (874T/A)  Malawian  HIV neg./ TB cases = 213/238;  Controls = 703  (Fitness et al., 2004) ns  pos. PTB  
IFNG Cr n ( (T874A, G2109A)  oatian  PTB  TB cases = 253;  Controls = 519  s  Etokebe et al., 2006) 
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IFNGR1  Gambian  PTB  TB cases = 297;  Controls = 285  ns  (  Awomoyi et al., 2004)
IFNGR1 (167T/C)  Japanese  TB cases = 114,  PTB  p = 0.213  Controls = 110  (Akahoshi et al., 2004) 
IFN 6)  Afri can GR1 (-611; -5 can Ameri PTB  TB cases = 76;  Controls = 114  (Rosenzweig et al., 2004) ns  
IFN 6)  GR1 (-611; -5 Caucasian  PTB  TB cases = 70;  Controls = 128  ns  (Rosenzweig et al., 2004) 
IFNGR1 (395)  Iranian  PTB  TB cases = 50;  Controls = 54  ns  (Mirsaeidi et al., 2006) 
IFNGR2 (839G/A)  J   apanese PTB  TB ,   cases = 114Controls = 110  p = 0.498  (Akahoshi et al., 2004) 
IkBL (T738C)  Columbian  PTB  TB cases = 122;  Controls = 166  ns  ( ) Gomez et al., 2006
IL10  Gambian  PTB  TB cases = 792;  Controls = 816  ns  (B ) 
(Lopez-Maderuelo et al., 
ellamy et al., 1998
IL10  Caucasian  PTB  TB cases = 113;  Controls = 207  ns  2003) 
IL12 - 3’ UTR  Russian  PTB  TB cases = 58;  Controls = 127  ns  (P ) uzyrev et al., 2002
IL12p40  Caucasian US  PTB  TB cases = 106;  Controls = 107  ns  (Ma et al., 2003) 
IL12p40  Afr an ican Americ PTB  TB cases = 180;  Controls = 167  ns  (Ma et al., 2003) 
IL12RB1 (641A/G)  Japanese  PTB  TB cases = 114,  Controls = 110  (Akahoshi et al., 2003) p = 0.610  
IL12RB 1196,  1 (+705, +1158, +
+1637, +1664)  Koreans  PTB  
TB cases = 115;  
Controls = 151  ns  (Lee et al., 2005) 
IL12RB2 (365C/T)  Japanese  PTB  TB cases = 114,  Controls = 110  p = 0.59  (Akahoshi et al., 2003) 
IL1RA  G   ujarati Asian PTB  TB cases = 89;  Controls = 114  ns  (  Wilkinson et al., 1999)
IL1RA  Indian  PTB  TB cases = 202;  Controls = 109  (Selvaraj et al., 2000) ns  
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TB cases = 358;   (Delgado , 2002) Χ2 = 3.27; p = 0.19  et al.IL1RA  Cambodian  PTB  Controls = 106  
TB cases = 89;  IL1beta  Gujarati Asian  PTB  ns  Controls = 114  (Wilkinson et al., 1999) 
IL1beta -511; +3953  Cambodian  PTB  p = 0.32 & 0.78  (Delgado et al., 2002) TB cases = 358;  Controls = 106  
TB cases = 35;  IL1RN  Gambian  PTB  ns  Controls = 298  (Awomoyi et al., 2005) 
IL6 (-174G/C)  Colombian  TB  ns  (Henao et al., 2006) TB cases = 190;  Controls = 135  
IL8 -251 & +781  Gambian  PTB  TB cases = 284;  Controls = 245  p = 42  0.50; p = 0. (Cooke et al., 2004) 
MBP (B; C; D)  Hispanic  PTB  TB cases = 198;  Controls = 46  ns  (El Sahly et al., 2004) 
36 
MB  D)  P (B; C; Caucasian  PTB  ns  (El Sahly et al., 2004) TB cases = 113;  Controls = 69  
TB cases = 176;  
Controls = 71  ns  (El Sahly et al., 2004) M D)  Afr an BP (C; ican Americ PTB  
MBP & 57)  (codons 52, 54 Polish  PTB  ns  (Druszczynska et al., 2006) 
Not Given  
Abstract Only  
M G  (Ni 4) MP-1 1G/2 Japanese  PTB  TB cases = 105;  Controls = 106  ns  nomiya et al., 200
NLI-IF  Caucasian US  PTB  TB cases = 94;  Controls = 145  p > 0.05  (Ma et al., 2002) 
NOD2  Gambian  PTB  TB cases = 320;  Controls = 320  ns  (Stockton et al., 2004) 
NOS2A (-954)  Mexican  PTB  (Flo l., res-Villanueva et aTB cases = 445;  Controls = 518  ns  2005) 
TB cases = 58;  SLC11A1  Russian (Slavic)  PTB  Controls = 127  ns  (Puzyrev et al., 2002) 
SLC11A1  Taiwanese  PTB  TB cases = 49;  Controls = 48  ns  (Liaw et al., 2002) 
SLC11A1  Moroccan  PTB  ns  (El Baghdadi et al., 2003)116 Pedigrees  
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SLC11 /A)   A1 (1703G Japanese  PTB  TB cases = 114,  Controls = 110  p = 0.144  (Akahoshi et al., 2004)
SLC11A1  Polish  PTB  TB cases = 85;  Controls = 93  ns  (Dubaniewicz et al., 2005)
 SLC11A1 (ATA(n))  Gambian  PTB  TB cases = 318;  Controls = 146  ns  (Awomoyi et al., 2006)
SLC11A1 (INT4)  Polish  PTB  Not Given  Abstract Only  ns  
(Druszczynska et al., 
2006) 
SLC11A2  South African  PTB  TB cases = 265;  Controls = 224  ns  (Hoal et al., 2004) 
SPP1 (2514C/T)  Japanese  PTB  TB cases = 114,  Controls = 110  p = 0.643  (Akahoshi et al., 2004) 
T  GFbeta1 (T869C) Japanese  PTB  TB cases = 101;  Controls = 110  ns  (Niimi et al., 2002) 
TGFbeta1  Colombian  TB  TB cases = 190;  Controls = 135  ns  (Henao et al., 2006) 
TLR t)   
T ;  2 (Int 2 m/sa Malawian  HIV neg./ pos. PTB 
B cases = 215/249
Controls = 742  ns  (Fitness et al., 2004) 
TL )  R2 (Arg677Trp; Arg753Gln Korean  NTM Lung Disease  
T   B cases = 80;
Controls = 84  ns  (Ryu et al., 2006) 
TLR4 (896A/G)  Malawian  HIV neg./ pos. PTB  
T ;  B cases = 162/120
Controls = 427  ns  (Fitness et al., 2004) 
TLR4  Gambian  PTB  TB cases = 307;  Controls = 298  Χ
2 = 1.00   0.19; p = ( 4) 
0)  W    
Newport et al., 200
TNFSF5 (CD4 est African PTB  121 Trios  ns  (Campbell et al., 2003)
VDR  Cambodian  PTB  TB cases = 358;  Controls = 106  (Delgado et al., 2002) Χ
2= 0.99; p = 0.60  
VDR ( )  
Malawian   
T ;  ns  (Fitness ., 2004) 
TaqI; ApaI; BsmI B cases ~212/225
Controls = 672   et al
HIV neg./ 
pos. PTB 
DNTM = ulous MDisseminated non-tuberc ycobacterial NTM = Non-Tuberculous Mycobacter
Ind = Ind     Ratio 
LOD = the odds    -value 
N/A = Not a     ry Tuberculosis 
ns = Not si
ial
ividuals  
Logarithm of 
  
  
OR = Odds 
pc = Corrected p
PTB = Pulmonavailable    
   risk  RR = Relativenificant g
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2.1 INTRODUCTION 
Sampling for human genetic studies begins by collecting samples from a predefined 
population.  Usually populations are subjectively defined based on their geographic 
location, cultural or other characteristic fea res and perceived racial information even 
ough it might not reflect their genetic makeup (Foster & Sharp, 2002).  Race and 
ethnicity are two very controversial concepts among the general public as well as scientists.  
Historically, geneticists have had one of two perspectives on these two concepts, one being 
the eugenics movement that believed in making use of scientific analysis to classify 
individuals biologically (Huxley, 1951)  and the other being the physical anthropology social 
movement that believed mainly in historical contributions and very little in biological 
contributions (Boas, 1942).  At present the differences between geneticists about these two 
contrasting perspectives still needs to be resolved. 
 
The word , was a 
product o uments 
against racial categorization, one: that rac  no biological basis (Editorial, 2001; 
Schwartz, 2001) and two: that there are racial ifferences but they are merely cosmetic and 
do not reflect any additional genetic distinctiveness (Wilson et al., 2001).  However, 
according to Risch (Risch et al., 2002) race is a key factor in genetic studies as it explains a 
tterns of variation provide a biological 
stification of the use of traditional racial categories (Race ethnicity and genetics working 
roup, 2005).  On the other hand Goldstein (Goldstein & Hirschhorn, 2004) argues that 
ce is meaningless and that the focus must shift from geographic ancestry to identifying 
ausal variants, as they would be likely to be informative across the world.  Individuals such 
 Schwartz and Goldstein believe there is only one race – the human race (Schwartz, 
001). 
ocial labels for different groups such as Chinese, African Americans and Yoruba can be 
ery misleading for genetic studies.  The Yoruba population is widely spread over West 
frica and includes other smaller groups, therefore labels such as these can mask 
gnificant intragroup variation (Foster & Sharp, 2002).  Of the genetic variation between 
dividuals, 90 to 95% occurs within human population groups whereas the remaining 5 to 
 
tu
th
 “race” derived from the Spanish word “raza”, meaning breed or stock
f the European era of exploration (Smedley, 1999).  There are two arg
e has
 d
portion of our genetic variation.  These pa
ju
g
ra
c
as
2
 
S
v
A
si
in
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10% occurs between population groups (Jorde et al., 2000; Lewontin, 1972; Rosenberg et 
al., 2002).  This variation has an influen e on the average differences in physical 
roduce a variety of results (Cardon & 
almer, 2003; Satten et al., 2001). 
cture that can induce false positives (Cardon & Palmer, 2003).  Usually it is assumed 
at in a study where a certain mutation is more frequent in the cases (affected individuals) 
c
characteristics, disease susceptibility and treatment outcome among different populations 
(Bamshad et al., 2003). 
 
2.1.1 Heterogeneity in association studies 
The most common approach used in genetic association studies is a case-control design.  
This approach needs to be carried out very carefully, since false-positive or negative 
associations might occur due to the absence of genetic homogeneity amongst the cases and 
controls  (Pritchard & Rosenberg, 1999; Wacholder et al., 2002).  Irrespective of the disease 
status, allele frequencies vary within and between populations, due to their unique genetic 
and historic background shaped by, amongst others, migration, non-random mating, 
genetic drift and stochastic variation that can p
P
 
Genetic heterogeneity may arise due to population substructure, which may be cryptic, or 
due to recent admixture (Ziv & Burchard, 2003).  If samples from diseased and healthy 
groups have different proportions of each ethnic group or, in the case of admixture, 
different percentages of ancestry from each ancestral subpopulation, they would be 
classified as stratified, whereas cases and controls that contain equal amounts of each 
ethnic group would not be stratified (Pritchard & Rosenberg, 1999).  Therefore population 
stratification, by definition, does not occur in homogenous populations (Wacholder et al., 
2002).  
 
One of the main reasons why case-control association studies are often not replicated, or 
produce inconsistent results, can be ascribed to population stratification or population 
substru
th
than controls (unaffected individuals), it is associated with disease susceptibility.  If a 
marker locus close to the causative mutation is in linkage disequilibrium with the mutation, 
differences in allele frequencies between cases and controls will also be detectable 
(Pritchard & Donnelly, 2001).  However in the presence of population stratification this 
approach would not be valid since high rates of “association” would be detected with 
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markers that are unlinked to the disease loci (Knowler et al., 1988; Lander & Schork, 1994; 
Pritchard & Donnelly, 2001).  
 
The contribution of different ancestries to individuals may vary tremendously in an 
mixed population.  For example, African Americans have different proportions of 
., 2001), Puerto Ricans have ± 30% African 
ciation studies, two circumstances must be met: 
pulation stratification can arise when the genetic background of cases and controls 
 different, it is important that both these groups should be sampled from the same place 
ad
African ancestry, but averaging 20% (Pfaff et al
ancestry and Mexicans have ± 9% African ancestry (Hanis et al., 1991).  Recent population 
admixture can mask or reverse the true genetic effects underlying a complex disease, 
therefore it is important that population admixture should be tested in an a association 
study to ensure that the results are not an artifact (Deng, 2001).  
 
“Cryptic population structure” can be defined as structure at a genetic level that is not well 
described according to ethnic or national labels (Pritchard et al., 2000).  For population 
stratification to affect genetic asso
 
1) Differences in disease prevalence between cases (affected) and controls 
(unaffected) must be present  
2) Variations in allele frequency must exist between groups (Wacholder et al., 
2000).  
The presence of just one of these criteria is not sufficient to cause population stratification 
(Cardon & Palmer, 2003).  
 
Since po
is
and that cases and controls should be carefully matched on their ethnic and genetic 
backgrounds (Cardon & Palmer, 2003; Reich & Goldstein, 2001).  Case-control association 
studies are valid tests for association, provided that the issue of population stratification is 
addressed (Pritchard & Rosenberg, 1999).   
 
2.1.2 Confounding 
Population structure may confound genetic association studies (Lander & Schork, 1994; 
Spielman et al., 1993).  The results of genetic association studies with unrelated individuals 
(cases and controls) may be confounded due to substructure or recent admixture present in 
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a population (Rosenberg et al., 2002).  This might lead to an excess of both false negative 
(non significant) or false positive (significant), also known as spurious association, results 
hakraborty & Smouse, 1988; Deng, 2001; Ziv & Burchard, 2003).  A false positive 
2; Ziv & Burchard, 2003).  
he main confounding factor in population stratification is ethnicity, which includes 
l., 2002).  
ion can be defined as the arbitrary transmission of genes from parent 
(C
association can be defined as an association between a marker locus and a phenotype when 
the marker is unlinked to any causal loci (Pritchard & Rosenberg, 1999).  False positives 
will be a more serious problem than false negatives, since setting the conventional 
significant P value at 0.05 would mean that out of a set of 1000 candidate alleles of which 
only 10 are truly causal, one would expect 50 false positives (1000 x 5%).  This number is 
considerably more than the actual 5 true positives (10 x 50%) in a study with 50% power.  
However, both are detrimental to research (Thomas & Witte, 200
T
underlying factors such as environment and cultural influences (Fig. 2.1).  However there 
might be explanations, other than population stratification, for false-positive reports in 
studies with unrelated controls (Table 2.1) (Wacholder et al., 2002). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Fig. 2.1. Classic confounding and population stratification.  In confounding, an exposure of interest 
correlated with the true risk factor but not truly causal of disease, can be misleadingly seen to be 
associated with risk of disease.  In population structure, as the genotype of interest is correlated 
with the true risk factor because both are correlated with ethnicity, it can be incorrectly regarded to 
be associated with risk of disease (Wacholder et a
 
  
 
Mendelian randomizat
to offspring that occurs during gamete formation and conception, therefore the way the 
phenotype and alleles co-segregate during transmission from parent to offspring (Davey 
Smith & Ebrahim, 2003).  Mendelian randomization relies on getting good estimates from 
 
   
 
   
   
Dotted unidirectional arrows   
Confounded association 
 Solid unidirectional arrows
 
  Direction of causal relationship
 
Broken bidirectional arrows   Non-causal correlation   
POPULATION STRATIFICATION
CONFOUNDING
Exposure of interest
isk factor DiseaseThe true r
Genotype of interest
DiseaseThe true risk factor
EthnicityEthnicity 
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genetic association studies.  Population stratification is of great importance as it could lead 
to confounded results when the gene-risk factor association and the gene-outcome 
association is studied in different populations (Lawlor et al., 2008). 
“The basic principle of Mendelian randomization is that genetic variants which mirror the biological effects 
of a modifiable environmental exposure and alter disease risk should be associated with disease risk to the 
extent predicted by their influence on exposure to the risk factor” (Davey Smith & Ebrahim, 2003; 
Davey Smith, 2006). 
The term Mendelian randomization was first used in assessing the efficiency of sibling 
bone marrow transplantations in the treatment of acute myeloid leukemia (AML).  This 
was done by comparing the outcome in patients with and without HLA-compatible siblings 
(Gray & Wheatley, 1991).   
Table 2.1.  Explanations, other than population stratification, for false-positive reports in studies 
he concern about population stratification started with the Pima Indian example 
nowler et al., 1988) where the genetic frequency of a Gm3,5,13,14 haplotype of the human 
munoglobulin G, was 75% and disease rate (type 2 diabetes) 15% in individuals of tribal 
lity, therefore any markers that were 
ver-represented in the Pima Indians compared to the Caucasians appeared to be 
 
with unrelated controls (Wacholder et al., 2002). 
. 
Alternative reasons for false-positives
e use of linic patients as cases and medical students as healthy controls
ow power
ommon polymorphism with low penetrance and low at
ultiple comparisons i.e. ubgroup analysis
nmeasured environmental factors
Th  c
L  
C
 
tributable risk
 sM
 U
 
T
(K
im
descent and 1% versus 60% respectively in those without any tribal ancestry.  A spurious 
association was reported for type II diabetes in Pima Indians, because those who had more 
Caucasian ancestry also had lower diabetes susceptibi
o
associated with the disease, in this case type II diabetes (Pritchard & Rosenberg, 1999; 
Thomas & Witte, 2002).  Other examples where population stratification gave false 
positives were with DRD2 and alcoholism (Blum et al., 1990), and CYP3A4 and prostate 
cancer among African-Americans (Kittles et al., 2002).  
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2.1.3 Genomic adjustment 
Where a group of unlinked markers is used, population stratification can be addressed by 
one of two model based methods or a non model-based (model-free) approach: 
1) Model-free genomic control (GC) approach uses an over-dispersion model to 
 proceed to an association study (Pritchard & Rosenberg, 1999). 
pproach
determine an empirical distribution (Bacanu et al., 2000; Devlin & Roeder, 1999; 
Reich & Goldstein, 2001).  
2) Model-based structure association approaches (SA) evaluate if stratification does 
exist and then
3) Model-based latent-class approaches (LCA) distinguish between homogenous 
subpopulations (Kim et al., 2001). 
 
2.1.3.1 Non-model based approach 
i) Genomic control (GC) a  
tion the null distribution of the χ  test for 
association will tend to shift toward elevated values leading to more false positives.  
The null distribution could be determined by using enough unlinked markers that 
are independent of the disease: this is called GC (Bacanu et al., 2000; Devlin & 
Roeder, 1999; Reich & Goldstein, 2001).  However a major drawback of this 
method is that large numbers of unlinked markers would be needed, which might 
be too expensive even with the new SNP technology, in order to obtain accurate 
results (Devlin et al., 2001).  This method is restricted to SNPs and it was estimated 
The genomic control (GC) approach makes use of the over-dispersion model.  In 
the presence of population stratifica 2
that 50 or more SNPs would be needed (Bacanu et al., 2000; Devlin & Roeder, 
1999).  The GC approach also assumes that the effect of population structure is 
constant over all loci (Devlin et al., 2001).  The genomic adjustment approach is 
simple calculation-wise and can deal with population stratification (Devlin & 
Roeder, 1999). 
 
2.1.3.2 Model based approach to population structure 
i) Structure association (SA) 
Another approach is a two-step process where the first step involves a panel of a 
few dozen markers to test for population stratification and the second step involves 
evaluating the candidate gene association only if homogeneity is not rejected while 
correcting for individual admixture (Pritchard & Rosenberg, 1999).  The drawback 
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of this method is that there are no guidelines on what to do if homogeneity is 
 (Pritchard et al., 2000).  Pritchard and his group 
s no 
ters) and the proportion of the genome of each 
individual that belongs to each K (Pritchard et al., 2000) and accommodates 
n 2.2).  A comparison between the GC and the SA 
2.2. 
 
ii) Late
rejected. 
 
Structure association (SA) was developed by Pritchard et al. (2000) with the 
principle that markers unlinked to the candidate genes must be used to infer 
subpopulation membership
proposed that the latent class approach would be able to control for population 
substructure.  The main assumption of the latent class model is that there i
confounding due to population substructure.  This Bayesian approach estimates the 
number of subpopulations K (clus
admixed populations (see sectio
approach can be seen in Table 
nt class approach (LCA) 
A novel latent-class model was introduced by Satten et al. (2001) to draw 
conclusions about the association between a candidate gene and a disease in a 
population where population stratification might be present. Satten et al. (2001) 
believed that this model-based approach outperformed that of Pritchard et al. for 
the following reasons: 
1) This is not a two-step approach to estimate structure 
2) The model is not conditional on the number of subpopulations 
3) A straightforward likelihood approach is used in this model and it does not  
    require a Gibbs sampler which is responsible for changing the number or  
    parameter in the model 
4) This model 
 
 
accounts for subpopulation structure between cases and controls 
     unlike Pritchard et al. (2000) that infer substructure without accounting for cases  
2.1.4 
Unlinke
(RFLPs), single nucleotide polymorphisms (SNPs)
these c
     and controls 
 
Markers 
d randomly selected markers such as restriction fragment length polymorphisms 
 or microsatellites, can be used to detect 
onfounding factors or correct for structure under the assumption that Hardy-
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Weinbe
2003).  It was suggested that microsatellites have more power than biallelic markers and at 
rst it was proposed that 15-20 unlinked microsatellites or ± 30 SNPs would be sufficient 
to detec
 
 
Table 2.2. C
approac
 
In orde ce of substructure in the SAC, the well described and 
publish
2000), w
 
2.2 STRUCTU
structure (Pritchard et al., 2000).  This algorithm, as applied in the program STRUCTURE, 
rg equilibrium exists within populations (Pritchard et al., 2000; Ziv & Burchard, 
fi
t population substructure (Pritchard & Rosenberg, 1999). 
omparison between the model-free genomic control approach (GC) and a model-based 
h using structured association (SA) as an example. 
e general approach, it corrects for 
ounding due to population substructure
e (Devlin et al., 2001)
els effect of confounding in a over -
ersion model (Devlin & Roeder, 1999)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Mor
conf
and admixtur
• Mod
disp
Genomic control (GC) Structured association (SA)
• Attempts to infer genetic ancestry for 
each individual sampled (Pritchard & 
Donnelly, 2001)   
• Models population substructure via latent 
 •
 
When the effect is ± constant across sub -  -
rful than 
SA (Pritchard & Donnelly, 2001) 
•
populations then GC is more powe
Attempts to eliminate spurious associations
 
variables (Pritchard et al., 2001)
• When the effect varies greatly across 
subpopulations then SA is more powerful 
than GC (Pritchard & Donnelly, 2001). 
• Attempts to eliminate spurious associations
• Assu tion structure
is co n et al.,
2001; Satten et al., 2001)
• Limi
• Primary source of confounding must be 
due to population substructure 
ust be powerful enough to
Limitations
mes that effect of popula
nstant over all loci (Devli
• Marker data m
ted to only binary markers infer number of subpopul
population
ations within the 
r to determine the presen
ed method (SA), using the program STRUCTURE (Pritchard, Stephens & Donnelly 
as chosen. 
RE 
 
The program STRUCTURE is based on a Bayesian model clustering algorithm that 
identifies subgroups with distinctive allele frequencies (Pritchard & Donnelly, 2001).  It 
makes use of unlinked randomly selected markers across the genome to infer population 
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available at (http://pritch.bsd.uchicago.edu) (Pritchard, Stephens & Donnelly 2000), puts 
individuals into different population clusters (K) each characterized by a different set of 
allele frequencies.  K is chosen in advance and the  posterior probability changes between 
independent runs with the same K and is inherent to the MCMC calculation (Kim et al., 
005b).  The admixture model can be exemplified by an individual that has a fraction of his 
ient of one across all the K clusters, 
hereafter t timates of these pr  (Kim et 
., fully us  d to 
ro ulated ; 
ritchard et al., 2000; Romualdi et al., 2002; Rosenberg et al., 2002; Wilson et al., 2001).  It 
as , 
K
Wh popu  
the group, then population structure is present (Pritchard & Donnelly, 2001).  The true 
value of K might often not be known but one should aim for the smallest value of K that 
 
should be treated with caution due to the following reasons: 
 estimates of ility of the 
genotypes given K, therefore a fairly a ho ill 
2) The posterior distribution of K is quite dependent on the priors and modeling 
assumptions in the Bayesian model-based clustering 
LATIONS 
2
genome from ancestors in a certain population (K).  All these fractions or membership of 
the K clusters must sum up to a membership coeffic
w he posterior average es oportions will be calculated
al 2005b).  This program was success ed in human studies where it was foun
 and real data (Bamshad et al., 2003p duce accurate clustering for both sim
P
h  also been used in dog studies (Parker et al. 2004). 
 
2.2.1 Problems with the interpretation f o  
en some individuals are assigned to one lation to a greater extent than the rest of
terpretation of the inferred value of Kcaptures major structure in the dataset.  The in
 
1) It is diff tain reliableicult to ob  Pr (XlK), which is the probab
d c procedure should be chosen that w
yield sensible results 
3) Biological interpretation can be difficult e.g. the clusters may not correspond with 
real populations and markers can be affected by gene flow (Pritchard et al., 2000).  
 
 
2.3 AFRICAN POPU
 
More than 2000 distinct ethnic groups exist on the African continent and these are largely 
responsible for the genetic diversity among the different African populations (Tishkoff & 
Williams, 2002).   
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Several studies done on mitochondrial DNA (mtDNA) and nuclear DNA confirmed that 
the African continent is home to the worlds most genetically diverse group  and that there 
is no single representative African population (Calafell et al., 1998; Hammer et al., 2001; 
Jorde et al., 2000; Relethford & Jorde, 1999; Stoneking et al., 1997; Tishkoff et al., 2000).  It 
is therefore suggested that Africa is the ancestral homeland of all modern humans.   
 
2.3.1 African origin of modern humans  
Information regarding the evolutionary history of the human race will enable us to 
understand patterns of variation and utilize these patterns in identifying alleles and 
genotypes that predispose individuals to a certain disease.  Archaeologically and genetically, 
the data supports a recent African origin (RAO).  This topic remains highly debatable, since 
three different models can explain the evolution of modern humans (Fig. 2.2) (Tishkoff & 
illiams, 2002).  The population history of Africa is a very complex system of population 
ene flow (Tishkoff & Williams, 2002). 
ig. 2.2 The recent African origin model, multiregional model and assimilation model to explain the 
2.3.2 South African population  
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Immigration from Africa, Europe and Asia to South Africa happened during the past three 
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people descended largely from British, German, French and Dutch immigrants.  The 
admixed population groups include the South African Coloureds and Asian people 
(Mountain, 2003; Nurse et al., 1985).  It was previously indicated that the San people were 
the first to have inhabited South Africa and evidence supporting this can be found in the 
fact that San people exhibit the most ancient mitochondrial DNA lineages (L1) (Tishkoff & 
illiams, 2002) and the most ancient Y-chromosome (Underhill et al., 2001).  The Indian 
e a hybrid population which originated from 
au geographical situation and turbulent history, 
W
population in South Africa is considered to b
different regions of the Indian subcontinent including South India, Gujerat and the Tamil 
community (Nurse et al., 1985).  The traditional distribution of these populations can be 
seen in Fig. 2.3, however due to large scale migration towards developed areas these 
traditional areas have become much less defined (Lombard et al., 2006).  The genetic 
diversity between different South African populations can clearly be seen in the different 
frequencies of the human leukocyte antigen (HLA) class I (Cao et al., 2004) and II alleles 
(Lombard et al., 2006) in the different population groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.3 The traditional distribution of the different population groups in South Africa (Adapted 
from Lombard et al., 2006). 
 
The population of South Africa, bec se of its 
is at present one of the most cosmopolitan in the world.  The amount of diversity within 
Africa has been recognized (Tishkoff & Williams, 2002), but South Africa was the 
destination of previously continentally divided groups, (Europe, Asia and the rest of Africa) 
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all of which added to the complex society of the present day.  The authorities during the 
apartheid era and the preceding colonial periods formalised and attempted to legislate the 
separation of ethnic groups in society.  A highly admixed population formed in the early 
days of Western Cape history, and subsequent restrictive practices had the effect of 
creating cohesion and moulding the mixed ancestry people into a group known today as 
the South African Coloured population (SAC) (Adhikari, 2005; Nurse et al., 1985; Van der 
Ross, 1993).  This is the official term used by Statistics South Africa in the 1996 and 2001 
national census (http://www.statssa.gov.za/census01/HTML/default.asp).  According to 
the census, the population of South Africa in 2001 consisted of 79.0% black African, 9.6% 
white, 8.9% Coloured, and 2.5% Indian or Asian, with Coloureds constituting 53.9% of the 
population of the Western Cape province. 
 
This unique and quintessentially South African population has suffered a great deal from 
marginalisation and stereotyping, under the old regime and the new (Adhikari, 2005).  The 
opulation has its roots in the indigenous Khoesan living in the area that is now Cape 
own and its surrounds at the time of the first colonization by European settlers of the 
utch East India Company (VOC) in 1652 (Mountain, 2003; Shell, 1994).  Although the 
hoekhoen (herders) and the San (hunter-gatherers) were originally distinct groups 
oonzaaier et al., 1996; Elphick, 1985; Mountain, 2003), the lines became blurred in the 
olonial era (Elphick, 1985; Mountain, 2003), and the term Khoesan is often used to 
enote both groups.  The VOC subsequently imported political exiles from the Dutch East 
ndies (Indonesia and Malaysia) (Mountain, 2004).  Other slaves, from many locations, 
ainly around the Indian Ocean (Nurse et al., 1985), including the Indian subcontinent 
5.9%), Africa, mainly the east coast (26.4%), Madagascar (25.1%) and Indonesia (22.7%) 
fly to provide farm labour.  This active slave trade began 
e seaborne slave trade in 1806, and the last 
ecorded illegal imports in 1822 (Shell, 1994).  In the early 1700’s, the slave population in 
omen in bot e slav  and free populations (Shell, 1994).  People brought in as slaves 
p
T
D
K
(B
c
d
I
m
(2
(Shell, 1994) were brought in chie
in 1658 and continued until the banning of th
r
the Cape regularly outnumbered the settlers (Mountain, 2003), and men outnumbered 
h th ew
would have been incorporated in the Coloured community after emancipation of the slaves 
in 1838 (Shell, 1994). 
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The Khoekhoen were not enslaved, but frequently served as indentured labourers or serfs 
on the farms (Mountain, 2003; Shell, 1994).  A small but significant number of women of 
Khoekhoe or slave descent and their children were integrated into the colonial household, 
often by marriage (Mountain, 2003; Shell, 1994).  The early Cape society was fairly open 
and mixed marriages were socially acceptable, usually between European men and women 
who were either Khoekhoen, manumitted (freed) slaves or of mixed parentage (Keegan, 
1996), and between Khoekhoen and slave (Mountain, 2003).  However, in the majority of 
cases, and particularly after 1700, the progeny of mixed marriages and liaisons were 
assimilated into the growing group known as the “Cape Coloureds” (Keegan, 1996; 
Mountain, 2003; Nurse et al., 1985), a term used since the mid nineteenth century (Keegan, 
1996).  These unions were more common in the farming areas (Mountain, 2003; Shell, 
994).  By the late 1700’s, racial restrictions were common, and these were formalised 
ticularly 1948-1994, the regulation of life according to perceived race 
ached its peak, with choice of marriage partners and place of residence determined by 
1
under the British administration from 1806 (Mountain, 2003), when class was more easily 
overcome in society than race and ancestry (Keegan, 1996). 
 
Several missionary stations were set up for the indigenous people, with the first at 
Genadendal in 1738 (Mountain, 2004).  The missionary influences amongst the aboriginal 
and Coloured people led to Christianization (Keegan, 1996), except among the small Cape 
Malay group that remained Muslim.  After the emancipation of the slaves by the British 
administration in 1834-1838, many indigent people and slaves that had left their owners, 
settled at these mission stations due to the availability of land and the prospect of living as 
free people in an established environment (Mountain, 2004). 
 
It is noteworthy that the mission stations set up among and for the Khoekhoen were 
subsequently found to be populated by people describing themselves as “Coloured” (Nurse 
et al., 1985), which was regarded as a more politically expedient designation (Nurse et al., 
1985).  Some mission stations formed the nucleus of a “coloured group area” according to 
legislation in 1950 (Boonzaaier et al., 1996; Mountain, 2003).  Many of the Khoesan had 
European or African (particularly Xhosa) ancestry (Keegan, 1996).  The formalisation of 
the racial order in society began in the late 1700’s and early 1800’s.  During the apartheid 
era from 1910 and par
re
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law.  Official segregation served to maintain the population make-up of the Coloured 
group.   
 
People designated as SAC, living in other parts of South Africa may well have slightly 
different proportions of ancestral admixture, due to different population dynamics, but the 
Western Cape is still home to the majority of the SAC population (61.1% according to the 
2001 census) and it is said that the Western Cape is the traditional centre of concentration 
of the Coloured people (Adhikari, 2005; Cilliers, 1963).  The popular perception of this 
population group is that it is made up of black, white and Khoesan contributions.  While a 
fair amount of genetic research has been done on the Bantu-speaking black ethnic groups 
of South Africa (Lombard et al., 2006; Nurse et al., 1985), the SAC group is under–
researched.  
 
We investigated a population that self-identifies as SAC, living predominantly in the 
burbs of Ravensmead and Uitsig in metropolitan Cape Town.  The population of 
ffiliation with Islam, and the 
roup is also known as the Cape Muslims (Mountain, 2004).  It is a minority group which 
structure can be described as the population being subdivided into different populations 
su
Ravensmead/Uitsig is 91% Christian, and only 1.5% Muslim (2001 SA census), which 
raises an important distinction with another group in South Africa known as the Cape 
Malays. This group has its origins in the political exiles brought from the Dutch East Indies 
(now mainly Indonesia) in the 1700’s (Mountain, 2004).  They brought the religion of Islam 
to South Africa, which served as a unifying force in the community and may have created a 
genetic subgroup. This group was not investigated here. The name “Malay” is at present 
often used by members of the group to denote chiefly the a
g
has not been incorporated into the core structure of the Coloured people (Nurse et al., 
1985). 
 
One aim of our study was to assess whether population substructure exists within the 
admixed SAC population from Ravensmead/Uitsig.  In order to do this, 209 unlinked 
randomly selected microsatellites were genotyped in 46 unrelated individuals with an 
unknown clinical status. 
 
A further aim was to investigate population structure in the SAC population.  Population 
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and to identify the actual subpopulations (ancestral populations) that exist.  Once the 
make-up of the study population is determined future studies such as admixture mapping 
an be performed.  A large genome-wide analysis was done, consisting of 959 individuals 
tion will provide valuable baseline data for subsequent analysis of disease 
sociation, and continent-wide genomic and population structure. 
rg, South Africa. 
ke and Adrian Hill from the University of Oxford) to test for 
opulation substructure in the SAC population.  These individuals were genotyped using a 
c
from the SAC group, genotyped with a panel of 500,000 single nucleotide polymorphism 
(SNP) markers, of which nearly 75,000 markers are shared with the International HapMap 
consortium (Frazer et al., 2007; The International HapMap Consortium, 2005) and Human 
Genome Diversity Project (HGDP) (Cann et al., 2002).  This is the first genome-wide 
investigation of this admixed South African population.  Whilst understanding the 
demographic history of the SAC population is of interest in its own right, it is anticipated 
that genome level studies will facilitate the identification of genes associated with complex 
diseases in this population. Therefore, characterizing the pattern of genetic variation in this 
study popula
as
 
2.4 MATERIALS AND METHODS 
2.4.1 Study population 
All the subjects used in this study originated from the Ravensmead and Uitsig suburbs near 
Tygerberg Hospital, Parow, Western Cape, South Africa.  Under the Group Areas Act of 
the apartheid government, the suburb of Ravensmead/Uitsig was declared an area for 
habitation by Coloureds only in 1962 and was rapidly settled.  Although this act has not 
been in force since a fully democratic government was elected in 1994, 98% of people in 
this suburb self-identified themselves as “Coloured” in the 2001 South African census.  
Informed consent was obtained from all study participants.  The study was approved by 
the Ethics Review Committee of the Faculty of Health Sciences, Stellenbosch University, 
Tygerbe
 
i) Population structure using microsatellite data 
Forty-six unrelated individuals of unknown clinical status from the Ravensmead-Uitsig 
community were genotyped for 209 unlinked randomly selected autosomal microsatellites 
(data from Graham Coo
p
commercially available set of microsatellite markers (LMSv2 MD10; Applied Biosystems, 
Foster City, CA) used for a genomewide linkage analysis (Cooke et al., 2008).  
53 
 
                                                                                                                 CHAPTER TWO 
 
ii) Population structure using SNP data 
An independent sample set consisting of 959 individuals (856 cases and 94 controls) from 
the SAC group residing in Ravensmead-Uitsig was genotyped with a panel of 500,000 
markers using the Affymetrix 500K SNP chip, of which nearly 75,000 markers could be 
used for comparison with those in the HGDP database. 
 
2.4.2 Population substructure   
All the microsatellites were in HWE and analyzed using STRUCTURE (version 2.2).  This 
program can be obtained from the website (http://pritch.bsd.uchicago.edu) (Pritchard, 
Stephens & Donnelly 2000).  The Pr (X|K) obtained in this study as well as guidelines on 
how to use STRUCTURE were obtained from the user manual set up by Pritchard, Wen & 
Falush, April 2007.  STRUCTURE is based on a Bayesian model clustering algorithm that 
identifies subgroups with distinctive allele frequencies (Pritchard & Donnelly, 2001).  It 
akes use of unlinked randomly selected markers across the genome to infer population 
ere 5 x 106.  These settings were used to run STRUCTURE for 
= 1-6 with 10 replicates per K. 
m
structure (Pritchard et al., 2000).  
 
When setting up STRUCTURE, preliminary runs were done using different models and 
parameters in order to determine the optimal parameter set to use.  The admixture model 
was used as a default in all parameter sets as the population is known to be admixed 
(section 2.3.2).  Both the allele frequency correlated and the allele frequency independent 
model was tested.  The parameter set used in this analysis was the admixture model 
together with the allele frequency independent model.  In the advanced parameter section 
we also included the print Q-hat option in order to see the estimated fraction of the 
individual’s genome that is assigned to each K cluster.  The burn-in period was 5 x 105 and 
the length burn in/reps w
K
 
The Pr (X|K) were calculated for K=1-4.  These values point out the probability that 
individuals will form part of a particular cluster based on their genotype data.  Note that K 
should be treated with caution due to reasons covered in section 2.2. 
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2.4.3 Population structure 
i) Sampling, genotyping and genotype calling 
All samples, and CEU controls from the International HapMap Project (Frazer et al., 2007; 
The International HapMap Consortium, 2005), were genotyped using the Affymetrix 500k 
SNP genotyping platform (http://www.affymetric.com) used in several studies.  SNP 
enotypes were called using the Affymetrix Power Tools pipeline (V1.10.0).  Firstly, 
STY concordance rate of less than 90% were discarded.  
g
samples that had a reported NSP/
The Dynamic Model (DM) algorithm's call-rate was used as an initial quality control 
measure. CEL files with a call-rate of 93% or higher were selected, and used to train probe 
specific models using the BRLMM algorithm 
(http://www.affymetrix.com/support/technical/whitepapers/brlmm_whitepaper.pdf).  
These models were then saved, and used to call all samples with STY and NSP CEL files 
DM call rate of 70% or higher.  All these SNPs were in HWE.  In addition to data 
generated in this study we obtained genome wide SNP data from two additional public data 
repositories, The International HapMap Project (Frazer et al., 2007; The International 
apMap Consortium, 2005) (http://www.hapmap.orgH ) and the Human Genome Diversity 
Project (Cann et al., 2002) (HGDP; http://hagsc.org/hgdp/files.html).  Populations were 
chosen from these public data sources to represent putative ancestral populations that may 
have contributed through admixture to the SAC population.  The populations chosen were 
representative of four major groups, namely 1) European, 2) non-Khoesan African 
(including Bantu and Pygmy populations), 3) Khoesan and 4) Asian (Table 2.3).  We 
reduced the SNPs genotyped in this study to a subset (n = 74,889) shared between SAC 
and the public data sources (Table 2.3). 
 
Population structure analyses were performed in order to identify the major genetic 
contributions to this uniquely admixed population.  We used STRUCTURE (Falush et al., 
003; Pritchard et al., 2000), which identifies population structure without prior assignment 
0).  The selection of 
ighly informative markers reduces the number of genotypes required for the accurate 
ference of ancestry.  Therefore, we selected SNPs from the set of shared markers (n = 
4,889) that were ancestry informative for the putative contributions to the SAC, and that 
2
of individuals to populations. STRUCTURE has an upper limit on the number of SNPs 
that can be analysed, and assumes both Hardy-Weinberg and complete linkage equilibrium 
between adjacent markers (Falush et al., 2003; Pritchard et al., 200
h
in
7
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were putatively unlinked.  W
Population Description n Source
CEU Utah residents with Northern and Western 
European ancestry from the CEPH collection
109 HapMap 3
LWK Luhya in Webuye, Kenya 83 HapMap 3
MKK Maasai in Kinyawe, Kenya 143 HapMap 3
YRI Yoruba in Ibadan, Nigeria 108 HapMap 3
BAN Bantu from Africa 19 HGDP
BPG Biaka Pygmies from Africa 21 HGDP
MAN Mandenka from Africa 22 HGDP
MPG Mbuti Pygmies from Africa 12 HGDP
SAN San from Africa 5 HGDP
CHB Han Chinese in Beijing, China 79 HapMap 3
GIH Gujarati Indians in Housto
Asian
European
African: non Khoesan
African: Khoesan
n, Texas 83 HapMap 3
PT Japanese in Tokyo, Japan 82 HapMap 3J
LAH Lahu from East Asia 8 HGDP
MEL Melanesian from Oceania 10 HGDP
PAP Papuan from Oceania 17 HGDP
 
Minimum inter-SNP 
distance
Number of SNPs
Random Not applicable 2500
Random (unlinked) 1 Mb 2431
AIMs Not applicable 2732
e used Rosenberg’s Ancestry Informative Markers (AIMs) 
003), yet taking potential linkage into account by 
 
 
selection method (Rosenberg et al., 2
selecting AIMs separated by a physical distance of at least 1MB.  Alternate marker selection 
strategies including random selection, random selection accounting for linkage 
disequilibium and AIMs not accounting for linkage disequilibrium were also tested (Table 
2.4). 
 
Table 2.3 Putative ancestral populations included in population structure analysis of South African 
Coloureds (SAC). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIMs (unlinked) 1 Mb 1121
 
 
 
 
 
Table 2.4 Alternate SNP marker selection strategies employed in the STRUCTURE analysis. 
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We first estimated the number of ancestral populations (K) in the combined SAC and 
public dataset listed in Table 2.3.  We used an admixture model with correlated allele 
frequencies.  Convergence of MCMC chains was assessed with five independent runs 
(burn-in = 1000, chain length = 2500) for each K between one and eight.  The number of 
ancestral subpopulations (K) was estimated as that which maximized the probability of the 
data, and minimized the variance in this probability over successive iterations (Pritchard et 
., 2000).  For each SNP subset we estimated the proportions of inferred ancestry for each 
proportions using DISTRUCT (Rosenberg, 2004).  A potential limitation in estimating 
proportions of ancestry for SAC in these analyses is that the admixture model used does 
not account for linkage disequilibrium due to admixture (Falush et al., 2003), known to 
occur in our study population (Nurse et al., 1985).  An alternate linkage model accoun or 
linkage disequilibrium due to admixture and has more accurate estimates of statistical 
uncertainty in admixed populations, yet has runtimes that scale exponentially with the 
number of ancestral subpopulations (Falush et al., 2003).  Therefore, we estimated ancestral 
proportions using the linkage model in STRUCTURE only for the optimal number of 
ancestral subpopulations identified in the previous analyses.  In this case, we used a larger 
sample of 10 000 SNPs since linkage due to admixture is incorporated into the model, but 
we still maintained a physical distance of at least 10 Kb between adjacent SNPs to limit the 
effect of background linkage disequilibrium.  This linkage model has the added benefit of 
estimating the average rate of decay of admixture linkage disequilibrium, and the time since 
admixture occurred.  Finally, we performed principal component analysis using 
SMARTPCA in the EIGENSOFT pakage (Patterson et al., 2006; Price et al., 2006) and 
included all SNP markers shared between the populations analyzed (n = 74889). 
 
 
2.5 RESULTS 
2.5.1 Population substructure 
or probability (P[KlX])a  for K=1 was 1 where K=2-4 was zero 
(Table 2.5).  Therefore the conclusion that can be drawn from this result is indicative of an 
absence of population structure in the South African Coloured population used in this 
study.  This can also be seen in the bar plots (Fig. 2.4).   
 
al
individual at the optimal number of ancestral populations (K), and plotted these 
ts f
In this study the posteri
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  Fig. 2.4 Bar plots for estimated membership from structure for K = 1- 6 obtained with the microsatellite data.  
h vertical line represents an individual on the X-axis while the Y-axis indicated the individual’s estimated Eac
membership fraction in the different clusters (K=1-6).   
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Each vertical line represents an individual and the six different colours are representative of 
the six different clusters (K=1-6).  These coloured segments represent the i
Posterior Probability
(P|K|X|)a
1 -34210.95
Total Sample
1.00
2 -34244.72 0.00
3 -34380.41 0.00
4 -34434.56 0.00
K In P (X|K)a
ndividual’s 
stimated membership fraction in the different clusters.  All the individuals are almost 
qually assigned to K=1–6.  The estimated posterior probabilities for K are only shown for 
also be zero. 
 
 
 
 
 
2.5.2 Population structure 
Genotype calling performance was determined by measuring concordance of the included 
HapMap cell line samples with the known genotypes of these individuals, and was found to 
be >99%.  Furthermore, four duplicate SAC samples were included in the SNP genotyping 
experiment, which allowed for validation of the genotype-calling algorithm on SAC 
samples.  Genotype concordance of these SAC samples was >97%. 
 
In the STRUCTURE analyses, including both SAC data and potential ancestral populations 
derived from public data sources; the number of populations was estimated as between 4 
and 7 (Fig. 2.5).  Datasets not accounting for putative linkage between SNPs provided 
higher estimates of K.  Although the estimate for the number of ancestral populations 
varied with each subset of SNPs, the inferred major contributions to the southern African 
coloured population were consistent (Figs. 2.6 - 2.9).  The four major contributions to SAC 
include Europeans, non-Khoesan Africans, Khoesan Africans and an Asian contribution.  
Of these, the Khoesan contribution is substantially the largest, followed by European, 
African and Asian (Table 2.6).  It is surprising that only a small sample of Khoesan 
individuals (n = 5) suggested such a substantial Khoesan contribution to the SAC 
population.  However, it is likely that a large sample of coloureds allowed for this 
a 
e
e
K=1-4 as the rest would 
 
Table 2.5 The estimated posterior probabilities for K in the South African Coloured samples. 
 
 
P (K | X) 
 
The probability that an individual will occupy a specific cluster given the genotype data 
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Asian African# Khoesan European
Admixture model 0.0892 ± 0.034 0.1966 ± 0.081 0.4334 ± 0.083 0.2808 ± 0.075
Linkage model  0.1082 ± 0.002 0.3593 ± 0.005 0.3230 ± 0.004 0.2095 ± 0.004
#non-Khoesan African
distinction, given that several individuals within the South African Coloureds have high 
proportions of Khoesan ancestry (Fig. 2.10).   
 
Estimates of the proportion of ancestry derived from the linkage model indicate the 
Khoesan contribution to SAC to be lower than in the admixture model (Table 2.6).  These 
differences are likely the result of Khoesan having approximately 30% shared ancestry with 
non-Khoesan African populations in the linkage model analysis (Fig. 2.11).  The European 
contribution is also substantially lower in the linkage model analysis (Table 2.6).  The 
linkage model also enabled the estimation of r  = 0.0001, the product of time (in 
generations) since admixture and the recombination rate (Falush et al., 2003).  Assuming 
recombination rates on the order of 10-5 per base pair per meiosis, the estimated time since 
admixture is 10 generations, broadly corresponding to 200 years (assuming generation time 
is 20 years).  Principal component analyses indicated that SAC span variation between 
Africans and non-Africans along the first eigenvector (Fig. 2.12) and eigenvector three 
pulled out the different African populations like San and Bantu.  The PCA results suggest 
that the ancestral Asian population that contributed to SAC is more closely related to the 
contemporary Gujarati Indian population, than to the Chinese (CHB) and Japanese (JPT) 
populations from HapMap 3 (Fig. 2.12), as also found recently (Tishkoff et al., 2009). 
 
 
Table 2.6  Mean and standard error on proportion of ancestry for each of four populations 
contributing to South African Coloureds (SAC), for admixture and linkage models. The unlinked 
AIMS were used for the admixture model.  Mean and standard errors are from multiple 
STRUCTURE analysis (n=5) with the number of ancestral populations (K) equal to 4.  
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Fig. 2.5  Estimates of the number of ancestral populations (K) for the SAC and combined HapMap 
and HGDP samples under an admixture model using the STRUCTURE software. The estimated 
probability of the data given the model is plotted against increasing K for each of the subsets of 
SNP data used (see Methods). 
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Fig. 2.9  Proportion of each individual’s ancestry for the number of ancestral populations from K = 2 to the estimated number of ancestral populations with 
greatest probability (Fig. 2.5C).  Plots shown are for linked Ancestry Informative Markers. 
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Fig. 2.10  Proportion of each individual’s ancestry (K = 4) sorted (in ascending order from left to right) by the proportion of ancestry for each of the major 
contributions to the SAC.  Khoisan red, African blue, Asian green and European grey. 
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Fig. 2.11 Proportion of each individual’s ancestry derived using the linkage model in STRUCTURE for the optimal number of ancestral populations (K = 4).  
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Fig. 2.12 Plot of the first four eigen vectors in the PCA an f SAC, HapMap 3 and HGDP 
populations selected as putative ancestral populations for t h African Coloured population.
alysis o
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2.6 DISCUSSION 
 
i) Population substructure 
 
The historical roots of the SAC populations are complex and diverse with contributions 
from various groups.  The genetic depth of this population is estimated at approximately 
10-15 generations which ties in with historical evidence that the population was founded 
between 150 and 350 years ago.  Since this population dates back more than 2 centuries 
and was kept separate by powerful social forces, one would expect that it should be 
relatively homogenous.  Our results finding no substructure in the population were 
congruent with those of Barreiro et al., (2006), who found no population stratification 
 
ii) Population structure 
Our results, and those recently reported (Tishkoff al., 2009), bear testament to the 
statement that the SAC population has the highest degree of intercontinental admixture of 
any global population (Tishkoff et al., 2009).  We have genotyped 959 individuals from the 
SAC population, and selected 75000 markers for population structure analyses.  We found 
that their genetic background agrees with the historical record and furthermore, reveals 
detailed insights into the events that resulted in the present-day SAC population.  We show 
that the SAC population group has 4 major ancestral components: the Khoesan, European, 
African and Asian (Indian), the proportions of which are dependent on the statistical 
model used in inference (Table 2.6).  Differences between the admixture and linkage model 
are to be expected since each accounts for different components of linkage disequilibrium. 
The admixture model ignores linkage disequilibrium along chromosomes as a result of 
admixture, whereas the linkage model does not (Falu ., 2003), and thus the latter is a 
better approximation of the population history of SAC. Nonetheless, the inferred ancestry 
proportions indicate a substantial contribution from the Khoesan, and considerable 
variation in ancestry proportions between individuals (Fig. 2.6, 2.10).  The degree of 
Khoesan ancestry reflects the role of indigenous Khoesan in the early establishment of the 
SAC population (Mountain, 2003).  It could be argued that the rather small Khoesan 
sample size contributes to uncertainty with respect to estimating ancestral proportions.  
However, these results are consistent with an independent study with a slightly larger 
population of Khoesan (Tishkoff et al., 2009).  Some authors have proposed that the 
Khoesan people in South Africa are becoming extinct (Mountain, 2003).  The San in 
particular endured bouts of genocide from all other groups (Mountain, 2003; Shell, 1994), 
 et 
sh et al
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and the Khoekhoe society had collapsed completely by 1713 (Elphick, 1985), the time of a 
devastating smallpox epidemic (Nurse et al., 1985).  Although many members of the 
Khoesan existed on the fringes of colonial society (Mountain, 2003), many others, 
particularly the women, were part of the household of the pioneer farmers, in the 
patriarchal or paternalistic societal system that had elements of slavery, indentured labour 
and authoritarian family life (Shell, 1994).  Often Khoekhoe men were bonded labourers 
on the farms (Keegan, 1996; Shell, 1994) and integrated into western society (Elphick, 
1985).  The putative near extinction of the Khoisan, however, is not apparent from our 
results; given that some SAC individuals harbour large proportions of Khoesan ancestry 
(Fig. 2.6, 2.10), and assuming the HGDP Khoesan population is a sufficiently pure source 
of ancestral Khoesan diversity.  
 
In addition to the strong Khoesan contribution to SAC, a large proportion of their ancestry 
is derived from non-Khoesan Africans (Fig. 2.6), in particular Bantu-speaking populations.  
Although we did not have samples for southern African Bantu, these groups are 
themselves admixed with the Khoesan (Nurse et al., 1985; Thorp, 2000; Tishkoff et al., 
2009), which is evidenced by click consonants in the Xhosa language (Tishkoff et al., 2009).  
Furthermore, substantial input from the European settlers (Dutch, German, British and 
French), and a smaller contribution from Asia is evident in the SAC (Fig. 2.6).  This Asian 
contribution may be consistent with 26% of imported slaves originating from East India, 
mainly Bengal (Shell, 1994), and the apparent shared ancestry between East Asians and 
Gujarati Indians (Fig. 2.6).  The use of HGDP Gujarati Indians as a proxy for the Indian 
populations that were the actual ancestral populations in the SAC is supported by the 
genetic homogeneity of Gujarati and Bengali populations (Tishkoff et al., 2009).  One 
analysis we performed, which included a random subset of SNPs, did detect the Gujarati 
Indian contribution to SAC (Fig. 2.8), however, we suspect this result may be influenced by 
the larger proportion of linked SNPs in that analysis, and the inability of STRUCTURE to 
account for background linkage disequilibrium.  Nonetheless, the Indian contribution to 
SAC is supported by PCA analysis of all 75000 markers (Fig. 2.12).  Low levels of ancestry 
from East Asia (CHB/JPT in HapMap) may be ascribed partly to the Chinese who formed 
part of the free blacks (Keegan, 1996), a group forming 9% of the Cape Town population 
by 1821 (Shell, 1994).  “Free blacks” were free persons not of European origin, and 
comprised manumitted slaves, a few political exiles, and several hundred Chinese convicts 
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(Mountain, 2004; Shell, 1994).  Interestingly, apart from the predominant European 
component, Chinese, Indian and Cape-born slaves have also been found to contribute to 
the Afrikaner population (Greeff, 2007; Heese, 1971). 
 
The 959 individuals investigated in our study show a greater proportion of Khoesan 
ancestry and lower proportion of both European and Indian ancestry than the 39 
individuals genotyped by Tishkoff et al., 2009, who showed approximately equal ancestries 
of Khoesan, European, black African and Indian (19-25% each).  It is possible that this 
group of 39 contained a reasonable proportion of people from the Cape Malay group, who 
could be expected to have a genetic makeup higher in Indian and lower in Khoesan 
ancestry, due to greater Indonesian or Malaysian ancestry.  The samples used by Tishkoff et 
al., 2009 were collected from blood donors in the Western Cape (MJ Kotze, personal 
communication), and not from a specific area.  An early study of blood group gene 
frequencies in Cape Town found similar ancestral contributions from European, black and 
Asian, but the criteria for inclusion were not clear (Botha, 1972).  
 
The resolution of inferred ancestral contributions could certainly be improved with the 
addition of both more suitable ancestral population samples from Malaysia and Indonesia, 
and with a larger sample of San.  It is encouraging that the genotype results concur with the 
historical record, but in addition provide quantitative information of the extent of the 
contribution of putative ancestral groups, not obtainable by conventional historical 
research. 
 
In addition to the results presented here being of historical anthropological interest, the 
inferred ancestral contributions are highly relevant for mapping of disease genes.  The SAC 
population in the Western Cape suffers from one of the highest incident rates of 
tuberculosis (TB) ever recorded (Kritzinger et al., 2009), and thus knowledge of their 
population structure, and ancestry, is critical to disease-gene mapping.  One approach for 
the genome-wide identification of genetic risk factors is admixture mapping (McKeigue, 
1997; Montana & Pritchard, 2004; Seldin, 2007; Zhu et al., 2006; Zhu et al., 2008).  The 
ect for mapping of disease genes in complex admixed populations SAC are an excellent subj
since their ancestral populations have substantially different rates of TB infection and 
disease (Stead et al., 1990).  An essential requirement for admixture mapping is the 
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oportions of the populations involved.  Thus the results reported 
re stigation of the impact of admixture on TB susceptibility, and 
otentially explain the apparent high vulnerability of this population to disease.  
port, 
i ika and Ayton Meintjes (UCT) for analysing the 500k SNP chip 
elucidation of ancestral pr
he  will enable the inve
p
Furthermore, given the high number of private alleles found in this population (Tishkoff et 
al., 2009), novel TB susceptibility alleles could be identified. 
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3.1 INTRODUCTION 
 
Eight genes, previously indicated to play an important role in TB susceptibility, were 
hosen as candidate genes for this study and will be discussed in this chapter.   
in Cape Town, Western 
ape, South Africa where the incidence of TB has been reported as up to ± 1000 per 100 
ment has previously been investigated in the SAC population by using 25 
nlinked SNP markers (Barreiro et al., 2006) and by a more in-depth investigation in this 
c
 
The polymorphisms in these genes include a three SNP haplotype in mannose-binding 
lectin (MBL) at codons 52 (Arg-Cys), 54 (Gly-Asp) and 57 (Gly-Glu) in exon 1, natural 
resistance-associated macrophage protein (NRAMP1) (GT)n repeat, NRAMP1 (TGTG) 
deletion, interleukin-1 receptor antagonist (IL-1Ra) (86 bp VNTR), the C-C chemokine 
regulated upon activation, normal T-cell expressed and secreted (RANTES) also known as 
CCL5 that is a ligand for chemokine receptor 5 (-403A/G), interferon-gamma (IFN-γ) 
(+874 T/A), interleukin 8 (IL-8) (+100 C/T), surfactant protein D (SP-D) (Met11Thr) and 
interferon-gamma receptor 1 (IFNGR1) (1050 T/G). 
 
Samples were collected from the suburb of Ravensmead-Uitsig 
C
000 population together with a low HIV prevalence (Munch et al., 2003).  The study 
population, known as the South African Coloureds (SAC), has a unique mixed ancestry 
dating back over 300 years, and consist of different ancestral population groups such as the 
European Caucasoid, Asian, Khoi, San and Black Africans (Nurse et al. 1985).  Since the 
admixture occurred several generations ago the population should be relative homogenous.  
This state
u
study where no significant substructure was observed (see chapter 2). 
  
Blood samples were collected with ethics approval from the Ethics Committee of the 
Faculty of Health Sciences, Stellenbosch University, South Africa whereafter DNA was 
extracted using standard methods.  This was a case-control study design in which all the 
cases (n=505) had culture proven TB and all the controls (n=318) had never been 
diagnosed with TB before although they were presumably exposed to the mycobacterium 
as they were in close contact with other TB patients in the same community.  The sample 
sizes for these association studies were determined by power calculations.  Tuberculous 
meningitis (TBM) cases (n=50) were included as an extreme phenotype and also as an 
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.1.1 Surfactant protein D (SP-D) 
he gene encoding the collectin surfactant protein D (SP-D) is located on chromosome 
ns (Fig. 3.1).  SP-D participates in the pulmonary 
P-D consists of 12 polypeptide chains of 43 kDa.  The single peptide is composed of an 
H2-terminal, a collagen region, a coiled-coil neck region and a C-type lectin carbohydrate 
cognition domain (CRD) (Crouch & Wright, 2001; Leth-Larsen et al., 2005).  SP-D binds 
 M. tuberculosis in a manner consistent with an interaction between the CRD of the 
rotein and the surface of the bacterium (Ferguson et al., 2002).  The main function of SP-
 is thought to be the agglutination of bacteria as it binds to M. tuberculosis, but it is 
nknown whether bacterial agglutination promotes uptake into the host cell or whether the 
glutinated M. tuberculosis are cleared. Therefore SP-D may be either a protective or risk 
ctor for M. tuberculosis infection (Ferguson et al., 1999).  SP-D has been used as a 
biomarker for pulmonary disease states as it is present on the extrapulmonary epithelial 
surfaces and in serum (Sørensen et al., 2006). 
 
Polymorphisms in SP-D have previously been associated with several diseases (Diangelo et 
al., 1999).  Recent studies in children indicated that serum SP-D concentrations are 
genetically determined and that the (Met11Thr) SNP, localized in the amino-terminal 
region of the protein, is significantly associated with serum SP-D levels (Sørensen et al., 
Fi
association has previously been found in the SAC population (Hoal-van Helden et al., 
1999).  All the participants were unrelated, HIV negative and the cases formed part of the 
bigger cohort discussed in Chapter 2.  Some but not all of the controls were also part of the 
samples discussed in Chapter 2. 
 
3
T
10q22.2-23.1 and consists of seven exo
innate immune response by opsonization or lysis of inhaled pulmonary pathogens and 
interaction with the macrophage cell surface molecules to modulate phagocytosis of 
Mycobacterim tuberculosis (Ferguson et al., 2002; Gardai et al., 2003; Wu et al., 2003).   
 
 
 
Met11Thr  
(rs721917) 
1 2 3 4 5 6 7  5’  3’ 
 
. 3.1 SP-Dg  and the polymorphism investigated in this study. 
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2006).  The Met11Thr SNP (dbSNP rs721917) is one of the most important SNPs in SP-D 
as it alters the codon corresponding to amino acid 11 where a Methionine (Met) is 
exchanged for a Threonine (Thr).  This SNP has been implicated in TB in a Mexican 
population where individuals with the Thr va nt are more susceptible to TB (Floros et al., 
2000).  This study aimed to determine whether a correlation exists between this 
polymorphism (Met11Thr) and susceptibility to TB in the South African Coloured 
population. 
 
 
ria
3.1.2 Mannose binding lectin (MBL) 
Mannose binding lectin (MBL), also known in the past as mannan-binding protein (MBP) 
is a C-type lectin in the lectin pathway which plays a major role in the pulmonary innate 
immune system (Ji et al., 2005).   
 
MBL is a identical 
polypeptide chains that c neck region and a 
carbohydrate-recognition domain , 2003).  Microbial 
carbohydrate structures are recognized by pa ogen associated molecular pattern (PAMP) 
receptors such as MBL (Buzás et al., 2006).  MBL plays an important role in the modulation 
of inflammation as it binds to the pathogen to initiate the lectin pathway which acts as the 
st line of defense against microbes (Holmskov et al., 2003; Turner et al., 2003).   
 multimeric molecule made up of six subunits each consisting of three 
 contain a collagen-like region, hydrophobi
 (CRD) (Fig. 3.2) (Presanis et al.
th
fir
 
 
 
 
 
 
 
 
 
 
 
 
M
                       
N-terminus cross-
linking region 
Collagen-like
region 
Neck
region 
Carbohydrate 
recognition domain 
(CRD) 
ultimeric 
olypeptide 
Oligomer of 6 
ubunits 
tructural subunit 
of 3 identical 
olypeptide 
Fig. 3.2 
p
s
S
p
chains 
The structure of MBL.  Adapted from (Turner & Hamvas, 2000)
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The exact mechanisms whereby MBL modulates inflammation are not well-known but it 
as been proposed that MBL exerts a complex effect on cytokine release by monocytes 
 et al., 2000).  It has become evident 
at MBL plays a multifaceted role in many diseases and a deficiency of the protein has 
h
(Jack et al., 2001).  Phagocytes represent the first cellular defense in the alveoli of which the 
surface is rich in C-type lectin pattern recognition receptors.   
 
The gene encoding the collectin mannose-binding lectin (MBL) maps to chromosome 
10q11.2-q21 and consists of 4 exons (Fig. 3.3).  Four allelic forms resulting in three SNPs 
within the collagen-like region of MBL exon 1 have been described.  The A allele = 
wildtype, B allele = SNP within codon 54 (Gly → Asp), C allele = SNP within codon 57 
(Gly → Glu) and D allele = SNP in codon 52 (Arg → Cys) (Lipscombe et al., 1992; 
Madsen et al., 1994; Sumiya et al., 1991).  These polymorphisms disrupt the assembly of the 
MBL peptide trimers or accelerate MBL degradation, resulting in profoundly reduced 
serum levels of functional polymeric MBL (Mullighan
th
been associated with increased susceptibility to some infectious diseases (Summerfield et al., 
1997).  Equivocal results have been found in the case of TB (Bellamy et al., 1998; Selvaraj et 
al., 1999), where promoting the uptake of bacteria into macrophages may be advantageous 
to the bacterium, and the variant alleles have been associated with protection against TB in 
Denmark (Soborg et al., 2003), Turkey (Cosar et al., 2008) and particularly tuberculous 
meningitis (TBM) in South Africa (Hoal-van Helden et al., 1999). 
. 
 
 
 rs5030737 (codon 52) rs1800450 (codon 54) 
 
 
 
 
 
 
3.1.3 Interferon-gamma (IFN-γ) and Interferon-gamma receptor 1 (IFNGR1) 
The interferon-gamma (IFN-γ) pathway is one of the most researched in TB since it is a 
flagship Th1 cytokine and plays a vital role in the protective immune response against M. 
Fig. 3.3 MBL and the polymorphisms investigated in this study.
1 2 3 4 5’  3’ 
rs1800451 (codon 57) 
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tuberculosis infection (Vidyarani et al., 2006).  IFN-γ is mainly secreted by CD4+ T cells, 
CD8+ T cells, natural killer (NK) cells and macrophages.  The functional IFN-γ and 
IFNGR form a complex essential for containing the growth of M. tuberculosis (Dorman et 
al., 2004).  A previous study showed that defects in either of these two genes influence the 
roduction of IFN-γ and signaling and therefore individuals were more prone to 
 Abel, 2002; Ottenhoff et al., 1998). 
IFNGR1) regarding exons and introns can be seen in Fig. 3.4.  
dy (Rossouw et al., 2003).  A meta-analysis 
erformed on this particular SNP indicated a significant protection conferred by the T 
p
mycobacterial infections (Casanova &
 
Several polymorphisms have been indentified in IFN-γ and in the α and β chains of the 
IFN-γ receptor (IFNGR) gene, that were mapped to chromosome 12 and 6 respectively 
(Papanicolaou et al., 1997; Zimonjic et al., 1995). The structure of these two genes (IFN-γ 
and 
 
 
rs2430561 (+874 A/T) A 
 2 31 4 5’  3’ 
 
 
B 
 
 
 
 
 
 
One of the most studied polymorphisms in IFNG is located in the first intron (+874 T/A) 
and has been associated with TB susceptibility in several populations such as Spanish 
(Lopez-Maderuelo et al., 2003), Chinese (Tso et al., 2005) and South African, where it was 
found in both a case-control and TDT stu
rs11914 (1050 T/G) 
1 2 3 7 5’  3’ 4 5 6
Fig. 3.4 [A] IFN-γ and [B] IFNGR1 and the polymorphisms investigated in this study. 
p
allele, to TB in 12 different population groups (Pacheco et al., 2008).  The +874 T allele 
provides a binding site for nuclear factor-κB, the transcription factor that induces IFN-γ 
expression, and the +874 AA genotype was predictive of a lower likelihood of sputum 
conversion in Japanese patients (Shibasaki et al., 2009). 
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Most of the polymorphisms identified in the IFNGR1 gene in patients with Mendelian 
susceptibility to mycobacterial infections, result in either a complete absence of protein 
expression or the expression of an abnormal protein that does not bind IFN-y.  If IFN-γ 
signaling is completely abolished, the effects for the patient will be detrimental (Awomoyi et 
al., 2004).  It is therefore clear that the receptor complex plays a crucial role in the IFN-γ 
pathway.  The SNP investigated in this study, previously shown to be associated with TB 
susceptibility in the South African Coloured population, is located in exon 7 (rs11914 1050 
/G). 
African Coloured population. 
cytes to 
flammatory sites.   
 tuberculosis patients, increased levels of IL-8 have been reported in the bronchoalveolar 
vage fluid (BAL dates or cerebrospinal fluid compared to the controls 
bula et al., 2008; et al., 1997; Mastroianni et al., 1994; Sadek et al., 1998).  In 
dition, other studies also showed increased IL-8 plasma concentration levels in patients 
se who survived (Friedland et al., 1995; Pace et al., 
999) and in vivo, as the anti-IL-8 antibodies were found to inhibit granuloma formation in 
bbits (Larsen et al., 1995). 
immune system as a chemoattractant, variants 
IL-8 may predispose individuals to infection (Hull et al., 2000).  IL-8 consists of 4 exons 
at chromosome position 4q12-q21 (Modi et al., 1990).  Several genetic 
T
 
This study aimed to determine whether a correlation existed between the IFN-γ rs2430561 
(+874 T/A) polymorphism, the IFNGR1 rs11914 (1050 T/G) polymorphism and 
susceptibility to TB in the South 
 
3.1.4 Interleukin 8 (IL-8) 
An effective response by the host during M. tuberculosis infection in the lung is the 
recruitment and activation of inflammatory cells to the lung through chemokine activity.  
Interleukin 8 (IL-8) is a tissue-derived peptide and one of the major 13 human CXC 
chemokines that is secreted by several cell types, such as leukocytes and airway epithelial 
cells, in response to inflammatory stimuli such as M. tuberculosis (Ma et al., 2003).  It 
functions as a neutrophil chemoattractant for the recruitment of leuko
in
 
In
la F), pleural exu
Dlugovitzky (A
ad
who died from TB compared to tho
1
ra
 
Due to the major role that IL-8 plays in the 
in 
and is located 
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polymorphisms (90) have been identified in this gene (Fig. 3.5).  An important IL-8 
promoter variant, -251 A/T (rs4073), has been associated with susceptibility to TB in 
racially mixed American populations (Ma et al., 2003).  However this association was not 
replicated in either the Gambian population (Cooke et al., 2004) or our South African 
oloured population (unpublished data).  In a pilot study previously conducted in the SAC 
CCR5, consists of three 
ons and is located on chromosome 17q11.2 –q12 (Fig. 3.6) in the chemokine cluster 
gion that has been shown to be important in susceptibility to TB (Jamieson et al., 2004). 
 of a group of chemoattractant molecules 
C
population a more unfamiliar SNP, +100 C/T (rs2227538), located 1 base pair upstream 
from the ATG start codon showed a trend of significant association with TB (unpublished 
data).  Therefore this study focused on this particular SNP. 
 
 
 
 
 
 
 
3.1.5 Regulated upon Activation, Normal T-cell Expressed and Secreted chemokine 
(RANTES), also known as CCL5 
The gene encoding the chemokine Regulated upon Activation, Normal T-cell Expressed 
and Secreted (RANTES), also known as CCL5 and the ligand 
Fig. 3.5 I
1 2 3 4
+100C/T  
(rs2227538) 
5’  3’ 3 UTR 
L-8 and the polymorphism (+100 C/T) investigated in this study.
ex
re
 
 rs2107538 (-403 A/G) 
 
 1 2 3 3’ 5’  
 
 Fig. 3.6 RANTES and the polymorphism investigated in this study.
 
RANTES is a potent chemokine that forms part
that functions in the development of protective TB granulomas (Roach et al., 2002).  It 
recruits several types of inflammatory cells including monocytes and T lymphocytes, 
induces a Th1 response, is expressed in T-cells, lymphocytes and macrophages and is 
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induced after M. tuberculosis infection (Simeoni et al., 2004).  RANTES plays a major role in 
the three-step model of inflammation as described by Butcher and Springer (Fig. 3.7) 
(Butcher & Picker, 1996; Springer, 1995). 
 
 
 Immune cell
G protein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In tuberculosis patients, an increased level of RANTES has been found in bronchoalveolar 
lavage fluid and in lung alveoli during active pulmonary tuberculosis (Sadek et al., 1998). 
The promoter region of the gene has been extensively screened for genetic variants because 
of its suspected importance in protein expression (Azzawi et al., 2001; Gonzalez et al., 2001; 
Liu et al., 1999; Nickel et al., 2000).  The three most frequent SNPs that were found in this 
RANTES
Glycosaminoglycan
Serpentine receptor
Endothelial cell
RANTES 
G
Fig. 3.7 RANTES attracts inflammatory cells from the bloodstream to the site of infection.  
eukocytes roll along the endothelium via interactions with selectins.  Upon inflammation, 
acrophages in the bloodstream release interleukin-1 (IL-1) and tumour necrosis factor (TNF) 
L
m
which in turn promotes the release of chemokines (including RANTES).  The various cell types 
follow the chemotactic gradient to the infection site.  In addition RANTES binds to 
glycoaminoglycans (GAG) on the endothelial cell surface.  Once the T lymphocytes reach the 
injury site they produce large amount of RANTES.  Adapted from (Krensky & Ahn, 2007). 
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region include -403 A/G (rs2107538), -109 T/C (rs1800825) and -28 C/G (rs2280788).  It 
has been hypothesized that these polymorphisms play an important role in TB 
susceptibility.  RANTES recruits M. tuberculosis-infected macrophages and suppresses 
intracellular growth of the bacterium.  The -403 A/G polymorphism is one of the most 
important SNPs in RANTES as the A allele showed an 8-fold increased transcription 
activity compared to that of the G allele (Nickel et al., 2000).  Therefore this study focused 
on whether a correlation exists between this polymorphism and susceptibility to TB. 
 
FeIron
Fe
Bacteria
H+
H+
Fe
Nramp1
 
 
 
Phagosome Nramp
 
 
 
 
 
 
Fig. 3.8 The NRAMP1 protein is a transmembrane 
cation iron transporter. It is recruited to the phagosome 
of the macrophage after both bacteria and iron are 
ingested. NRAMP1 transports iron and protons such as 
H+ out of the phagosome into the macrophage 
cytoplasm. Adjusted from (Gruenheid et al., 1997). 
1
.1.6 Natural resistance-associated macrophage protein 1 (NRAMP1) also known as 
age activation.  The gene 
ncoding the natural resistance-associated macrophage protein (NRAMP1) is located on 
tains 15 exons that span 12kb of DNA and consist of 550 
Gruenheid et al., 1997). 
 
 
 
3
Solute carrier family 11a member 1 (SLC11A1) 
The first susceptibility gene to be identified from a mouse model of mycobacterial disease 
was NRAMP1 (SLC11A1), which is involved in macroph
e
chromosome 2q35 and con
amino acids.  NRAMP1 plays an important role in the early innate immune response to 
mycobacterial infection by activating the microbial responses in infected macrophages.  It 
is a divalent transporter localized to the late endosomal membrane that regulates 
cytoplasmic cation levels by specifically regulating the iron metabolism in the macrophages, 
leading to possible containment of early mycobacterial infections (Wyllie et al., 2002).  It 
has also been hypothesized that variants in the NRAMP1 gene may alter the function of 
the protein (Fig. 3.8) (
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Numerous genetic variants of NRAMP1 have been associated with TB in several studies of 
which the 3’UTR and 5’ (GT)n variants were shown to be the most important (Bellamy et 
al., 1998; Hoal et al., 2004).  The 5’ (GT)n variant, a microsatellite, is a repeat  in the 
promoter region and the 3’UTR variant is a TGTG deletion located 55nt downstream of 
the last codon in exon 15 (1729 +55del4) (Fig. 3.9). 
 
 
 
5’ (GT)n 
repeat 
3’UTR (TGTG 
deletion) 
 
 
 
 
The 5’ (GT  functional importance as it influenced 
 reporter assay (Searle & Blackwell, 1999).  The 118 
 TB whereas the 120 
lele ((GT)10) was associated with lower promoter activity and susceptibility to TB 
9
y associated with TB (Gao et al., 2000), however a 
a 
oal et al., 2004).  The 3’UTR allelic frequencies differed significantly amongst the 
ifferent Gambian ethnic groups in West Africa, once again highlighting the importance of 
e make-up of the population groups used in genetic case-control studies (Bellamy et al., 
998). 
ue to all these conflicting results, a meta-analysis of NRAMP1 polymorphisms was 
arried out confirming the importance of the 3’UTR and 5’ (GT)  variants and their 
)n variant has been shown to be of
NRAMP1 expression in a luciferase
allele ((GT)9) was associated with higher expression and resistance to
al
(Awomoyi et al., 2002; Hoal et al., 2004).  In a Japanese study it was found that the 5’ (GT)  
variant was found to be significantl
Brazilian study did not find this variant to be associated with TB (Shaw et al., 1997). 
 
The 3’UTR variant has also been linked to a significantly increased risk of pulmonary 
tuberculosis in West Africa (Bellamy et al., 1998), Asia (Ryu et al., 2000) and South Afric
(H
d
th
1
 
D
c n
involvement in tuberculosis susceptibility (Li et al., 2006).  It is unclear whether any of the 
other polymorphisms in NRAMP1, such as the 3’UTR TGTG deletion affects the function 
or whether they are in linkage disequilibrium with another functional polymorphism that 
has not yet been described.   
1 2 3 14   3’ 5’ 15 4 5
ig. 3.9 NRAMP1 and the polymorphisms investigated in this study.F
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3.1.7 Interleukin-1 receptor antagonist (IL-1Ra) 
The interleukin-1 receptor antagonist (IL-1Ra) gene is located on chromosome 2q14-q21 in 
close proximity to the IL-1α and IL-1β ge
 
nes (Fig. 3.10).  Both these genes (IL-1α and IL-
β) are involved in regulation of immunological and inflammatory reactions as they bind to 
e IL-1 receptor and set off the recruitment and activation of macrophages leading to 
otent pro-inflammatory immune responses (Dinarello, 1988).  IL-1Ra also binds to the 
ceptor but acts as a competitive inhibitor of IL-1 biological activity, therefore the 
teraction between IL-1 and IL-1Ra determines the initiation, persistence or termination 
f the pro-inflammatory response (McIntyre et al., 1991).  Polymorphisms in IL-1Ra have 
reviously been associated with TB susceptibility (Bellamy et al., 1998; Gomez et al., 2006; 
ilkinson et al., 1999). 
ne of the most important IL-1Ra variants is the 86bp tandemly repeated sequence, also 
1
th
p
re
in
o
p
W
 
 
800Kb 300Kb
IL-1R1 IL-1 α
IL-1 β
IL-1Ra
86bp VNTR
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 3 45’ 3’
Fig. 3.10  The IL-1 gene cluster: Interleukin -1 receptor 1 (IL-1R1), interleukin-1 alpha and beta 
(IL-1α & IL-1β) and interleukin-1 receptor antagonist (IL-1Ra).  IL-1Ra is expanded to show the 
polymorphism investigated in this study.  Adapted from (Walley et al., 2004). 
 
O
known as a minisatellite, consisting of two to six copies in intron 2 (Lennard et al., 1992).  
This variable number of tandem repeat (VNTR) variant has previously been associated 
with  several clinical conditions such as sepis and increased risk of death due to sepsis (Ma 
et al., 2002), ankylosing spondylitis (McGarry et al., 2001), febrile seizures (Tsai et al., 2002) 
and susceptibility to TB (Bellamy et al., 1998).   
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The IL-1Ra allele 2 has been associated with several auto-immune diseases (Blakemore et 
al., 1995; Clay et al., 1994) and the macrophages of allele 2 carriers produced increased IL-
1Ra and decreased IL-1-α levels when stimulated in vitro with granulocyte-macrophage 
colony stimulating factor (Danis et al., 1995).  The Gambian study in West Africa found the 
IL-1Ra allele 2 heterozygote’s to be less frequent among TB patients than controls 
(Bellamy et al., 1998).  It is difficult to predict the effect in IL-1Ra allele 2 homozygote’s 
since the prevalence was reported to be considerably lower in Black Africans and African 
mericans than in the white population (Mwantembe et al., 2001; Rider et al., 2000). 
til the optimal Tm (570C) was reached.  After 
these five cycles the reaction was carried out for a further 35 cycles of 950C for 30 s, 570C 
for 30 s and 720C for 30 s and a final extension at 720C for 5 min. 
 
This Met11Thr (rs721917) SNP wa  
PCR.  Of the PCR product (59bp), 10.
appropriate buffer and 1U of the res ples 
were incubated overnight at 370C.  agment sizes produced upon enzyme digestion were 
59bp, 40 bp and 19 bp.  The restriction enzyme digested PCR products were analysed on a 
15% (w/v) non-denaturing poly e, 10% (w/v) 
ammoniumpersulfate and TEMED) at room temperature at 200V for 45 min.  For 
electrophoresis 1x TBE buffer (0.089M Tris, 0.089M Boric acid and 20mM EDTA, pH 
A
 
 
3.2 MATERIALS AND METHODS 
3.2.1 SP-D 
Genomic DNA from all patients was analysed using the polymerase chain reaction (PCR) 
to identify the presence of the wild type and/or variant allele at the Met11Thr SNP in SP-
D.  The primers used to analyse this variant are shown in Table 3.1 (Diangelo et al., 1999).  
PCR was performed in a total reaction volume of 25μl containing 100ng template DNA, 
1.5μl of each primer (10μM stock), 2.5μl dNTPs (2.5mM stock) (Bioline), 2μl MgCl (25mM 
stock), 1U HotStarTaq DNA polymerase (Qiagen) and PCR buffer.  The PCR 
amplification conditions were as follows: initial denaturing step at 950C for 15 min, 
followed by 5 cycles of 950C for 30 s, 620C for 45 s and 720C for 30 s, decreasing the 
melting temperature (Tm) by 10C every cycle un
s detected by restriction enzyme digestion following 
5μl was used in a total volume of 15μl containing the 
iction enzyme FspI (New England Biolabs).  Samtr
Fr
acrylamide gel (15% polyacrylamid
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ls included age and gender, in order to 
just for the differences in age (usually small) and gender (usually large) between the 
e assessed both genotype and allelic association for individual variants.  The 
enotypes were treated as categorical variables for the genotype association and numerical 
for the allelic association.  For variants with more than 2 alleles, each allele’s counts were 
modeled separately, in order to identify the specific allele having a significant effect.  All the 
8.0) was used and DNA fragments were visualized with UV light following staining in 
0.5μg/ml ethidium bromide.   
 
Hardy-Weinberg equilibrium (HWE) was assessed in the control group.  Logistic regression 
was used for all modeling in this study and all mode
ad
groups.  W
g
analyses were done in R (www.r-project.org) and R package DGCgenetics (http://www-
gene.cimr.cam.ac.uk/clayton/software/DGCgenetics. 
(10μM 
ock), 2.5μl dNTPs (2.5mM stock) (Bioline), 2μl MgCl (25mM stock), 1U HotStarTaq 
hese SNPs (rs5030737, rs1800450 and rs1800451) were detected by restriction fragment 
bs) restriction enzyme to reveal the presence or absence of  
 
3.2.2 MBL 
Genomic DNA from all patients was analysed using the polymerase chain reaction (PCR) 
to identify the presence of the wild type and/or variant alleles in MBL.  The two sets of 
primers (MBLexon1For/Rev and MBLFor/Rev D allele) used to analyse these variants 
(Madsen et al., 1995) are shown in Table 3.1.  Two separate PCRs were performed in a total 
reaction volume of 25μl each containing 100ng template DNA, 1.5μl of each primer 
st
DNA polymerase (Qiagen) and PCR buffer.  The PCR amplification conditions for the 
first primer set (MBLexon1For/Rev) were as follows: initial denaturing step at 950C for 15 
min, followed by 35 cycles of 950C for 30 s, 580C for 1 min and 720C for 2 min and a final 
extension at 720C for 5 min. The PCR conditions were exactly the same for the second 
primer set (MBLFor/Rev D allele) except for the Tm that was at 550C for 30 s.  
 
T
length polymorphism (RFLP) following PCR.  PCR amplification with the 
MBLexon1For/Rev primer set yielded a fragment size of 349bp.  This PCR product was 
digested with two different enzymes, BanI and MboII (New England Biolabs), to reveal the 
presence or absence of the B and C allele respectively.  PCR amplification with the 
MBLFor/Rev D allele primer set yielded a fragment size of 125bp and was digested with 
the MluI (New England Biola
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For:   CTGGAAGCAGAAATGAA
Rev: ACCAGGGTGCAAGCACT
PrimerA: TTCTTACAACACAAAATC
PrimerT: TTCTTACAACACAAAATC
Rev: TCAACAAAGCTGATACTC
IntCFor: CCTTCCAACCATTCCCTT
IntCRev: TCACGGATTTCTGTTGTGTT
For: ACTCGCATTAGGCCAACGAG
Rev:  HEX-TTCTGTGCCTCCCAAGT
For: GCATCTCCCCAATTCATGGT
Rev:  6FAM-AACTGTCCCACTCTAT
PrimerA: CATGGATGAGGGAAAGGCG
PrimerG: CATGGATGAGGGAAAGGCG
IntCfor: GGTCGCTTAGCAAGTAAATG
SharedRev: GTCCACGTGCTGTCTTGATC
For:   AGTCGACCCAGATTGTAGGA
Rev:  AGGATCCAGGCAGTTTCCTC
ForD: CATCAACGGCTTCCCAGGCA
RevD: AGGATCCAGGCAGTTTCCTC
For: CTTTAATCAATTTTTCTCCC
Rev: TCACTCTCAGAACAATTTCT
For: HEX-CTCAGCAACACTCCTAT
Rev: CTCATCTTCCTGGTCTGC
PrimerC: ACCATCTCACTGTGTGTAGA
PrimerT: ACCATCTCACTGTGTGTAGA
Rev:  ATTGTCTGAGTTACCTTGCTC
IntCFor: GGTCGCTTAGCAAGTAAATG
IntCRev: GTCCACGTGCTGTCTTGATC
 
cation Primer sequence (5'-3')
Table 3.1.  Primers used in the PCR amplification of variants investigated in this study 
 
 
 
 
 
 
 
 
 
 
Variant
NRAMP1
Lo PCR product
GAC
GCG
AAATCA
AAATCT
CA
A
TC
TAGC
CCTG
G
A
G
CAGAG
TGGAAGG
AAGACGCG
TGGAAGG
C
T
G
(GT)n repeat
IFNGR1
(1050 T/G) rs119
IL1Ra 
(86bp VNTR)
IL-8 
(100 C/T) rs2227538
MBP
codon 52 (Arg-Cys) rs
odon 54 (Gly-Asp) rs
codon 57 (Gly-Glu) rs
RANTES
(403 A/G) rs2107538
SP-D
(Met11Thr) rs721
NRAMP1
(TGTG) deletio
IFN-γ
(874 A/T) rs2430561
118 bp, 120 bp or 
122 bp
426 bp
618 bp
125 bp
349 bp
381 bp
681 bp
59 bp
410 bp, 240 bp, 500 b
325 bp or 595 bp
464 bp
Deletion = 240 bp
No deletion = 244 bp
426 bp 
261 bp
14
( 5030
(c 1800
( 1800
n 1
on 2
917 
p, 
n 1
moter 
on
on 1
moter
on
n 15
moter
on
n 7
n
737
450
451
Exo
Intr
Exo
Pro
regi
Intr
Pro
regi
Exo
Pro
regi
Exo
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the D allele.  Of the two PCR products 10.5μl were used in a total volume of 15μl 
containing the appropriate buffer and 1U of the suitable restriction enzyme.  Samples were 
incubated overnight at 370C.  The restriction enzyme-digested PCR products were analysed 
on a 2% (w/v) agarose gel at 200V for 1 hour.  For electrophoresis 1x Sodium Boric (SB) 
buffer was used and DNA fragments were visualized with UV light following staining in 
0.5μg/ml ethidium bromide.  See section 3.2.1 for statistical analysis. 
 
3.2.3 IFN-γ and IFNGR1 
i) IFN-γ (+874 T/A) 
enomic DNA from all patients was analysed using the Amplification Refractory Mutation 
ide ligation technique where two sets of primers 
or both SNP alleles (wildtype and variant) (Newton et al., 1989).  This was a 
amplification conditions were as follows: initial denaturing step at 950C for 15 min, 
G
System (ARMS).  ARMS is an oligonucleot
are designed f
two (one for each allele) tube reaction.  An internal control is critical when using the ARMS 
to confirm the robustness of the PCR reaction in both tubes (Fig. 3.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ARMS primers used to analyse this variant (Pravica et al., 2000) can be seen in Table 
3.1.  PCR was done in a total reaction volume of 30μl containing 100ng template DNA, 
1.5μl of each primer (10μM stock), 3μl dNTPs (2.5mM stock) (Bioline), 2μl MgCl (25mM 
stock), 1U HotStarTaq DNA polymerase (Qiagen) and PCR buffer.  The two-step PCR 
Fig. 3.11 An example of how an ARMS-PCR works (Strachan & Read, 1999)
PCR with primer 1 or 2 
and common primer 
Design allele‐specific 
and common primers
Allele‐specific primer 1
Allele‐specific primer 2
Common reverse primer
Allele 1
Allele 2T 
A
A
T
Allele 1 DNA 
5’
Allele 2 DNA
A3’
Common reverse 
primer 
3’5’ T
Primer 2
3’5’ T
Primer 1
3’5’  A
Primer 2 
T3’ 
Common reverse 
primer
3’5’  A
Primer 1 
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followed by 10 cycles of 950C for 15 s, 620C for 50 s and 720C for 1 min and then 25 cycles 
of 950C for 20 s, 560C for 50 s and 720C for 1 min.  Final extension was at 720C for 10 min. 
M stock), 1U HotStarTaq DNA 
olymerase (Qiagen) and PCR buffer.  The PCR amplification conditions were as follows: 
ing step at 950C for 15 min, followed by 35 cycles of 950C for 1 min, 530C for 
.2.4 IL-8 
s: 
 
The PCR products were 426bp (internal control) and 261bp (SNP) and analysed on a 2% 
(w/v) agarose gel at 200V for 1 hour.  For electrophoresis 1x SB buffer was used and 
DNA fragments were visualized with UV light following staining in 0.5μg/ml ethidium 
bromide.  See section 3.2.1 for statistical analysis. 
 
ii) IFNGR1 (1050 T/G) 
Primers used for this PCR can be seen in Table 3.1.  PCR was performed in a total reaction 
volume of 25μl containing 100ng template DNA, 1.5μl of each primer (10μM stock), 2.5μl 
dNTPs (2.5mM stock) (Bioline), 2μl MgCl (25m
p
initial denatur
1 min and 720C for 1 min and a final extension at 720C for 4 min. 
 
This SNP was detected by restriction enzyme digestion following PCR.  Of the PCR 
product (381bp), 10.5μl was used in a total volume of 15μl containing the appropriate 
buffer and 1U of the restriction enzyme BfaI (New England Biolabs).  Samples were 
incubated overnight at 370C.  Fragment sizes produced upon enzyme digestion were 381bp, 
213bp and 168bp.  The restriction enzyme digested PCR products were analysed on a 2% 
(w/v) agarose gel at 200V for 1 hour.  For electrophoresis 1x SB buffer was used and 
DNA fragments were visualized with UV light following staining in 0.5μg/ml ethidium 
bromide.  See 3.2.1 for statistical analysis. 
 
3
Genomic DNA from all patients was analysed using the ARMS two (one for each allele) 
tube reaction including an internal control (see section 3.2.3).  The ARMS primers used to 
analyse this variant were designed according to the recommendations of Newton et al. 
(Newton et al., 1989) and can be seen in Table 3.1.  PCR was performed in a total reaction 
volume of 25μl containing 100ng template DNA, 1.5μl of each primer (10μM stock), 2.5μl 
dNTPs (2.5mM stock) (Bioline), 2μl MgCl (25mM stock), 1U HotStarTaq DNA 
polymerase (Qiagen) and PCR buffer.  The PCR amplification conditions were as follow
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initial denaturing step at 950C for 15 min, followed by 35 cycles of 950C for 30 s, 580C for 
30 s and 720C for 1 min and a final extension at 720C for 10 min. 
 
The PCR products were 618bp (internal control) and 426bp (SNP) and analysed on a 2% 
(w/v) agarose gel at 200V for 1 hour.  For electrophoresis 1x SB buffer was used and 
DNA fragments were visualized with UV light following staining in 0.5μg/ml ethidium 
bromide.  See section 3.2.1 for statistical analysis. 
 
3.2.5 RANTES 
Genomic DNA from all patients was analysed using the two tube ARMS including an 
internal control (see section 3.2.3).  The ARMS primers used to analyse this variant can be 
seen in Table 3.1.  PCR was done in a total reaction volume of 25μl containing 100ng 
template DNA, 1.5μl of each primer (10μM stock), 2.5μl dNTPs (2.5mM stock) (Bioline), 
2μl MgCl (25mM stock), 1U HotStarTaq DNA polymerase (Qiagen) and PCR buffer.  The 
PCR amplification conditions were as follows: initial denaturing step at 950C for 15 min, 
0C for 30 s, 600C for 30 s and 720C for 1 min followed by a final 
0C for 10 min. 
l) and 464bp (SNP) and analysed on a 2% 
For electrophoresis 1x SB buffer was used and 
sualized with UV light following staining in 0.5μg/ml ethidium 
NA from all patients was analysed using the polymerase chain reaction (PCR) 
ABI PRISM 3130xl Genetic Analyser (Perkin 
alysis software 
 3.7.  Microsatellites, also known as short tandem repeats (STRs), are 
sequence of 2-7 nucleotides.  The primers 
ese variants (Bellamy et al., 1998) can be seen in Table 3.1.  The two 
n repeat and the 3’UTR deletion were fluorescently labeled 
 permit multiple loci analysis in the same 
μl containing 
followed by 30 cycles of 94
extension at 72
 
The PCR products were 681bp (internal contro
(w/v) agarose gel at 200V for 1 hour.  
DNA fragments were vi
bromide.  See section 3.2.1 for statistical analysis. 
 
3.2.6 NRAMP1 
Genomic D
followed by microsatellite analysis using the 
Elmer, Applied Biosystems, Warrington WA, Great Britain) and the an
GeneMapper version
polymorphic DNA loci that contain a repeat 
used to analyse both th
forward primers of the 5’ (GT)
(HEX: green and 6FAM: blue respectively) to
capillary injection.  PCR was performed in a total reaction volume of 25
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100ng template DNA, 0.25μl of each NRAMP1 5’(GT)n primer (10μM stock), 0.6μl of 
each NRAMP1 3’UTR primer (10μM stock), 2.5μl dNTPs (2.5mM stock) (Bioline), 2μl 
MgCl (25mM stock), 1U HotStarTaq DNA polymerase (Qiagen) and PCR buffer.  The 
PCR amplification conditions were as follows: initial denaturing step at 950C for 15 min, 
followed by 25 cycles of 940C for 30 s, 620C for 30 s and 720C for 1 min followed by a final 
extension at 720C for 5 min.  See section 3.2.1 for statistical analysis. 
 
3.2.7 IL-1Ra 
Genomic DNA from all patients was analysed using the polymerase chain reaction (PCR) 
eaction volume of 
5μl containing 100ng template DNA, 0.25μl of each primer (10μM stock), 2.5μl dNTPs 
.5mM stock) (Bioline), 2μl MgCl (25mM stock), 1U HotStarTaq DNA polymerase 
iagen) and PCR buffer.  The PCR amplification conditions were as follows: initial 
enaturing step at 950C for 15 min, followed by 25 cycles of 940C for 30 s, 560C for 30 s 
d 720C for 1 min followed by a final extension at 720C for 5 min.  See section 3.2.1 for 
atistical analysis. 
.3 RESULTS 
.3.1 SP-D 
his Met11Thr SNP was detected, and was seen in both cases and controls (Fig. 3.12).  
he controls were in Hardy-Weinberg equilibrium (HWE) for this polymorphism 
=0.351), and no significant difference was found between the TB cases or TBM cases 
2).   
followed by microsatellite analysis using the ABI PRISM 3130xl Genetic Analyser (Perkin 
Elmer, Applied Biosystems, Warrington WA, Great Britain) and the analysis software 
GeneMapper version 3.7.  The primers used to analyse this variant (Murtha et al., 2006) can 
be seen in Table 3.1.  The forward primer was fluorescently labeled (HEX) to permit 
electrophoretic analysis of the VNTR.  PCR was performed in a total r
2
(2
(Q
d
an
st
 
3
3
T
T
(P
versus controls with respect to genotypic or allelic frequencies (Table 3.
 
3.3.2 MBL 
These three SNPs (rs5030737, rs1800450 and rs1800451) were detected, and seen in both 
groups (Fig. 3.13).  The controls were in HWE (P=0.239).  No significant difference was 
found between the TB cases or TBM cases versus controls with respect to genotypic 
frequencies (P=0.368, P=0.116 respectively).  The borderline significant association found 
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with the D allele when comparing TBM cases to controls (P=0.045) might be an artifact 
due to the low frequency of the D allele and the small sample size of the TBM group 
(Table 3.3).   
T/T C/T C/C 
 
 
 
59bp 
40bp 
 
 
19bp 
Table 3.2 Genotypic and allelic distribution of the Met11Thr SNP in South African Coloured  
TB patients compared to controls.  A single P-value is given for genotype and allele association, 
adjusted for age and gender.  
Genotypic distribution
no. of patients (%)
SP-D T/T C/T C/C P- value T C P- value
201 (40%) 196 (40%) 97 (20%) 598 (61%) 390 (39%)
Allelic distribution
B patients, n=494
103 (34%) 141 (46%) 60 (20%) 347 (57%) 261 (43%)
T/T C/T C/C P- value T C P- value
16 (35%) 20 (43%) 10 (22%) 40 (43%) 52 (57%)
103 (34%) 141 (46%) 60 (20%) 347 (57%) 261 (43%)
0.234
0.778
Controls, n=304
0.315
TBM patients, n=46 0.887
Controls, n=304
T
 
 
 
 
 
Fig. 3.12 Restriction enzyme analysis of the Met11Thr SNP in SP-D
 
Table 3.3 Genotypic and allelic distribution of the MBL exon 1 variant. 
Variant
TB patients
(n = 499)
Controls 
(n = 313)
1 2
MBL 
Genotypic distribution
no. of patients (%)
Allelic distribution
P- value TB patients Controls P- value
A/A 363 (73%) 211 (67%) A 860 (86%) 524 (84%) 0.241
63 (13%) 50 (16%) 0.368 B 67 (7%) 50 (8%) 0.369
56 (11%) 39 (13%) C 56 (6%) 39 (6%) 0.401
* Association is significant P≤0.05
A/B
A/C
A/D 15 (3%) 13 (4%) D 15 (1%) 13 (2%) 0.173
B/B 2 (0%) 0 (0%)
Variant
TBM patients
(n = 49)
Controls 
(n = 313)
P- value TBM patients Controls P- value
MBL 
A/A 39 (80%) 211 (67%) A 88 (90%) 524 (84%) 0.242
A/B 4 (8%) 50 (16%) 0.116 B 4 (4%) 50 (8%) 0.215
A/C 6 (12%) 39 (13%) C 6 (6%) 39 (6%) 0.572
A/D 0 (0%) 13 (4%) D 0 (0%) 13 (2%) 0.045*
 
 
 
A1  single P-value is given for genotype association, adjusted for age and gender.
2Separate tests were done for each allele versus all others.
                                                                                                             CHAPTER THREE 
 
92 
 
A 
 
 500bp 
 
 
B 
 
349bp 
200bp 
 500bp 
 
 
 
 
 
C 
 
 
 
200bp 
 
 
D 
 
 
 
 
 
 
E 
 
 
 
  
 
 
100bp 
125bp 
A/B A/A
200bp 
500bp 
260bp 
349bp 
89bp 
A/A A/C
200bp 
500bp 
349bp 
279bp 
70bp 
A/A A/D
200bp 
500bp 
125bp 
100bp 
. 3.13 Restriction enzyme analysis of the 3 SNPs located in exon 1 of MBL, [A] PCR product with 
Lexon1 primer set, [B] PCR product with MBL D allele primer set, [C] Digestion with BanI (B 
Fig
MB
allele), [D] Digestion with MboII (C allele), [E] Digestion with MluI (D allele). 
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3.3.3 IFN-γ and IFNGR1 
The +874 A/T and +1050 G/T SNPs in IFN-γ and IFNGR1 respectively, were detected, 
and seen in both groups (Fig. 3.14 and Fig. 3.15).  
 
 
 
ATAA TTAA TT AA
A A T A T A T T A T T A 
 
 
 
 
 
 
A 
 
 
 
B 
 
 
 
 
 
 
 
The controls were in HWE for both the IFN-γ (P=0.284) and the IFNGR1 (P=0.257) 
NPs.  For the IFN-γ polymorphism, no significant difference was found between either 
P=0.448) or allele frequencies (P=0.244) 
S
the TB cases or controls with respect to genotype (
nor the TBM cases (P=0.593, P=0.311 respectively) (Table 3.4).  Significant differences 
were found with the IFNGR1 polymorphism regarding allele frequencies in both TB and 
TBM cases versus controls (P=0.022, P=0.037 respectively) but not with genotype 
frequency (Table 3.5). 
381bp 
213bp 
168bp 
G/T G/G G/T
381bp 
G/T T/T T/T 
Fig. 3.14 The IF
Fig. 3.15 Detection of the polymorphism +1050 G/T in IFNGR1: [A] PCR product followed by, [B] 
restriction enzyme analysis. 
N-γ +874 A/T polymorphism detected using the ARMS method 
261bp 
426bp Internal control
Allele specific
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IFN- γ A/A A/T T/T P- value A T P- value
266 (53%) 194 (39%) 40 (8%) 726 (73%) 274 (27%)
158 (50%) 124 (40%) 33 (10%) 440 (70%) 190 (30%)
A/A A/T T/T P- value A T P- value
27 (57%) 16 (34%) 4 (9%) 70 (74%) 24 (26%)
158 (50%) 124 (40%) 33 (10%) 440 (70%) 190 (30%)
M patients, n=47 0.593 0.311
Controls, n=315
Genotypic distribution
no. of patients (%)
Allelic distribution
TB patients, n=500 0.448 0.244
ontrols, n=315
TB
C
 
 
Table 3.4 Genotypic and allelic distribution of the IFN-γ variant in TB cases vs controls and TBM  
cases vs controls, adjusted for age and gender. 
 
 
  cases vs controls, adjusted for age en gender. 
IFNGR1 T/T T/G G/G P- value T G P- value
418 (85
no. of patients (%)
TB patients, n=492
Genotypic distribution Allelic distribution
%) 69 (14%) 5 (1%) 905 (92%) 79 (8%)
250 (79%) 59 (19%) 6 (2%) 559 (89%) 71 (11%)
T/T T/G G/G P- value T G P- value
40 (91%) 4 (9%) 0 (0%) 84 (95%) 4 (5%)
250 (79%) 59 (19%) 6 (2%) 559 (89%) 71 (11%)
*Association is significant P≤0.05
TBM patients, n=44 0.105 0.037*
Controls, n=315
0.064 0.022*
Controls, n=315
 
 
 
 
.3.4 IL-8 
his +100 C/T (rs2227538) SNP was detected in both groups.  An example of the SNP 
etected is depicted in Fig. 3.16. The controls were in HWE for this polymorphism 
=0.305).  No significant difference was found between the TB or TBM cases versus 
ontrols with respect to genotypic frequencies (P=0.062, P=0.680 respectively), however a 
significant association was found between the TB cases and controls for the allelic 
frequency (P=0.019) (Table 3.6).   
 
 
 
 
 
Table 3.5 Genotypic and allelic distribution of the IFNGR1 variant in TB cases vs controls and TBM  
3
T
d
(P
c
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C T C T C T
C T C T C T
CC TT CC
CT CC CT
618bp 
426bp 
Internal  
 
 
 
 
 
 
 
 
 
control Allele
specific  
 
 
all three genotypes of the +100 C/T IL
 
IL-8 C/C C/T T/T P- value C T P- value
379 (76%) 105 (21%) 12 (3%) 863 (87%) 129 (13%)
259 (83%) 49(16%) 4 (1%) 567 (91%) 57 (9%)
C/C C/T T/T P- value C T P- value
38 (79%) 9 (19%) 1 (2%) 85 (89%) 11 (11%)
259 (83%) 49(16%) 4 (1%) 567 (91%) 57 (9%)
Association is significant P≤0.05
BM patien 0.680 0.518
ontrols, n=
Genotypic distribution
no. of patients (%)
Allelic distribution
B patients, n=496 0.062 0.019*
rols, n=312
*
T
C
ts, n=48
312
T
Cont
 Fig. 3.16 Detection of -8 polymorphism. 
able 3.6 G c and allelic distribution of the IL-8 variant in TB cases vs controls and TBM  
ses v
 
 
 
T
ca
enotypi
s controls, adjusted for age and gender.
 
 
 
 
.3.5 RANTES 
e-103 A/G (rs2107538) SNP in RANTES was detected in both groups and is depicted 
 Fig. 3.17. The controls in HWE (P=0.909).  No significant difference was found 
etween the TB cases and controls with respect to genotype (P=0.451) or allele frequencies 
=0.347).  However, the allele frequency was significantly different between the TBM 
 
3
Th
in were 
b
(P
cases and controls (P=0.037) (Table 3.7), although not significantly different between TB 
cases and controls (P = 0.347). 
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GG AG AA AGAA
   
 
 
R
T
ANTES A/A A/G G/G P- value A G P- value
141 (29%) 228 (46%) 122 (25%) 514 (52%) 472 (48%)
81 (26%) 153 (50%) 75 (24%) 315 (51%) 303 (49%)
A/A A/G G/G P- value A G P- value
17 (37%) 21 (46%) 8 (17%) 55 (60%) 37 (40%)
81 (26%) 153 (50%) 75 (24%) 315 (51%) 303 (49%)
Genotypic distribution
no. of patients (%)
Allelic distribution
B patients, n=493 0.451 0.347
ntrols, n=309
*Association is significant P≤0.05
ents, n=46 0.110 0.037*
ontrols, n=309
Co
T
C
BM pati
 
 
681bp 
A G A G A G A A
 
 
 
 
 
 
 
.3.6 NRAMP1 
oth the 5’ (GT)n repeat and the 3’UTR deletion variants in NRAMP1 were detected in 
oth groups (Fig. 3.18).  The control group was in HWE for both the 5’ (GT)n repeat 
=1.00) and the 3’UTR deletion (P=0.634).  No significant difference was found between 
equency (P=0.077, P=0.979 respectively).  The 118 and 120 allele frequencies were 
gnificantly different between the TB cases and controls (P=0.011, P=0.011 respectively) 
 
3
B
b
(P
the 5’ (GT)n repeat variant and the TB or TBM cases and controls with respect to genotype 
fr
si
(Table 3.8).  No significant association was found between the 3’UTR deletion and TB or 
TBM in this study (Table 3.9).   
 
 
 
 
 
464bp 
Internal 
control 
 G G
Allele 
specific 
Fig. 3.17 The detection of all three genotypes of the RANTES - 403 A/G polymorphism. 
able 3.7 Genotypic and allelic distribution of the -403 A/G RANTES variant in TB cases vs controls T
and TBM cases vs controls, adjusted for age and gender.
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Variant
TB patients
(n = 498)
Controls 
(n = 315) P- value
1 TB patients Controls P- value2
NRAMP1 repeat
118/118 301 (61%) 216 (69%) 118 776 (78%) 523 (83%) 0.011*
118/120 173 (35%) 91 (29%) 0.077 120 217 (22%) 106 (17%) 0.011*
118/122 1 (0%) 0 (0%) 122 3 (0%) 1 (0%) 0.686
120/120 21 (4%) 7 (2%)
120/122 2 (0%) 1 (0%)
Variant
TBM patients
(n = 49)
Controls 
(n = 315)
P- value TBM patients Controls P- value
AMP1 repeat
0.979 120 16 (16%) 106 (17%) 0.926
118/122 0 (0%) 0 (0%) 122 0 (0%) 1 (0%) 0.675
120/120 1 (2%) 7 (2%)
120/122 0 (0%) 1 (0%)
Genotypic distribution
no. of 
 Table 3.8 Genotypic and allelic distribution of the NRAMP1 5’ (GT)n repeat in TB cases vs 
s controls. 
 
NR
118/118 34 (69%) 216 (69%) 118 82 (84%) 523 (83%) 0.947
118/120 14 (29%) 91 (29%)
patients (%)
Allelic distribution
*Association is significant P≤0.05
 
controls and TBM cases v
 
AMP del N/N N/D D/D P- value N D P- value
393 (80%) 85 (17%) 14 (3%) 871 (89%) 113 (11%)
261 (84%) 48 (15%) 3 (1%) 570 (91%) 54 (9%)
N/N N/D D/D P- value N D P- value
37 (76%) 12 (24%) 0 (0%) 86 (88%) 12 (12%)
261 (84%) 48 (15%) 3 (1%) 570 (91%) 54 (9%)
M patients, n=49 0.221 0.195
ontrols, n=312
Genotypic distribution
no. of individuals (%)
Allelic distribution
 patients, n=492 0.202 0.170
ontrols, n=312
NR
TB
TB
C
C
 
 
 
 
 
 
 
 
 
 
 
re the most common, which corresponds with previous 
udies (Tarlow et al., 1993; Witkin et al., 2002). 
Table 3.9 Genotypic and allelic distribution of the NRAMP1 3’UTR deletion in TB cases vs controls  
and TBM cases vs controls, adjusted for age and gender. 
 
A1  single P-value is given for genotype association, adjusted for age and gender.
2Separate tests were done for each allele versus all others. 
 
3.3.7 IL-1Ra 
All five alleles previously reported for the IL-1Ra 86bp VNTR were detected and an 
example of the different alleles obtained can be seen in Fig. 3.19.  The control group was in 
HWE (P=0.721).  The five different alleles represent 2 to 6 repeats (Table 3.10).  Allele 1 (4 
repeats) and allele 2 (2 repeats) we
st
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 Fig. 3.18 Examples of an electropherogram sample run for microsatellite 
analysis of the 5’(GT)n and 3’UTR variants in the NRAMP1 gene.  [A] The 
5’(GT)n variant: homozygote 118/118 heterozygote 118/120, homozygote 
120/120 and heterozygote 120/122.  [B] The 3’UTR variant: homozygote 
N/N, heterozygote N/D and homozygote D/D. (N= no deletion, D = 
deletion). 
A B
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  Fig. 3.19 All alleles obtained with the microsatellite analysis of the 86bp VNTR in the IL-1Ra 
gene.  The grey areas are the bins set up for the different alleles. 
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Variant TB patients
(n=465)
Controls 
(n=281) P-value
1 TB patients Controls P-value2
IL-1Ra 
1/1 308 (67%) 173 (62%) 0.037* 1 742 (80%) 425 (75%) 0.019*
1/2 94 (21%) 62 (22%) 2 146 (15%) 112 (20%) 0.025*
1/3 13 (3%) 1 (0%) 3 15 (2%) 3 (1%) 0.102
1/4 14 (3%) 11 (4%) 4 20 (2%) 17 (3%) 0.152
1/5 5 (1%) 5 (2%) 5 7 (1%) 5 (1%) 0.685
2/2 24 (5%) 25 (9%)
2/3 2 (0%) 0 (0%)
2/4 2 (0%) 0 (0%)
3/3 0 (0%) 1 (0%)
4/4 2 (0%) 3 (1%)
5/5 1 (0%) 0 (0%)
Variant TBM patients
(n=41)
Controls 
(n=281)
P-value TBM patients Controls P-value
IL-1Ra 
1/1 26 (63%) 173 (62%) 0.817 1 65 (79%) 425 (75%) 0.332
1/2 11 (27%) 62 (22%) 2 15 (18%) 112 (20%) 0.441
1/3 0 (0%) 1 (0%) 3 0 (0%) 3 (1%) 0.554
1/4 2 (5%) 11 (4%) 4 2 (3%) 17 (3%) 0.896
1/5 0 (0%) 5 (2%) 5 0 (0%) 5 (1%) 0.348
2/2 2 (5%) 25 (9%)
2/3 0 (0%) 0 (0%)
2/4 0 (0%) 0 (0%)
3/3 0 (0%) 1 (0%)
4/4 0 (0%) 3 (1%)
5/5 0 (0%) 0 (0%)
Genotypic distribution
no. of patients (%) Allelic distribution
*Association is significant P≤0.05
 
Table 3.10  IL-1Ra allele frequencies among TB cases and controls in this South African population
Allele
Frequency in 
controls
Frequency in 
cases
PCR product size Number of repeats
1 0.76 0.80 410 bp 4
2 0.20 0.16 240 bp 2
3 0.01
4 0.03
0.02 500 bp 5
0.02 325 bp 3
5 0.01 0.01 595 bp 6
 
 
Statistically significant associations were observed with TB status for the genotypes 
=0.037) and alleles 1 and 2 (P=0.019, P=0.025 respectively).  No statistically significant 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(P
difference was found when comparing the TBM cases to the controls (Table 3.11). 
 
Table 3.11 IL-1Ra 86bp VNTR genotype and allele frequencies among TB and TBM cases and 
controls.  
 
1A single P-value is given for genotype association, adjusted for age and gender.
Separate tests were done for each allele versus all others. 2
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3.9 DISCUSSION 
usceptibility to tuberculosis was investigated by means of case-control association studies 
in the SAC population.  Polymorphisms in SP-D, MBL, IFN-γ, IFNGR1, IL-8, RANTES, 
 were investigated.  All these genes play an important role in either 
e uptake of M. tuberculosis in the alveolar macrophages or in the inflammatory response 
d have previously been associated with TB. 
between TB susceptibility in the SAC 
population and the polymorphisms in SP-D, MBL, IFN-γ or RANTES.    These 
polymorphisms have previously been associated with TB susceptibility in other population 
groups and in smaller studies in our SAC population unpublished data obtained by several 
colleagues in the TB host genetics group).  This, once again, demonstrates the common 
phenomenon in association studies where the first report can show a positive association 
and subsequent studies are often negative as a result of genetic differences between 
opulations (allele based) or a difference in sample size.  If a positive association was 
etected in a small sample size but did not hold when the sample size was increased (in the 
n group) the first association may have been due to chance therefore unable 
ignificance was observed comparing the 
genotypic frequencies in TB cases and controls (P=0.064).  The T allele was more prevalent 
in the cases than controls.  However, this is a synonymous SNP (Ser/Ser) therefore it will 
be unlikely to have an effect on the protein expression.  This SNP might be in linkage 
disequilibrium with another genetic marker or there may be an interaction between this 
particular SNP and other polymorphisms in the IFN-γ pathway.   
 
A statistically significant difference in allelic frequency for the IL-8 +100 C/T (rs2227538) 
SNP was found between the TB cases and controls (P=0.019) while a trend towards 
significance was observed with the genotypic frequency (P=0.062).  The T allele was more 
prevalent in the TB cases while the C allele was more prevalent in the controls suggesting 
that the T allele might be a risk factor for susceptibility to TB.  In light of the fact that this 
S
IL-1Ra and NRAMP1
th
an
 
We found no statistically significant associations 
p
d
same populatio
to be replicated. 
 
For the IFNGR1 1050 T/G (rs11914) polymorphism, a statistically significant difference in 
allelic frequencies was found between the TB cases and TBM cases, and controls (P=0.022, 
P=0.037 respectively) and a trend towards s
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polymorphism is located one base pair upstream from the ATG of the IL-8 
gene, any nucleotide change here might affect the transcriptional level of the gene.  
Increased levels of IL-8 have been reported in the bronchoalveolar lavage fluid (BALF) of 
TB patients compared to controls (Dlugovitzky et al., 1997; Mas 994; Sadek 
et al., 1998) as well as increased IL-8 plasma concentration levels o die from 
TB compared to those who survive (Friedland et al., 1995; Pace herefore it 
can be hypothesized that having the T allele leads to an increa n rate and 
therefore increased IL-8 expression.  However, the functional work to support this 
hypothesis has not been done. 
 
Of the two NRAMP1 variants, the 5’ (GT)n repeat and 3’UTR (TGTG) deletion 
investigated in this study, a statistically significant difference betw nd controls 
was only observed for the 5’ (GT)n repeat.  The allelic frequencies of the 118 and 120 
alleles were significantly different between the TB cases and co 1, P=0.011 
respectively).  In our SAC population, the 118 allele, which is the most common allele, has 
a higher frequency in the controls than the cases whereas the 120 allele is more frequent 
among the TB cases than controls.  Our findings concur with those of others where the 
118 allele has been associated with higher expression and resistance to TB in a number of 
widely disparate populations and the 120 allele with lower promoter activity and 
susceptibility to TB (Awomoyi et al., 2002; Hoal et al., 2004).  The mechanisms of how 
NRAMP1 influences resistance or susceptibility to TB are still speculative, but it has been 
shown that the 120 allele is associated with a higher induced level of the anti-inflammatory 
cytokine interleukin 10 (IL-10) (Awomoyi et al., 2002).  One of the major roles of 
NRAMP1 is that it acts as a divalent transporter that regulates cytoplasmic cation levels by 
specifically regulating the iron metabolism in the macrophages leading to possible 
containment of early mycobacterial infections (Wyllie et al., 2002) whereas one of the major 
roles of IL-10 is to deactivate macrophages.  Therefore the association observed with the 
120 allele of the 5’ (GT)n NRAMP1 variant might be due to an interactive effect with IL-
10. 
 
In all of the above reports, statistically significant differences were found with allelic 
frequencies only, but not with genotypic frequencies between the TB cases and TBM cases, 
and controls.  Not much can be deduced from allelic associations, as an individual has two 
 start codon 
troianni et al., 1
 in patients wh
et al., 1999).  T
sed transcriptio
een the cases a
ntrols (P=0.01
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alleles at any locus, making up an individual’s genotype.  These two alleles can act additively 
or interact to influence susceptibility to a complex disease.  Therefore, associations between 
genotypic frequencies and the disease may provide more information than the allelic 
association. 
 
For the IL-1Ra 86bp VNTR variant, statistically significant differences in genotypic 
frequency (P=0.037) and allelic frequencies (P=0.019, P=0.025 for allele 1 and 2 
respectively) were found between the TB cases and controls.  Possibly due to the low 
frequency of alleles 3, 4 and 5 no significant association with TB was found in this study.  
In our study and in concordance with the Gambian study (Bellamy et al., 1998), allele 1 was 
associated with an increase in probability of developing TB whereas allele 2 was associated 
with a decreased probability.  A previous study reported that macrophages of IL-1Ra allele 
2 carriers produced increased IL-1Ra, IL-1β and decreased IL-1α levels when stimulated in 
vitro with granulocyte-macrophage colony stimulating factor (Danis et al., 1995).  It has 
been proposed that imbalanced levels of IL-1Ra and IL-1β proteins may play a major role 
in the determination of the severity of an inflammatory reaction (Santtila et al., 1998). 
 
In the past decade, several candidate genes have been investigated regarding host genetic 
susceptibility to TB.  Since TB is a complex disease the genetic susceptibility component of 
TB seems to be divided amongst many genes and is probably not due to one or even a few 
SNPs.  Although we found significant associations between single polymorphisms in 
different genes and TB susceptibility, it is possible that the effect of one gene might not be 
revealed if the effect of another gene is not considered and therefore, focusing on single 
polymorphisms at a time may generate false negatives.  It has become increasingly evident 
that gene-gene interactions might play a vital role in an individual’s susceptibility to a 
complex disease. 
 
In conclusion, data presented here suggests and confirms previous pilot studies of 
associations between the IFNGR1, IL-8, IL-1Ra (unpublished data) and NRAMP1 
(Bellamy et al., 1998; Hoal et al., 2004) polymorphisms and TB susceptibility in the SAC 
population. 
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4.1 INTRODUCTION 
B is a complex disease and the susceptibility component of TB seems to be made up of 
any genes as well as different genes being implicated in different populations (Maartens & 
ilkinson, 2007).  Many polymorphic genes have been associated with TB susceptibility 
able 4.1) of which meta-analysis has been done on interferon-gamma (IFN-γ) (Pacheco et 
., 2008) and natural resistance-associated macrophage protein (NRAMP1 / SLC11A1) (Li 
 al., 2006), confirming their role in tuberculosis susceptibility.  Due to the complex nature 
f the immune system and the polygenic nature of complex diseases it has become 
creasingly evident that gene-gene interactions play a far more important part in an 
to a complex disease than single polymorphisms would on their 
G) and DC-SIGN (-871 A/G); IFN-γ (+874 T/A); interferon-gamma 
ceptor 1 (IFNGR1) (1050 T/G); interleukin 8 (IL-8) (+100 C/T); interleukin-1 receptor 
 
T
m
W
(T
al
et
o
in
individual’s susceptibility 
own (Ritchie et al., 2001; Tsai et al., 2003; Williams et al., 2000).  Gene-gene interaction, also 
known as epistasis, can be defined as the interaction between genes that are not on the 
same locus and which can be very distant from each other in the genome.  In a gene-gene 
interaction, one gene can enhance (synergistic epistasis) or hinder (antagonistic epistasis) 
the expression of another gene (Nagel, 2005). 
 
Gene-gene interaction analysis is still a fairly new approach to elucidate susceptibility to 
complex diseases, therefore little has been published regarding gene-gene interactions in 
infectious diseases such as TB.  Gene-gene interactions have been found in non-infectious 
diseases such as asthma (Kim et al., 2006; Lee et al., 2004), Parkinson’s disease (Deng et al., 
2004; Pankratz et al., 2003), diabetes (Bergholdt et al., 2005; Koeleman et al., 2004) and 
rheumatoid arthritis (Martinez et al., 2006).  Therefore, one aim of our study was to assess 
the possibility of gene-gene interactions, focusing on 11 polymorphisms in nine genes that 
have previously been associated with TB in our studies and / or others. 
 
These include two SNPs in the dendritic cell-specific ICAM-3 grabbing nonintegrin (DC-
SIGN) (-366 A/
re
antagonist (IL-1Ra) (86 bp VNTR); a three-SNP haplotype in mannose-binding lectin 
(MBL) at codons 52 (Arg-Cys), 54 (Gly-Asp) and 57 (Gly-Glu) in exon 1; NRAMP1, also 
known as SLC11A1 (GT)n repeat, NRAMP1 (TGTG) deletion; the C-C chemokine 
regulated upon activation, normal T-cell expressed and secreted (RANTES), also known as 
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CCL5, that is a ligand for chemokine receptor 5 (-403A/G); and surfactant protein D (SP-
D) (Met11Thr). 
 
Table 4.1. Genes associated with TB
Genes References 
CR1 (Fitness et al., 2004) 
DC-SIGN (Barreiro et al., 2006) 
HLA DR2 
(Rajalingam et al., 1996) 
(Hawkins et al., 1988;  
Sanjeevi et al., 1992) 
IFN-γ 
(Tso et al., 2005) 
(Lopez-Maderuelo et al., 2003;  
Rossouw et al., 2003) 
IFN-γ-R1 
(Awomoyi et al., 2004) 
(Bulat-Kardum et al., 2006;  
Cooke et al., 2006) 
IL-1 complex (Wilkinson et al., 1999) (Gomez et al., 2006) 
IL-1RA (Bellamy et al., 1998) 
IL-8 (Ma et al., 2003) 
MBL 
(Hoal-van Helden et al., 1999) 
(Garcia-Laorden et al., 2006;  
Soborg et al., 2003) 
RANTES (CCL5) (Chu et al., 2007) 
(Delgado et al., 2002) 
 
 
A combined data set consisting of 106 variants was constructed from our database and also 
used for gene-gene interaction analysis.  All of these genes had previously been selected as 
candidate genes for susceptibility to TB based on their biological function and proposed 
role in the multistep course of this complex disease, or were selected according to similar 
work in the literature. 
 
SLC11A1/ NRAMP1 (Liu et al., 2004) (Hoal et al., 2004;  
Malik et al., 2005) 
SP-D (Floros et al., 2000) 
Vitamin D receptor (Bellamy et al., 1999) 
(Babb et al., 2007;  
Roth et al., 2004;  
Wilkinson et al., 2000) 
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In addition to host genotype conferring susceptibility, it has been hypothesized that the 
interaction between the genotype of the human host, and the bacterial strain genotype, 
could influence the susceptibility of the host in terms of both the progression to disease 
and perhaps the type of disease seen.  Several M. tuberculosis strains, such as LAM (Latin 
American and Mediterranean), Haarlem, C strain and X strain exist all over the world, and 
the W-Beijing family of strains has been studied extensively (Malik & Godfrey-Faussett, 
005).  An investigation into 875 strains from 80 different countries led to the hypothesis 
ckgrounds, with some alleles completely absent in certain populations 
ombard et al., 2006) and that the HLA genotype has been associated with susceptibility to 
 have 
reater virulence compared to other strains (Rad et al., 2003) and they have also been 
2
that ancestral M. tuberculosis originated and drifted together with humans “out of Africa” 
(Gagneux et al., 2006).  Remarkably, evidence exists that six lineages of M. tuberculosis have 
adapted to specific populations (Maartens & Wilkinson, 2007) and Hanekom et al. showed 
that strains from a defined sublineage may have been selected by a human population in a 
defined geographical setting (Hanekom et al., 2007).  This argument is supported by the fact 
that the HLA allele frequencies, vary widely between human populations with different 
historical ba
(L
M. tuberculosis.  To our knowledge, only one study has looked at the interaction between 
bacterial strains and host genotypes thus far and found an association between the C allele 
of the Toll-like receptor 2 (TLR2) 597 T/C SNP of the host and the bacterial genotype in 
M. tuberculosis disease (Caws et al., 2008). 
 
The Beijing family of strains, most easily recognised by its distinctive spoligotyping pattern 
(Bifani et al., 2002), was first reported in 1995 (van Soolingen et al., 1995).  This is probably 
the most dominant or distinctive strain worldwide and has been reported in many 
countries, such as Vietnam, Thailand, Hong Kong, Russia and South Africa (Anh et al., 
2000; Chan et al., 2001; Drobniewski et al., 2002; Glynn et al., 2006; Prodinger et al., 2001; 
Warren et al., 2004).  It has been suggested that Beijing strains are hypermutable and
g
associated with a higher frequency of drug resistance (Dale et al., 2005; Rad et al., 2003; van 
der Spuy et al., 2009). 
 
From the original Mycobacterial complex, M. tuberculosis has evolved into three principle 
genetic groups (PGG 1, 2 and 3).  Based on the combinations of two polymorphisms at the 
katG codon 463 and gyrA codon 95 site, isolates of M. tuberculosis were assigned to one of 
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these three groups (Sreevatsan et al., 1997).  PGG 1, known as the ancestral group, is 
genetically more diverse than PGG 2 and 3, since it is older and therefore has accumulated 
variation.  It consists mainly (95%) of the Beijing family, whereas PGG2 consists of LAM, 
CC and Haarlem families and PGG3 of other less frequent strains.  Therefore comparing 
.2 
.2.1 Study population 
i) Condensed set 
The same culture proven or smear positive TB cases (n=505) and controls (n=318) that 
were used for the case-control association study (chapter 3) were used for the gene-gene 
interactions between the 11 variants genotyped.   
 
ii) Combined set 
Culture proven or smear positive TB cases (n = 339) and controls (n = 206) were used for 
the combined dataset of 106 variants scattered across many genes.  The number of 
participants is less than for the original gene-gene interaction study (11 variants) as they 
were selected to maximize overlapping genotype information and minimize missing values.  
All these variants have previously been genotyped by our group in the same study cohort.  
This combined dataset included well-known and well-characterised genes that have 
previously been shown to possibly play a role in susceptibility to TB. 
 
In Ravensmead-Uitsig, in which we performed the majority of the DNA collection, others 
in our department have also extensively researched the strains of M. tuberculosis present, and 
the relative virulence of the strains in terms of their spread and prevalence in the 
community (Warren et al., 2004).  Over the past decade several thousand individuals with 
culture proven TB have been characterised with respect to the M. tuberculosis strain 
harboured.  The overlap between patients with bacterial strain information and a genetic 
profile was about 50%.  Therefore only those patients (n = 229) could be used to study this 
interaction.   
 
L
Beijing to non Beijing strains will be essentially the same as comparing PGG 1 to other 
PGGs. 
 
 
4 MATERIALS AND METHODS 
 
4
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Collect sputum samples
Decontaminate sputum 
in level 3 laboratory
Inoculate into MGIT 
vials 
Löwenstein-Jensen 
medium (LG)
Grow for 3 weeks
Scrape off the pure 
DNA
Highly 
discriminative 
RFLP
Breaks down e.g. 
Beijing into 
sublineages
Boil an aliquot
Get crude DNA
Spoligotyping and 
genetic screening
Divide strains into 
major families
Beijing, LAM, 
Haarlem, LCC
.2.2  Genotyping 
See chapter three for detailed genotyping information and primer sequences for 
polymorphisms in MBL, NRAMP1, IL-1Ra, RANTES, IFN-γ, IL-8, SP-D and IFNGR1.  
Based on the fact that two DC-SIGN polymorphisms (-366 A/G (rs4804803) and -871 
A/G (rs735239)) had previously been genotyped in the same study cohort and had been 
associated with TB susceptibility (Barreiro et al., 2006), it was decided to include these two 
SNPs in the condensed gene-gene interaction analysis.  These two promoter 
polymorphisms were genotyped using the template-directed dye-terminator incorporation 
with fluorescence polarization detection (TDI-FP) using Victor PCR.  See (Barreiro et al., 
2006) for detailed genotyping inf ormation regarding all the other 
TB susceptibility genes used in the combined dataset, is not shown here, but can be found 
in our department. 
 
4.2.3 Bacterial strains 
utum samples were collected from suspect TB patients followed, by a process of 
 
 
 
 
 
 
 
 
Fig. 4.1  A simplified illustration, explaining the process from sputum collection to the M. tuberculosis 
strain information. 
4
ormation.  Genotyping inf
Sp
decontamination and inoculation (Fig. 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                             CHAPTER FOUR 
 
The WHO recommended certain media to be used of which the Löwenstein-Jensen (LG) 
edium was one (World Health Organization, 2001).  Thereafter, genotyping by RFLP 
ere is no need to model both alleles, because 
e effect of one will necessarily be the converse of that of the other.  (If allele X increases 
rward to interpret. 
m
analysis or spoligotyping was done (Warren et al., 2002).  Bacterial strains can be divided 
into two groups, namely clustered or non-clustered, also known as unique.  The clustered 
group can be divided into big clusters (defined as five or more individuals harbouring the 
same strains) and small clusters (defined as less than five patients with the same strains). 
 
4.2.4 Statistical analysis 
Hardy-Weinberg equilibrium (HWE) was assessed in the control group for all the genetic 
variants tested.  Logistic regression was used for all modeling in this study and all models 
included age and gender, in order to adjust for the differences in age (usually small) and 
gender (usually large) between the groups.  We assessed both genotype and allelic 
association for individual variants.  The genotypes were treated as categorical variables for 
the genotype association and numerical for the allelic association.  For variants with more 
than 2 alleles, each allele’s counts were modeled separately, in order to identify the specific 
allele having a significant effect.  For SNPs, th
th
one’s likelihood by a factor of 2, allele not-X will decrease it by a factor of 2.)  In order to 
assess the interaction between genes, the alleles from pairs of variants were coded 
numerically.  The  interaction between all pairs of variants described in the combined set 
above, as well as two SNPs (-871 and -336) in the DC-SIGN-encoding gene CD209, that 
were previously associated with TB in our study population (Barreiro et al., 2006) was 
assessed.  The outcome modeled was logit(TB),  the natural log of the odds ratio (OR) of 
TB versus no TB, so that single effect sizes can be converted to odds ratios, and 
interpreted as such.  Unfortunately interaction terms are not so straightfo
 
We also created a model for case-control status (logit(TB)) as a function of age, gender and 
all eleven candidates as main effects (not interactions) and selected an optimal model from 
it, using a stepwise backwards procedure, by repeatedly discarding the least important term 
(by AIC, Akaike’s criterion) until the optimal selection of terms is reached.   
 
A dichotomous genotype-trait association test was performed to assess the interactions 
between the human genotype and the bacterial strain.  This test was adjusted for age.  All 
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the analyses were done in R (www.r-project.org) and R package DGCgenetics 
(http://www-gene.cimr.cam.ac.uk/clayton/software/DGCgenetics). 
 
4.3 RESU
 
There were 55 (17%) males in the control  in the cases of the 
condensed edian age was 30 in the c or the TB cases.  The 
odds of having TB decreases significantly with increasing age ( R=0.987; P=0.021) after 
adjusting for   Therefore all our mo ere were adjusted 
for age and gender.  All variants genotyped in ntrol 
group.   
 
4.3.1 Ass ies 
None of the five SNPs (rs721917, rs2430561, rs d rs2227538) in SP-D, 
IFN-γ, RANT IFNGR1 and IL-8 respectiv L three SNP haplotype 
showed a statistically significant difference between the TB cases and controls at the 
genotype leve significant trends in all  for the SNPs in 
IFNGR vely.  This implies that ve effect, but we did not 
have enough power to detect and confirm it w .  Allele T of the IL-8 
SNP i TB by 48% (OR=1.4 reas the G allele of the 
IFNGR1 SNP decreased the odds of TB by 34% 22) (Table 4.2). 
 
The 11 MP1 (GT)n repeat sh  significant decrease of  
almost 30 % in odds of having TB (versus no TB) ach 118 allele compared 
 the other alleles (OR=0.71; P = 0.011).  The frequency of allele 122 was 0.003 and 0.002 
 the TB cases and controls respectively, confirming previous reports regarding the rarity 
 
LTS 
group and 227 (45%)
ontrol group and 31 fset.  The m
O
dels and all results reported hgender.
 this study were in HWE in the co
ociation stud
2107538, rs11914 an
ES, ely, or the MB
l, but ele f tectedrequency were de
1 and IL-8 respecti  there is an additi
ith the genotype test
8; P=0.019), whencreased the odds of 
(OR=0.66; P=0.0
8 allele of the NRA owed  a statistically
 associated with e
to
in
of this allele.  The 122 allele frequency was too low for any conclusions to be drawn.  The 
NRAMP1 (TGTG) deletion did not show a statistically significant difference between the 
TB cases and controls at the genotype or allele level (Table 4.2). 
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Variant
(rs number)
TB patients
n (frequency)
Controls 
n (frequency) P -value
1 TB patients
n (frequency)
Controls
n (frequency) P -value
1,2,3
SP-D (rs721917)
C/C 97 (0.20) 60 (0.20) C 390 (0.39) 261 (0.43)
C/T 196 (0.40) 141 (0.46) T 598 (0.61) 347 (0.57)
T/T 201 (0.40) 103 (0.34)
IFN-γ  (rs2430561)
A/A 266 (0.53) 158 (0.50) A 726 (0.73) 440 (0.70)
A/T 194 (0.39) 124 (0.39) T 274 (0.27) 190 (0.30)
T/T 40 (0.08) 33 (0.10)
RANTES  (rs2107538)
A/A 143 (0.29) 81 (0.26) A 514 (0.52) 315 (0.51)
A/G 228 (0.46) 153 (0.50) G 472 (0.48) 303 (0.49)
G/G 122 (0.25) 75 (0.24)
IFNGR1  (rs11914)
T/T 418 (0.85) 250 (0.79) T 905 (0.92) 559 (0.89)
T/G 69 (0.14) 59 (0.19) G 79 (0.08) 71 (0.11)
G/G 5 (0.01) 6 (0.02)
IL-8 (rs2227538)
C/C 379 (0.76) 259 (0.83) C 863 (0.87) 567 (0.91)
C/T 105 (0.21) 49 (0.16) T 129 (0.13) 57 (0.09)
T/T 12 (0.02) 4 (0.01)
NRAMP1 (TGTG)     
deletion
D/D 14 (0.03) 3 (0.01) D 113 (0.11) 54 (0.09)
D/N 85 (0.17) 48 (0.15) N 871 (0.89) 570 (0.91)
N/N 393 (0.80) 261 (0.84)
NRAMP1 (GT)n 
repeat
118/118 301 (0.60) 216 (0.69) 118 776 (0.78) 523 (0.83) 0.011
118/120 173 (0.35) 91 (0.29) 0.077 120 217 (0.22) 106 (0.17) 0.011
118/122 1 (0.00) 0 (0.00) 122 3 (0.00) 1 (0.00) 0.686
120/120 21 (0.04) 7 (0.02)
120/122 2 (0.00) 1 (0.00)
MBP (Exon 1)
A/A 363 (0.73) 211 (0.67) A 860 (0.86) 524 (0.84) 0.241
A/B 63 (0.13) 50 (0.16) 0.368 B 67 (0.07) 50 (0.08) 0.369
A/C 56 (0.11) 39 (0.12) C 56 (0.06) 39 (0.06) 0.401
A/D 15 (0.03) 13 (0.04) D 15 (0.02) 13 (0.02)
B/B 2 (0.004) 0 (0.00)
0.170
0.202
AlleleGenotype
0.064
0.062
0.315
0.448
0.451
0.234
0.244
0.347
0.022
0.019
 
 
 
 
 
Table 4.2.  Case-control analysis of polymorphisms and TB in the South African Coloured 
pulation. 
 
 
 
 
 
 
po
-values are adjusted for age and gender.  
-values < 0.05 are bold. 
 
 
1 P
2 P
 
 
 
3 Each allele is tested against all other alleles combined 
112 
 
                                                                                                             CHAPTER FOUR 
 
All five alleles previously reported for the IL-1Ra 86 bp VNTR were present in our study 
(see chapter 3).  Allele 1 (4 repeats) and allele 2 (2 repeats) were the most common, which 
corresponds with previous studies (Tarlow et al., 1993; Witkin et al., 2002).  Statistically 
significant associations with TB were observed for alleles 1 and 2.  Allele 2 was associated 
with a decrease in the OR (OR=0.74; P=0.025) and allele 1 with a corresponding increase 
(OR=1.34; P=0.019).  Possibly due to the low frequency of alleles 3, 4 and 5, no significant 
sociation with TB was found in this study (Table 4.3), or in any other study that we are 
are of. 
as
aw
 
 
 
 Table 4.3.  IL-1Ra 86bp VNTR
Genotype Allele
Variant
TB patients
n (frequency)
Controls 
n (frequency) P -value
1 TB patients
n (frequency)
Controls
n (frequency) P -value
2
IL-1Ra 
86bp VNTR
1/1 308 (0.66) 173 (0.62) 0.037 1 742 (0.80) 425 (0.76) 0.019
4 (0.20) 62 (0.22) 2 146 (0.16) 112 (0.20) 0.025
3 (0.03) 1 (0.00) 3 15 (0.02) 3 (0.01) 0.102
1/2 9
1/3 1
1/4 14 (0.03) 11 (0.04) 4 20 (0.02) 17 (0.03) 0.152
1/5 5 (0.01) 5 (0.02) 5 7 (0.01) 5 (0.01) 0.685
2/2 24 (0.05) 25 (0.09)
2/3 2 (0.00) 0 (0.00)
2/4 2 (0.00) 0 (0.00)
3/3 0 (0.00) 1 (0.00)
4/4 2 (0.00) 3 (0.01)
5/5 1 (0.00) 0 (0.00)
 
 
 
 
 
 
 genotype and allele frequencies among TB cases and controls.   
all others.  
1 A single P-value is given for genotype association, adjusted for age and gender.   
2 Separate tests adjusted for age and gender were done for each allele versus 
Significant P-values are bold. 
 
 
4.3.2 Optimal model 
The optimal model, which best describes and predicts TB case-control status, contained 
age, gender and four variants, NRAMP1 (GT)n repeat, IFNGR1, IL-1Ra, IFN-γ and IL-8 
of which the following were individually statistically significant: gender (P < 0.001), 
NRAMP1 (P = 0.014), IFNGR1 (P = 0.016) and IL-1Ra allele 2 (P = 0.026)(Table 4.4). 
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 Table 4.4.  Summary o
 
Effect SE P- value
Age:                                 no. of years -0.01 0.01 0.127
Gender:                          male 1.47 0.19 <0.001
NRAMP1  (GT)n repeat: no. of 120 alleles 0.37 0.15 0.014
IFNGR1 (1050 T/G):    no. of G alleles -0.47 0.19 0.016
IFN-γ (+874 T/A):        no. of T alleles -0.19 0.13 0.134
IL-1Ra (86bp VNTR):   no. of 2 alleles -0.30 0.14 0.026
IL-1Ra (86bp VNTR):   no. of 4 alleles -0.63 0.33 0.053
IL-8 (+ 100 C/T):          no. of T alleles 0.34 0.18 0.060
Variables
 
 
 
 
 
 
 
 
 
 
4.3.3 Gene-gene in
containin
 
Variant Allele Variant Allele P-value
NGR1 (1050 T/G)  G NRAMP1 (TGTG) deletion Deletion 0.0078
MP1  (GT)n repeat 120 NRAMP1 (TGTG) deletion Deletion 0.0184
MP1  (GT)n repeat 120 DC-SIGN (-871 A/G) G 0.0108
P  (Exon 1) C DC-SIGN (-871 A/G) G 0.0495
P  (Exon 1) C IL-1Ra (86bp VNTR) 2 0.0343
P  (Exon 1) D RANTES (-403 A/G) G 0.0477
N-γ  (+874 T/A)       T RANTES (-403 A/G) G 0.0312
N-γ  (+874 T/A)      T IL-8 (+ 100 C/T)      T 0.0493
IF
NRA
NRA
MB
MB
MB
IF
IF
teractions 
  Condensed set 
racting pairs we detected significant interactions between eight 
illustrate the modelled interactions graphically 
able 4.5; Fig. 4.2).  
able 4.5.  Pairs of variants showing significant interactions in models adjusted for age and gender.  
or variants with more than 2 alleles, the specific allele in the model is given.   
 
 
 
 
he vertical axis on the graphs in Fig. 4.2 is the logit of the probability of having TB, and 
dicates the risk of having TB.  We will interpret it as such.  In graphs from non-SNPs, 
e effect of a single allele is illustrated, and the others are combined and denoted N. Each 
raph shows the risk of TB for nine possible genotype combinations for a 30 year old male.  
he modelled graphs for females and other ages will show the same pattern with only the 
f the optimal model for logit(TB), selected from the model  
g age, gender and alleles from 11 variants (P < 0.001).
i)
Of the 103 possible inte
pairs of variants.  The models containing the interactions are awkward to interpret.  
Therefore we list the pairs of variants and 
(T
 
T
F
 
T
in
th
g
T
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starting points differing.  Women start lower, and the risk gets slightly lower with each year 
of age in both sexes.  If the lines on the graphs were parallel, that would indicate no 
interaction between the variants.  The differences between the slopes determine the extent 
of the interaction.  The nature of each of the eight interactions is described below.  The 
models fitted the observed data extremely well, with P-values below 0.0001 for all eight 
models.  
 
A highly significant interaction was detected between INFGR1 and the NRAMP1 (TGTG) 
peat 118 allele (Fig. 4.2C). 
le C haplotype 
e risk of TB increased with each DC-SIGN G allele, while the MBL C/C homozygotes 
deletion.  With the INFGR1 T/T genotype, the deletion had no effect on the risk of having 
TB, but for INFGR1 T/G heterozygotes, the logit(TB) increased slightly and for the 
INFGR1 G/G homozygotes the risk increased dramatically with the number of deletions 
(Fig. 4.2A) 
 
The impact of the interaction between NRAMP1 (GT)n repeat and the NRAMP1 (TGTG) 
deletion on the risk of developing TB was as follows:  In the absence of the 120 allele the 
odds of getting TB decreased slightly with each deletion.  In the presence of a single 120 
allele the risk of TB increased with each deletion, while the 120/120 homozygotes showed 
a remarkable increase in logit(TB) with each deletion.  The pattern was reversed for the 118 
allele (Fig. 4.2B). 
 
A significant interaction was detected between NRAMP1 (GT)n repeat and DC-SIGN (-871 
A/G).  With the DC-SIGN A/A genotype, each 120 allele increased the logit(TB), whereas 
with each DC-SIGN G allele, the risk of TB decreased with the number of 120 alleles.  The 
decrease in the risk of developing TB was more prominent for the DC-SIGN G/G 
homozygotes than in the heterozygotes.  This pattern is reversed for the NRAMP1 (GT)n 
re
 
The impact of the interaction between MBL and DC-SIGN (-871 A/G) on the risk of 
developing TB was as follows:  In the absence of the MBL C haplotype the risk of getting 
TB decreased slightly with each DC-SIGN G allele; in the presence of a sing
th
showed a strong increase in logit(TB) with each DC-SIGN G allele (Fig. 4.2D).  This 
interaction was of borderline significance. 
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A significant interaction was detected between MBL and IL-1Ra.  In the absence of the 
MBL C allele haplotype the odds of getting TB decreased slightly with each IL-1Ra allele 2.  
 the presence of a single C allele the risk of TB increased with each IL-1Ra allele 2, while 
e MBL C/C homozygotes showed a large increase in risk of TB with each IL-1Ra allele 
h  reversed for IL-1Ra allele 1 (Fig. 4.2E). 
cant interaction was detected between IFN-γ and RANTES.  The risk of 
eveloping TB was the highest with IFN-γ A/A and RANTES A/A genotypes.  IFN-γ 
ted by RANTES 403 genotype.  IFN-γ +874 homozygotes 
In
th
2.  T e pattern was
 
An individual with RANTES G/G showed an increase in risk of developing TB with 
increasing number of MBL D haplotypes, whereas the RANTES A/G showed a decrease.  
The most prominent decrease with increase in number of D alleles was in RANTES A/A 
homozygotes.  The pattern was reversed with MBL A haplotypes (Fig. 4.2F). 
 
A signifi
d
heterozygotes were not affec
showed strong trends with increasing number of G alleles, increasing for IFN-γ +874 T/T 
and decreasing for IFN-γ +874 A/A (Fig. 4.2G). 
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ig. 4.2  Graphical representation of modelled interactions
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The extent of the interaction between IFN-γ and IL-8 on the risk of developing TB was of 
γ T allele did not have an effect on the 
f a single IFN-γ T allele the risk of TB increased with 
ach IL-8 T allele, while the IFN-γ T/T homozygotes showed a dramatic increase in 
git(TB) with each IL-8 T allele (Fig. 2.4H). 
in our database resulted in 106 variants 
attered across many genes in 545 individuals.  The optimal model which best describes 
d predicts TB case-control status could not be accurately constructed for the combined 
A). 
.3.4 Host genotype and bacterial genotype analysis 
The host genetic information (variant) with the bacterial strain information / type (trait) 
combined in a dichotomous genotype-trait association test yielded interesting results (Table 
4.7 and Fig. 4.4).  When comparing clustered vs non-clustered strains only the G allele of 
DC-SIGN -336 was associated with clustering (P = 0.034) (Fig. 4.4A).  In the association 
test between big clusters (defined as five or more individuals harbouring the same strains) 
and small clusters (defined as less than five patients with the same strains) the D allele of 
MBL and G allele of RANTES were significantly associated with cluster size (P = 0.040 
and P = 0.0006 respectively) (Fig. 4.4B).  No significant association was found for any of 
the variants when segregating non-clusters vs big clusters.  No significant association was 
found with either the Beijing family or the LCC family and any gene variant.  The T allele 
of IFN-γ was shown to significantly decrease the probability of having a Haarlem strain (P 
= 0.044) and increase the odds of having a LAM strain (P = 0.012) (Fig. 4.4C & D).  Both 
IL-1Ra allele 3 and DC-SIGN -366 allele G were associated with LAM (P = 0.048 and P = 
borderline significance.  The absence of the IFN-
odds of getting TB.  In the presence o
e
lo
 
ii) Combined set 
Combining all the genetic information available 
sc
an
data set due to the labour intensive method used for the smaller data set.  Computational 
methods suitable for large data sets could not be used as they impute missing genotypes 
which are not valid.  First, optimal models were constructed separately, whereafter a 
combined candidate model was created from all the smaller optimal selections to create the 
final model.  However, a number of statistical errors are possible in this kind of analysis 
(data not shown).  Of the 318 statistically significant pair-wise interactions found, 67 were 
highly significant (P < 0.01) (Table 4.6) and 251 were significant (P < 0.05) (Fig. 4.3 
Appendix 
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0.035 respectively) (Fig. 4.4E & F).  No statistically significant association with any gene 
variant was found when comparing the major Beijing strain (F29) (Streicher et al., 2007) 
with the major LAM strain (F11).  The only variant that was associated with the principal 
genetic groups was the T allele of IL-8 with PGG 2, compared with PGG 1 and 3 (P = 
0.034).  Since PGG3 is a small group that consists of only a few individuals, it was decided 
to compare only PGG1 with PGG2 but no statistically significant association was found 
with any of the variants.  Of all of the significant results obtained with gene-trait 
association tests, only the association of RANTES – 403 (P = 0.0006) with cluster size 
survived stringent correction of multiple testing. 
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Ge lele P
TN 0
AP 0
IL 0
IL 0
IL 0
TN 0
CO 0
CO 0.
CO 0
INS 0.
PA 0.
PPA 0
TN 0
TN 0
GP 0.
MS 0
MS 0.
MS 0
IL6S 0.
IL 0
0.
0
0.
ne name_rs number_allele Gene name_rs number_al  value
FRSF1A_rs767455aT TLR2_rs5743704aC .0077
G16L_rs2241880aT TLR2_rs5743704aC .0052
1RN_rs2419598aT IL12B_rs730691aC .0038
1RN_rs2419598aT IL18_rs187238aG .0093
1RN_rs2419598aT MHC2TA_rs3087456aG .0024
F_rs1799964aT TEX264_rs4355273aG .0071
2region_rs11718165aA DCSIGN336aA .0078
2region_rs11718165aA SOCS3_rs4969169aC 0060
2region_rs11718165aA TEX264_rs28994878aC .0022
IG2_rs7566605aG CARD15_rs2066844aC 0094
DI4_rs2240340aA SPD_11aT 0045
RG_rs2067819aG CARD15_rs2066847awt .0047
FR2_rs3397aC MBPExon1aA .0053
FR2_rs3397aC IL12B_rs3212227aA .0098
130_rs3730293aT NRAMP1promCAa118 0014
4A2_rs569108aT MBPExon1aA .0053
4A2_rs569108aT NRAMP1TGTGdelaN 0012
4A2_rs569108aT BTNL2_rs2076530aA .0042
T_rs3729961aC NRAMP1promCAa118 0027
23R_rs11209026aG BTNL2_rs3817974aA .0089
IL23R_rs11209026aG CO2region_rs11718165aA 0077
TNFSF15_rs7848647aC MS4A2_rs569108aT .0014
PTPN22_rs2476601aG NELL1_rs1607616aT 0077
G  name_rs number_allele P  value
N P1promCAa118 0.0077
I 74aA 0.0050
C R1_AP3aT 0.0046
C 15_rs2066844aC 0.0082
I a1 0.0041
I P1TGTGdelaN 0.0044
I xon1aA 0.0050
IL _rs448943aC 0.0062
I P1TGTGdelaN 0.0033
S _rs13720aC 0.0004
T _rs448943aC 0.0077
T 2243248aT 0.0009
T xon1aA 0.0085
T 74aA 0.0077
T rs1800890aT 0.0020
T _rs3760399aT 0.0037
T R1_AP3aT 0.0035
T rs1800890aT 0.0098
T B2_rs11576006aT 0.0082
T rs1800890aT 0.0095
T rs3804100aT 0.0069
M B2_rs375947aA 0.0079
P rs4969168aC 0.0063
ene name_rs number_allele Gene
RAMP1TGTGdelaN NRAM
L.8_.100aC IFNg8
ARD15_rs2066844aC IFNG
TSZ_rs13720aC CARD
L4_rs2243248aT IL1Ra
L18_rs189667aA NRAM
L18_rs360718aA MBPE
18_rs360718aA CTSZ
L18_rs187238aG NRAM
ocs3_rs4969168aC CTSZ
EX264_rs28994878aC CTSZ
LR2_rs5743704aC IL4_rs
LR2_rs5743708aG MBPE
LR4_rs1927914aC IFNg8
LR4_rs1927914aC IL10_
LR4_rs1927914aC CCL2
LR4_rs4986791aT IFNG
LR4_rs11536889aG IL10_
LR4_rs11536891aT IL12R
LR4_rs11536891aT IL10_
LR4_rs11536891aT TLR2_
DR1_rs3789243aC IL12R
TGER4_rs1992660aA Socs3_
 
 
 
 
 
T ant interactions (P < 0.01) in models 
er for the SNP and the cific allele for variants with more th ele
able 4.6.  Pairs of varian
followed by the rs numb
ts showing highly signific adju
 spe an 2 all
sted 
Gene name_rs number_all
X5q31_rs11739135aG
RUNX1_rs2268277aC
RUNX1_rs2268277aC
X1_rs2268277aC
_rs472631aT
_rs815541aC
_rs7624718aA
_rs7624718aA
_rs7624718aA
rs3731568aA
rs3731568aA
rs3731568aA
rs6708488aA
rs6708488aA
rs6708488aA
rs718290aT
_GTa18
941a8
xon11delaGAAG
rs3948463aG
rs3948463aG
ele Ge
IL1
ne nam
RN_rs
SZ_rs4
R4_rs
F_rs18
PN22_
s3_rs49
0_rs1
e_rs number_allele P  value
2419598aT 0.0095
CT 48943aC 0.0055
TL 1927914aC 0.0017
RUN TN 00629aG 0.0083
Wnt5a PT rs2476601aG 0.0090
Wnt5a Soc 69168aC 0.0061
Wnt5a IL1 800890aT 0.0034
Wnt5a TEX264_rs28994878aC 0.0070
Wnt5a INSIG2_rs7566605aG 0.0005
Fzd5_ IL1Raa1 0.0056
Fzd5_ IL10_rs1800890aT 0.0075
Fzd5_ TNFRSF1A_rs767455aT 0.0094
Fzd5_ MDR1_rs1045642aC 0.0002
Fzd5_ MDR1_rs2032582aG 0.0000
Fzd5_ Wnt5a_rs9311564aA 0.0008
Fzd5_ TNFRSF1A_rs767455aT 0.0098
TLR2 MS4A2_rs569108aT 0.0095
D5S2 CTSZ_rs448943aC 0.0090
sp11E IL10_rs1800890aT 0.0072
sp110_ PTGER4_rs1992660aA 0.0010
sp110_ IL1RN_rs2419598aT 0.0016
for age and gender.
s.  
  The gene name is given 
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Variant
Clustered vs
non clustered
P/MBL Exon1nB 0.5081
P/MBLExon1nC 0.3095
P/MBLExon1nD 0.9877
AMP1promCAn120 0.3055
AMP1promCAn122 0.9866
AMP1TGTGdelnD 0.8272
NGR1_AP3nG 0.813
N-γ874nT 0.7938
1Ran4 0.8754
1Ran3 0.7342
0.968
2 0.3671
nT 0.7251
_.403nG 0.3915
871nG 0.1612
336nG 0.0347
Big c
sma
g vs
ijing
Beij
L
 vs
rs
P
s
MB 07 0.613 21 0.7210
MB 59 0.500 92 0.7559
MB 22 0. 0.992 87 0.9926
NR 70 0. 0.907 72 0.9631
NR 42 0. 0.987 44 0.9919
NR 13 0. 0.276 23 0.6432
IF 0.338 00 0. 0.982 83 0.0926
IF 0.546 98 0. 0.164 57 0.2473
IL- 0.482 87 0. 0.133 30 0.9931
IL- 0.533 57 0. 0.988 05 0.9919
IL-1Ran5 0.853 40 0. 0.647 36 0.9929
SPD_11n 0.469 65 0. 0.663 81 0.2063
IL.8_.100 0.881 46 0. 0.593 41 0.1633
RANTES 0.0006 72 0. 0.212 55 0.2354
DCSIGN 0.822 52 0. 0.732 38 0.7760
DCSIGN 0.790 19 0. 0.895 86 0.6900
lusters vs
ll clusters
Non clusters 
vs big clusters
Beijin
non-Be
0.2146 0.3129 0.33
0.8950 0.4376 0.78
0.0401 0.9882 0.42
0.7930 0.3753 0.72
0.9846 0.9908 0.08
0.5757 0.9074 0.27
0 0.7719 0.88
5 0.9375 0.44
2 0.7983 0.35
2 0.5581 0.98
4 0.9619 0.35
5 0.3157 0.37
7 0.7222 0.31
0.3669 0.11
7 0.2499 0.74
6 0.1622 0.92
Haarlem vs
non-Haarlem
LAM vs 
non-LAM
LCC vs
non-LCC
0.3077 0.7925 0.4976
0.4032 0.9856 0.6128
6199 0.4303 0.9733
4692 0.7083 0.1807
9917 0.9859 0.9866
1640 0.6899 0.8869
6236 0.8365 0.5090
0443 0.0123 0.1674
3848 0.1938 0.9886
9912 0.0485 0.6416
9892 0.6929 0.9882
3992 0.5388 0.9651
5507 0.0945 0.3208
5612 0.2906 0.7060
3304 0.3904 0.6399
6607 0.0351 0.0600
ing (F29) vs
AM (F11)
PGG1 vs
others
PGG2
othe
1 0.1694 0.26
7 0.6680 0.56
2 0.5342 0.79
2 0.9681 0.99
9 0.9840 0.98
6 0.3530 0.27
0 0.7713 0.45
2 0.1923 0.06
9 0.2696 0.16
9 0.5646 0.36
4 0.4727 0.69
7 0.7547 0.33
7 0.1489 0.03
9 0.2257 0.65
7 0.8861 0.76
0 0.9484 0.76
GG3 vs
other
PGG1 vs 
PGG2
0.1801
0.6315
0.5989
0.9776
0.9841
0.3087
0.9817
0.1347
0.2362
0.5032
0.5281
0.6178
0.1011
0.3016
0.8455
0.8955
 
 
 
Table 4.7.  P-values for dichotomous trait-genotype (allele count) association tests, adjusted for age.  
Significant interactions are highlighted in green (P < 0.05) and in P <  red ( 0.001).
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4.4 DISCUSSION 
 
The condensed group of 11 variants involved in TB susceptibility genotyped here enabled 
us to test the theory that disease outcome may be due to the interaction of several gene 
effects.  With only four associations found between the individual variants and TB 
susceptibility, but eight instances of statistically significant gene-gene interactions, the 
importance of epistasis is clearly identifiable in this study. 
 
One of the eight interactions were between two variants in the NRAMP1 gene, namely the 
5’(GT)n repeat and the 3’ UTR (TGTG) deletion.  Both of these have previously been 
associated with TB independently (Table 1) and were shown to have separate main effects 
at the 5’ and the 3’ together with dominance effects at the one end but not the other 
(Bellamy et al., 1998).  From this it can be deduced that there are separate functional 
polymorphisms in linkage disequilibrium (LD) with these two markers that play an 
important role in susceptibility to TB. 
 
The interaction observed between NRAMP1 and IFNGR1 can be explained by their 
mutual involvement in macrophage activation.  Functional IFNGR1 is essential for 
containing M. tuberculosis (Dorman et al., 2004) and suggests a critical role for IFN-y and or 
its receptors.  NRAMP1 is essential in macrophage activation as it activates microbicidal 
responses in the infected macrophage and therefore plays an important role in the early 
innate response to mycobacterial infection (Li et al., 2006).  NRAMP1 also enhances the 
pro-inflammatory responses which are important in the containment of mycobacterial 
infection.  Macrophage activation is greatly enhanced by IFN-γ and IFN-γ response 
elements that are present in the human NRAMP1 promoter region (Searle & Blackwell, 
1999), providing further evidence for their interaction. 
 
The interactions observed between IFN-γ and both IL-8 and RANTES are likely to be due 
to their pro-inflammatory nature.  IFN-γ is a Th1 type cytokine that plays a crucial role in 
n, including M. tuberculosis 
idyarani et al., 2006).  It activates macrophages and plays a vital role in antimicrobial 
rotection, as demonstrated in a knockout mouse model where an increase in susceptibility 
to tuberculosis could be seen once the gene was knocked out (Cooper et al., 1993).  IL-8, a 
the initial protective immune response against an infectio
(V
p
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neutrophil activating peptide, is an important chemokine in the human inflammatory 
process and functions as a potent chemoattractant for the recruitment of leukocytes to 
inflammatory sites (Ma et al., 2003).  IL-8 is a tissue-derived peptide that mediates the 
activation and migration of neutrophils and T lymphocytes into tissue from the peripheral 
blood.  RANTES, also known as CCL5, is a ligand for chemokine receptor 5 and recruits 
veral types of inflammatory cells including eosinophils, monocytes and T lymphocytes to 
ation.  The recruitment of cells is vital for granuloma formation and 
ition receptors such as DC-SIGN.  On the basis that DC-SIGN might 
acellular signalling events leading to cytokine secretion, it has previously been 
M. tuberculosis to their own 
se
sites of inflamm
RANTES recruits infected macrophages more effectively than uninfected macrophages 
(Skwor et al., 2006). 
 
MBL and DC-SIGN are both C-type lectins and function in uptake and signalling in the 
pulmonary innate immune system (Ji et al., 2005).  Microbial carbohydrate structures are 
recognized by pathogen associated molecular pattern (PAMP) receptors such as MBL and 
DC-SIGN (Buzás et al., 2006).  MBL plays an important role in the modulation of 
inflammation as it binds to the pathogen to initiate the lectin pathway acting as the first line 
of defence against microbes (Holmskov et al., 2003; Turner et al., 2003).  Phagocytes 
represent the first cellular defence in the alveoli, the surface of which is rich in C-type lectin 
pattern recogn
mediate intr
proposed that this C-type lectin could be used by pathogens like 
advantage as part of an immune strategy (Geijtenbeek et al., 2003; Tailleux et al., 2003).  
Bearing in mind that these two C-type lectins, MBL and DC-SIGN, have complementary 
functions in the lectin pathway, a functional interaction seems likely. 
 
The nature of two of the eight interactions (MBL : ILRa and NRAMP1 : DC-SIGN) for 
TB susceptibility is not clear and might have been detected by chance as it is difficult to 
find simple biological explanations for the interactions observed.  However, MBL plays a 
very important role in the innate immune response by modulating inflammation and IL-1 
and therefore IL-1Ra is responsible for a cascade of events leading to a potent pro-
inflammatory immune response (Dinarello, 1988).  The mechanism by which MBL 
modulates inflammation is not clear but it has been proposed that it exerts a complex effect 
on cytokine release by monocytes (Jack et al., 2001).  A previous study showed that 
monocyte release of certain cytokines, such as IL-1, was enhanced at MBL concentration 
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below 4μg/ml but reduced at higher concentrations, suggesting that both the MBL 
genotype and the presence or absence of an on-going acute phase response will help to 
determine the nature of such cytokine responses in individuals (Turner, 2003).  Given the 
interrelationships and complexity of the innate immune system, and the fact that different 
pathways frequently form part of the same network (Delves & Roitt, 2000; Raza et al., 
2008) these interactions could well indicate functionality in the same network known as 
downstream interactions. 
 
The combined data set consisting of 545 individuals and 106 variants yielded a vast number 
f pair-wise interactions.  Of the 318 statistically significant interactions (P < 0.05) found, 
7 were highly significant (P < 0.001).  This large number of interactions found could be 
xplained by the fact that all of the selected genes were well-characterised candidate genes 
for susceptibility to TB based on their biological function and proposed role in the 
multistep course of this complex disease.  However, we have to consider the fact that some 
of these interactions might be spurious due to the large number of data points analysed.  
All of these interactions need to be thoroughly investigated to assess the plausibility and 
importance of each pair wise interaction separately.  The analysis of this immense 
combined data set showed once again how complex and integrated human biological 
systems are, making it difficult at this point to be fully understood.  This gene-gene pair-
wise interaction analysis is a multi gene approach that may be the future for host genetic 
susceptibility studies of TB as the effect of one gene might not be revealed if the effect of 
another gene is not considered. 
 
From our bacterial strain data, it can be seen that LAM is the most prevalent family of 
strains, however the frequency of occurrence of Beijing family of strains is on the increase.  
Individuals belonging to the Beijing family of strains can be grouped together in a small 
group based on their strain information and relative small strain differences whereas in the 
LAM family, individuals are much more distant from each other as it is a broader family.  
The LCC and Haarlem strain families are very small and therefore play a less important role 
in the TB epidemic.   
 
It has been hypothesized that the interaction between the genotype of the human host, and 
the bacterial strain genotype, could influence the susceptibility of the host in terms of both 
o
6
e
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the progression to disease and perhaps the type of disease seen.  These interactions were 
tested here by means of a dichotomous genotype-trait association test.  Most of the 
interactions were slightly statistically significant except for RANTES -403 that was strongly 
associated with cluster size (P = 0.0006).  The odds of being part of a small cluster 
eases highly significantly with each G allele at this locus, i.e. each G allele halves the 
ihood of an individual being more susceptible to a unique strain that will form a small 
ter.  It is difficult to draw any reliable conclusions from the weak associations found as 
t of them will probably disappear after multiple corrections.  The low numbers in some 
he bacterial traits as well as the human genotype categories such as the Haarlem strain 
 21) and the MBL D allele (n =6) might have contributed to the weak associations 
d.   
everal polymorphisms have been associated with TB susceptibility, our main focus 
 test how polymorphisms in multiple genes acting simultaneously, affect the immune 
n and therefore susceptibility to TB which is a result of multiple genetic and 
nmental factors.  The effect of one gene might not be revealed if the effect of 
r gene is not considered and therefore, focusing on single polymorphisms at a time 
enerate false negatives.  This is the first time, to our knowledge, that interactions 
n these genes have been shown.  However there is a potential limitation to this 
namely spurious associations, particularly where the mechanism of interaction of the 
involved is not immediately clear or intuitive.  The genes studied above were all well-
 and well-characterised in the search for susceptibility genes to TB.  Considering the 
t of data rapidly becoming available from SNP chip studies, similar interaction 
 between known susceptibility genes and others could well identify new candidates 
ed in TB susceptibility.  Methods for studying gene-gene interactions are based on a 
cus and multi gene approach, consistent with the nature of complex-trait diseases, 
ay provide the paradigm for future genetic studies of TB. 
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5.1 INTRODUCTION 
Due to the complexity of the immune system and the multifactorial nature of a complex 
disease such as TB, it has become increasingly evident that unravelling the underlying 
mechanisms of the genetic component may lead to new insights into the pathogenesis of 
TB and the development of new treatment strategies (Selvaraj et al., 2008). 
 
Cytokines (also known as immunomodulating agents) such as interferons, interleukins, 
tumor necrosis factor and lymphokines as well as chemokines are small regulatory proteins 
that are released by cells to regulate the immune response by triggering inflammation.  The 
management of several components of the host immune system is required to respond 
successfully to an invading pathogen such as M. tuberculosis (Frankenstein et al., 2006).  
Depending on the type and amount of cytokine and chemokine secretion, activated at the 
recognition of a pathogen, the host defensive mechanisms can be stimulated or over- 
stimulated leading to tissue injury, fever or cachexia (Zganiacz et al., 2004).  The 
interactions between lymphocytes, antigen-presenting cells and the cytokines secreted by 
them are therefore responsible for regulating the immune response to TB.  A simplified 
version of some of the effects following M. tuberculosis infection can be seen in Fig. 5.1.   
 
It is well known that owing to various polymorphisms in several cytokine genes, the 
protein levels of the main modulators of the immune system, cytokines and chemok , 
are changed in several diseases such as cancer (O'Hayre et al., 2008), cardiovascular diseases 
(Aukrust et al., 2007), inflammatory diseases (Szekanecz & Koch, 2007) and infectious 
diseases (García-Zepeda et al., 2007; Jankovic et al., 2001) including susceptibility or 
resistance to TB (Cooke et al., 2006; Henao et al., 2006; Lopez-Maderuelo et al., 2003; M t 
al., 2003; Rossouw et al., 2003; Vidyarani et al., 2006).  The functional polymorphisms or 
haplotype patterns in some of these cytokine genes might be vital for protective imm e 
responses and may serve as biomarkers of protection or susceptibility to TB (Selvaraj ., 
2008). 
 
The discovery of biomarkers for use as surrogates for the response to TB treatment may 
play a crucial role in monitoring efficiency in both the current TB drugs as well as clinical 
trials for new TB drugs.  There are three possible classes of biomarkers: (1) markers for 
relapse, that may reduce the duration of clinical trials, (2) markers to assess early treat t 
ines
a e
un
et al
men
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um cultures and (3) markers for baseline differences that can lead to 
the identification of patients who require specialised treatment (Brahmbhatt et al., 2006; 
 
that may replace sput
Siawaya et al., 2008).  Cytokines represent once candidate class for promising biomarkers. 
 
 Fig. 5.1 A simplified version of some downstream effects after infection with M. tuberculosis 
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Therefore measurements of these modulators / cytokines can give new insights into the 
disease (more specifically the mechanisms underlying it) leading to enhanced diagnosis and 
treatment. (Colobran et al., 2007; McInnes & Schett, 2007).  To accurately predict which 
single modulator will give the best possible explanation as to what the underlying 
mechanism of the disease is, is near impossible, therefore, in my opinion, measuring 
multiple immunomodulators simultaneously is a way forward. 
 
There are several techniques available to measure immunomodulators.  The most widely 
used technique still remains the enzyme-linked immunosorbant assay (ELISA).  However 
is technique is limited to measuring only one immunomodulator at a time, making it 
y (LINCO Research).   
th
labour intensive and time consuming.  Due to the complex network of immunomodulators 
and possible interactions that might exist, measuring only one modulator at a time will not 
be efficient in assessing its biological relevance.  Therefore new multiplex technologies 
have been developed to measure a large number of cytokines simultaneously in one 
reaction.  The two major advantages of this technique are: 1) a low volume of sample is 
required to simultaneously detect many immunomodulators of interest and 2) time is saved 
as many measurements are done at once.  
 
It is now possible to look at the relationship between secreted cytokines / proteins and the 
genotype information of the individuals opening a new door to identification of response 
markers.  The present study investigated 18 cytokines including pro-inflammatory, anti-
inflammatory and chemokine factors in healthy (mantoux positive or negative) children 
using the well described and commonly used Linco-plex immunoassa
 
5.2 MATERIALS AND METHODS 
 
5.2.1 Study cohort 
All the subjects used in this study originated from the Ravensmead and Uitsig suburbs near 
Tygerberg Hospital, Parow, Western Cape, South Africa where the incidence of TB has 
been reported as ± 1000 per 100 000 population, but with a low HIV prevalence.  A total 
of 340 healthy HIV negative children were collected from the Ravensmead-Uitsig 
community and used in the Lincoplex assay.  All participants in this study or their legal 
guardians provided written informed consent for participation in the study.  The Ethics 
Review Committee of the Faculty of Health Sciences, University of Stellenbosch, South 
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Africa approved this investigation (95/072).  The Mantoux skin test was carried out on all 
participants using M. tuberculosis PPD.  The Mantoux skin reactivity was read between 48-72 
h after the test.  Results were available for 309 (90.8%) of the individuals.  The sex 
distribution was approximately equal, with 49.5% males and 50.5% females, with a median 
age of 14 years. 
 
5.2.2 Sample collection and antigen stimulation 
0 ml of blood was drawn from all the participants at the community centre and kept at 
r plate and a vacuum pump for the washing steps.  All 
ther reagents as well as the antibody-immobilized beads were supplied with the kits 
m pump followed by two wash steps with wash buffer.  The 
iotinylated detection antibody cocktail was added into each well and left to incubate on a 
1
37oC in a portable incubator while it was transported to the lab in 1-2 hours.  Heparinised 
(anti-coagulant factor) whole blood was diluted 1 in 10 with serum-free medium (RPMI, 
Gibco, Laboratory Scientific Services).  Cells were stimulated in quadruplicate with two 
antigens, M. bovis bacillus Calmette-Guerin (BCG) and early secreted antigen -6 (ESAT-6).  
The negative control was without any antigen stimulation.  Cell cultures were incubated at 
37oC with 5% CO2,whereafter the supernatants were harvested at day 3 and 7.  Since a very 
high correlation was found between day 3 and day 7 with the ELISA results across both 
antigens (BCG and ESAT-6) and the percentage of individuals responding to antigen was 
higher at day 7, only day 7 samples were used for the Linco-plex immunoassay (see section 
5.3.6). 
 
5.2.3 Measurement of cytokines using the Linco-plex immunoassay  
The human cytokine 18-plex Linco-plex assays were done according to manufacturer’s 
instructions using a 96-well filte
o
(LINCO Research).  A standard curve was used in each assay ranging from 3.2 pg/ml to 10 
000pg/ml.  After blocking the filter plate with assay buffer, an appropriate matrix diluent, 
in this case RPMI with glutamine, was added to all the wells.  The 18 antibody-immobilized 
beads were sonicated separately, whereafter they were mixed together according to 
manufacturer’s instructions.  This was followed by adding the samples in the appropriate 
wells as well as the mixed beads.  After 1 hour incubation on a shaker, the fluid was 
removed by a vacuu
b
shaker for 30 min. at room temperature whereafter the streptavidin-phycoerythrin was 
added to each well.  This was left to incubate on the shaker for 30 min. at room 
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temperature, whereafter the contents were gently removed by a vacuum pump.  After 
another two wash steps sheath fluid was added to all the wells and put on a shaker for 5 
min to allow the beads to resuspend.  After this the plate was placed in the Luminex 
instrument where the beads were analyzed immediately on a Bio-plex array reader.   
 
Quality controls were provided with each kit to measure the reliability and precision of the 
selected cytokines.  All 18 cytokines measured fell into the manufacturer’s expected range 
(Table 5.1).  A stringent quality control, the supernatant of a 7 day whole blood assay 
(WBA) from a volunteer, was aliquoted out, stored at -80oC and used on every plate for 
each run. 
 
 
Anti-inflammatory cytokines
IL-1α TNF-α IFN-γ IL-4
IL-7 IL-17 IP-10 IL-10
IL-8 sCD40L MCP-1 IL-13
IL-12p40 GM-CSF MIP-1α IL-1Ra
IL-12p70 RANTES
Pro-inflammatory and Th1 type cytokines
 
 
 
5.2.4 Statistical analysis 
Spearman correlation tests were used to correlate variables (Mantoux, age, BCG and 
ESAT-6) and cytokines.  A one-way analysis of variants was used for the Mantoux reading 
0 mm vs Mantoux reading > 0 mm.  Parallel analysis was used to compute the factor 
loadings (O'Connor, 2000).  The program STATISTICA version 8.0 (www.statsoft.com) 
was used for all the analyses. 
 
5.3 RESULTS 
 
5.3.1 Mantoux results 
The distribution of the Mantoux readings (mm) can be seen in Fig. 5.2.  In our data there 
ere two major peaks, one at 0 mm and one at 15 mm.  According to the international 
m is scored as negative and between 5 mm and 10 
 to the 
athogen.  Any Mantoux reading ≥ 10 mm is regarded as a positive TST.  Of the total 
udy group, 123 had no measurable Mantoux reaction (0 mm) whereas 17 had a reaction 
able. 5.1 Cytokines included in the 18-plex Lincoplex assay T
w
standards any TST measurement < 5 m
mm is regarded as intermediate, indicating that individuals have been exposed
p
st
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of ≥ 5 mm, 61 ≥ 10 mm and 106 ≥ 15 mm.  It has been suggested that one would expect a 
eak between 5 mm and 10 mm as a result of the BCG vaccination (Mahomed et al., 2006; 
ai et al., 2005).  However we did not see this in our study group nor did we see a peak 
etween 0 mm and 5 mm.  Our two main peaks in this bimodal distribution were at 0 mm, 
dicating that they had no measurable anit-mycobacterial immune response, and at 15 mm, 
dicating that they have a significant immune response.  
 
 
 
 
 
A Spearman correlation test was performed between all the cytokine production levels 
[pg/ml] and the Mantoux readings > 0 mm.  Three separate correlation tests for BCG 
stimulated, ESAT-6 stimulated and unstimulated samples were done for each cytokine.  
The results for the main Th1-type cytokine IFN-γ were as follows (Fig. 5.3), the BCG 
stimulated group (r = 0.18, P = 0.55), the ESAT-6 stimulated group (r = 0.28, P < 0.00) 
and the unstimulated group (r = -0.04, P = 0.61).  All the other cytokines gave similar 
results.  A correlation value of r ≥ 0.80 is considered to be a strong correlation; however 
some of the P-values were statistically significant in our study even though the correlation 
values differed only slightly from zero.  Therefore the few significant P values obtained in 
our study do not indicate a good correlation, but merely a trend that might be caused by 
other factors.  The P-values in these graphs are an indication of the degree of certainty that 
we have that the correlation coefficient (r) is as stated. No major correlations were found 
between any of the 18 cytokines and the Mantoux readings.  From this it can be deduced 
p
P
b
in
in
Fig. 5.2 The distribution of the Mantoux readings for all the study participants
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e production of these specific cytokines and the Mantoux 
n levels [pg/ml] 
d these two groups.  Three separate correlation tests for BCG stimulated, ESAT-6 
5), 
SAT-6 stimulated (P = 0.49), or in the unstimulated group (P = 0.44).  IL-4 was detected 
that the correlation between th
readings are not well correlated.   
 
The data was divided into two groups based on their Mantoux response, viz. 0 mm and > 0 
mm.  A correlation test was performed between all 18 cytokine productio
an
stimulated and unstimulated samples were done for each cytokine.  Focusing on the Th1-
type cytokines, we found increased cytokine production levels in the group with a Mantoux 
measurement of > 0 mm compared to the group with 0 mm.  The response of two Th1-
type cytokines, IFN-γ and IL-8, can be seen in Fig. 5.4A and B respectively.  This 
difference was statistically significant in the BCG-stimulated (P ≤ 0.01) and ESAT-6 
stimulated groups (P ≤ 0.01), but as expected not in the unstimulated group (P = 0.33).   
 
The Th2-type cytokines showed a slight decrease in cytokine production levels in the group 
that had a Mantoux measurement of > 0 mm compared to the group that had a 
measurement of 0 mm.  The response of the main Th2-type cytokine, IL-4, can be seen in 
Fig. 5.5.  This difference was not statistically significant in the BCG-stimulated (P = 0.5
E
at very low levels throughout the Lincoplex assay and considerably lower compared to that 
of IFN-γ.  The low detection level of IL-4 can be due to either low sensitivity of the assay 
to detect IL-4 or due to a low production of IL-4 amongst the participants. There was 
therefore no evidence for differences in IL-4 levels and a Mantoux positive or negative 
reaction.   
 
                                                                                                             CHAPTER FIVE 
 
 
135 
y
0 5 10 20 25 30 35 40 4515
Mantoux
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
y
0 5 10 15 20 25 30 35 40 45
Mantoux
-1000
0
1000
2000
3000
4000
5000
6000
0 5 10 15 20 25 30 35 40 45
Mantoux
-100
0
100
200
300
400
500
600
700
800
r = 0.18    
P = 0.55
r = 0.28   
P < 0.00
r = -0.04   
P = 0.61
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.3 Correlatio tween Mantoux readings > 0 mm and IFN-γ production [pg/ml] for BCG stimulated samples, ESAT-6 stimulated 
samples and unstimulated samples.  r = Spearman correlation. 
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ulated 
d unstimulated samples were done for each cytokine.  In this study, no major 
y (Fig. 5.6 A & B).   
 significant in the BCG-stimulated 
(P < 0.00) and ESAT-6 stimulated groups (P < 0.00), but not in the unstimulated group (P 
= 0.49) (Fig. 5.6A).  Focusing on IL-4 we found that the correlation was statistically 
significant in the BCG- and ESAT-6-stimulated groups and in the unstimulated group (all 
three P < 0.00) (Fig. 5.6B).  It is difficult to draw conclusions from the IL-4 cytokine 
production levels, as these were very low throughout the Lincoplex assay (see section 
.3.1).  The low levels of IL-4 relative to IFN-γ are clearly evident in Fig. 5.6. 
5.3.2 Age 
The median age of the study group was 14 years, ranging from 2 months to 40 years.  A 
Spearman correlation test was performed between all the cytokine production levels 
[pg/ml] and age.  Three separate correlation tests for BCG stimulated, ESAT-6 stim
  
an
correlations were found between any of the 18 cytokines and age.  As explained in section 
5.3.1, some of the P- values were statistically significant even though the correlation values 
differed only slightly from zero.  As the results were more or less the same for all 18 
cytokines, I will discuss only the main Th1- and Th2-type cytokines i.e. IFN-γ and IL-4 
respectivel
 
The correlation between IFN-γ and age was statistically
5
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5.3.3 Correlation between BCG and ESAT-6 for all the cytokines 
A Spearman correlation test was performed between the production levels [pg/ml] of all 18 
cytokines for both the BCG stimulated and ESAT-6 stimulated samples.  The correlations 
were statistically significant for all 18 cytokines.  Some of these correlations can be seen in 
ig. 5.7 [A] for IFN-γ, [B] for IL-8, [C] for IL-1Ra and [D] for IL-4.  The IFN-γ response 
 
F
was higher in the BCG stimulated samples than the ESAT-6 stimulated samples. The IL-8 
production was high in both BCG and ESAT-6 stimulated samples.  A strong correlation 
was found between BCG and ESAT-6 stimulated samples for both IL-1Ra (r = 0.83) and 
IL-4 (r = 0.90).  This indicates that BCG induces IL-1Ra and IL-4 production to the same 
level as ESAT-6. 
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Fig. 5.7 Correlation between BCG and ESAT-6 stimulated responses for [A] IFN-γ, [B] IL-8, [C] IL-1Ra and [D] IL-4  
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5.3.4 Comparison of cytokine production levels 
A correlation test was performed between antigen-specific cytokine production levels of all 
18 cytokines.  The highest statistically significant correlations that were found are 
summarised in Fig. 5.8. The full set of results is represented in a correlati
5.9).  We found strong correlations between IFN-γ and the granulocyte-macrophage 
colony-stimulating factor (GM-CSF) for both BCG and ESAT-6 (r = 0.89 and r = 0.92 
respectively).   
                   
on matrix (Fig. 
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TNF-alpha 0.71 ˉ 0.71 ˉ ˉ ˉ ˉ ˉ
CG ESAT‐6
 
 
 
 
A strong positive correlation w served between IP-10 and IFN-γ for both BCG and 
ESAT-6 stimulation (r = 0.75 and r = 0.91respectively).  IP-10 production levels were 
strongly correlated with GM-CSF levels for ESAT-6 stimulation (r = 0.84).  Production 
levels of IL-17 and GM-CSF, and IL-17 and IFN-γ were highly correlated when stimulated 
with ESAT-6 (r = 0.80 for both), but the correlation weakened when stimulated with BCG 
(r = 0.68 for both) (see Fig. 5.8).  All of the above mentioned cytokines are pro-
inflammatory cytokines and form part of the Th1 response.  Other strong correlations after 
ESAT-6 stimulation were betw -13 and both GM-CSF and IFN-γ (r = 0.79 in both 
cases). 
Fig. 5.8 A summary of the Spearm relation matrix, portraying the r values of orrelations 
found. The values in red text indicate statistically significant correlations with valu 7 in yellow 
as ob
een IL
an cor major c
es ≥ 0.
blocks and values ≥ 0.8 are shown blocks.in red
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Fig. 5.9 A matrix of the Spearman correlation coefficients (r values) between antigen-specific cytokine production levels of all 18 cytokines.  The 
upper quadrant portrays the result of stimulation by the ESAT-6 antigen (blue) and the lower quadrant by BCG antigen (green).  The values in 
red text indicate statistically significant correlations with values ≥ 0.7 in yellow blocks and values ≥ 0.8 are shown in red blocks. 
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5.3.5 Factor analysis 
When working with a large amount of data, factor analysis is a procedure used to explain 
the data in a logical and compressed way or, as in our case, according to biological 
relevance.  Principal component analysis is used to group all the variables, in this case 
cytokines, into groups called factors.  A significant proportion of the data can be explained 
by the derived factors. Parallel analysis was used in the program STATISTICA version 8.0 
(www.statsoft.com) to compute the factor loadings. 
 
The factor analysis starts off with a scree plot of all the multiple variables.  Two plots were 
drawn for this dataset, one for BCG (Fig. 5.10 A) and one for ESAT-6 (Fig. 5.10 B).  These 
lots are used to minimize the variables and group them into smaller groups called factors 
he different factors obtained from the BCG and ESAT-6 analysis can be seen in Tables 
.2 A & B respectively.  In both analyses the size of the first factor / eigenvalue was the 
largest, followed by the other factors contributing less and less.  The size of an eigenvalue 
refers to the amount of variance (%) in the dataset that can be explained by that eigenvalue.  
The four major factors explained the data by a cumulative effect of 54.34% for BCG and 
54.44% for ESAT-6 whereas the rest of the factors had no significant impact. 
 
p
to examine their combined effect within the factor instead of separately.  There are three 
lines on each plot, where the blue line represents the principal component of the actual 
data (raw data obtained in study, therefore not modelled data); the red line represents the 
principal component of the stimulated data and the green line represents the resampled 
data.  Based on where the actual data (blue line) crosses the stimulated and resampled data 
(green and red line respectively) the number of factors involved can be deduced.  In our 
study both datasets could be explained by four factors / eigenvalues.   
 
T
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Eigenvalue variance Eigenvalue
Cumulative %
1
Size of % Total Cumulative 
4.69 26.08 4.69 26.08
2 2.22 12.35 6.92 38.43
3 1.61 8.93 8.52 47.36
4 1.26 6.98 9.78 54.34
Factor
Eigenvalue variance Eigenvalue
Cumulative %
Size of % Total Cumulative 
1 4.59 25.52 4.59 25.52
2 2.42 13.43 7.01 38.94
3 1.57 8.74 8.58 47.68
4 1.22 6.76 9.80 54.44
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B
Fig. 5.10 Two scree plots of [A] BCG stimulated and [B] ESAT-6 stimulated samples of all the multiple variables. The blue line represents 
the principal component (PC) of the actual data; the red line represents the PC of the stimulated data and the green line represents the PC of 
the resampled data.  
 
Table 5.2 Two line plots [A] BCG stimulated and [B] ESAT-6 stimulated samples of all the multiple variables.
A B
 
                                                                                                             CHAPTER FIVE 
146 
 
A process called factor loading assigns certain loading parameters to e
Variables (18 cytokines) Factor 1 Factor 2 Factor 3 Factor 4
GM-CSF 0.775 0.463 -0.048 0.109
IFN-g 0.716 0.356 -0.053 0.120
IL-10 0.139 0.383 0.148 0.023
IL-12p40 0.065 0.194 0.439 0.057
IL-12p70 -0.041 -0.008 0.585 -0.060
IL-13 0.719 0.151 -0.036 -0.105
IL-17 0.676 -0.030 0.099 -0.143
IL-1alpha 0.070 0.699 0.504 0.110
IL-1Ra 0.100 0.056 0.374 0.393
IL-4 0.007 0.060 0.809 -0.070
IL-7 -0.124 0.050 0.028 0.433
IL-8 0.300 0.220 -0.075 0.676
IP-10 0.661 -0.139 -0.088 0.251
MCP-1 -0.016 0.018 -0.071 0.766
MIP-1alpha 0.098 0.857 -0.104 -0.012
RANTES -0.065 0.811 0.105 0.150
SCD40L 0.798 0.068 0.234 -0.034
TNF-alpha 0.466 0.630 0.109 0.225
ach cytokine (Tables 
which contains two cytokines for 9% and factor four which contains two 
ytokines for 7%.  Both TNF-alpha and IL-1alpha (highlighted in orange) were present in 
o factors, but were counted once only where they had the highest value.  Four of the 
ytokines were significantly associated with a certain factor but to a lesser extent (marked in 
ellow). 
 
 
Focusing on the ESAT-6 factor analysis (Table 5.4), factor one which contains six 
cytokines accounted for about 26% of the variance, factor two which contains four 
cytokines for 13%, factor three which contains three cytokines for 9% and factor four 
which contains two cytokines for 7%.  Both IL-10 and IL-1alpha (highlighted in orange) 
Table 5.3 Factor loadings for the BCG stimulated samples of which all were Varimax normalized.  
ytokine loadings ≥ 0.7 are marked in red, > 0.5 in yellow and those present in two factors are marked 
 orange.  
5.3 and 5.4).  A well-known standard rotation method called Varimax normalized is used to 
rotate the factor axis to determine which cytokine loads onto which factor.  Based on this 
analysis it becomes evident which cytokines are the main contributors to each factor. 
Cytokines that have values ≥ 0.7 (highlighted in red) are considered to be major 
contributors to that specific factor.  Where cytokines appear in more than one factor, they 
are counted only in the factor where they have the highest value.  Focusing on the BCG 
factor analysis (Table 5.3), it can be seen that factor one which contains six cytokines 
accounted for about 26% of the variance, factor two which contains four cytokines for 
12%, factor three 
c
tw
c
y
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Variables (18 cytokines) Factor 1 Factor 2 Factor 3 actor 4
GM-CSF 0.814 0.302 0.049 .207
IFN-g 0.861 0.127 0.040 .053
IL-10 0.189 0.354 0.027 0.551
IL-12p40 0.047 0.243 0.266 0.359
IL-12p70 0.069 0.078 0.765 .132
IL-13 0.567 0.108 -0.048 0.185
IL-17 0.717 0.078 0.052 0.211
IL-1alpha 0.222 0.560 0.563 0.217
IL-1Ra 0.211 0.327 0.012 0.006
IL-4 -0.035 -0.033 0.852 0.076
IL-7 0.023 0.148 0.234 0.587
IL-8 0.253 0.675 -0.006 0.051
IP-10 0.773 -0.033 -0.070 .155
MCP-1 0.186 0.173 -0.109 0.446
MIP-1alpha -0.031 0.788 -0.031 .183
RANTES -0.207 0.786 0.088 0.006
SCD40L 0.823 0.055 0.238 .093
TNF-alpha 0.278 0.570 0.171 0.036
F
-0
-0
-0
-
-0
-
-0
-0
were present in two factors, but were counted once only where they had the highest value. 
Cytokines marked in yellow were significantly associated with a certain factor but to a lesser 
extent.  It was notable that one of the cytokine correlations, IL-7 in factor 4, was negative. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.6 Comparison between ELISA and Lincoplex data 
The enzyme-linked immunosorbant assays (ELISAs) are still widely used, but the reduced 
sample volume and time-saving advantages of the Lincoplex system have made it a far 
more attractive method to use. While with an ELISA only one cytokine ca
a time, up to 42 cytokines can be detected simultaneously with the Lincoplex.  All the 
enzyme-linked immunosorbant assays (ELISAs) were done by others in the department 
prior to the Lincoplex analysis.  Cells were stimulated in quadruplicate with BCG and 
ESAT-6 and incubated at 37oC with 5% CO2. The supernatants were harvested on days 3 
and 7 whereafter the IFN-γ response was measured.  With the day 7 data from both the 
ELISA and lincoplex analyses we could do a comparison between these two assays based 
on their ability to measure IFN-γ levels.  From the comparison between the Lincoplex and 
ELISA day 7 BCG stimulated IFN-γ concentration levels [pg/ml] it is evident that the 
Table 5.4 Factor loadings for the ESAT-6 stimulated samples of which all were Varimax normalized.  
Cytokine loadings ≥ 0.7 are highlighted in red, > 0.5 in yellow and those prese  two factors are 
highlighted in orange.  
n be detected at 
nt in
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wer concentrations than ELISAs (Fig. 
pearman correlation test was performed between the ELISA and Lincoplex 
day 7 BCG and ESAT-6 stimulated IFN-γ production (Fig. 5.12A & B respectively).  The 
IFN-γ results from these two techniques were highly correlated for both BCG (r = 0.86) 
and ESAT-6 (r = 0.88) antigens (Fig. 5.12). 
 
 
 
 
 
lincoplex technique is more sensitive in detecting lo
5.11A).  However, the ELISA detected higher IFN-γ concentrations than the Lincoplex 
assay.  The same trend was observed for the ESAT-6 stimulated IFN-γ production levels 
(Fig. 5.11B).  The cut off value used for ELISA IFN-γ measurements was 4000pg/ml, 
therefore any values beyond 4000pg/ml were extrapolated and might not be as accurate.  
The BCG stimulated IFN-γ levels were much higher than the ESAT-6 stimulated values 
(Fig. 5.11).  A S
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Fig. 5.12 Correlation between [A] BCG stimulated and [B] ESAT-6 stimulated samples of IFN-γ. 
Fig. 5.11 Histogram A  and [ E l a f N-γ a h o
data and the green L
A B
 
 
 
 
s of [ ] BCG stimulated B] SAT-6 stimu ated s mples or IF  levels.  The blue b rs represent t e Linc plex 
bars E ISA data. 
A B
r = 0.86
P < 0.00 
r = 0.88
P < 0.00 
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5.4 DISCUSSION 
 
In general we found no major correlation between the Mantoux readings and any of the 18 
cytokines measured.  Focusing on the correlation test between BCG stimulated samples 
and Mantoux readings we found no correlation (as expected), perhaps since BCG used for 
the WBA, and PPD, used for the skin test, originates from two different Mycobacterium 
species.  PPD is homogenous purified protein derivatives from Mycobacterium tuberculosis 
whereas BCG is derived from Mycobacterium bovis.  Furthermore the skin test is a delayed 
sponse as the measurements are taken only 48 -72h after administration.  Another reason 
ocusing on the correlation test between ESAT-6 stimulated samples and Mantoux 
osure to M. 
berculosis.  The PPD skin test, assesses whether one has been exposed to M. tuberculosis and 
one will only have an ESAT-6 response once one has been exposed to M. tuberculosis, as it is 
a protein secreted by the M. tuberculosis complex.  Therefore anyone that has a positive skin 
test should theoretically have an ESAT-6 response as they have been exposed to the M. 
tuberculosis complex.  
 
Once the data was divided into two groups, viz. >0 mm and 0 mm (no response), we 
found very strong associations for both the BCG and ESAT-6 stimulated samples (P < 
re
why a good correlation would not necessarily be expected is because one is comparing 
delayed results with a 7 day BCG stimulated assay of peripheral blood.   
 
The Mantoux skin test can be confounded by cross-reactivity with non-M. tuberculosis 
antigens resulting in false positives (Farhat et al., 2006; Wang et al., 2002) and is also prone 
to an increased rate of false negative results among immune-compromised individuals 
(Madhi et al., 2000).  To overcome the problem of limited Mantoux skin test specificity, 
alternative assays have been developed that utilize antigens such as ESAT-6 with increased 
specificity for M. tuberculosis (Menzies et al., 2007).  
 
F
readings, we found very weak correlations (r = 0.28).  ESAT-6 is a small protein consisting 
of 95 amino acids and is secreted by the Mycobacterium tuberculosis complex (Sørensen et al., 
1995).  Due to the extremely small size of the protein, a very sensitive assay is needed to 
detect ESAT-6 responses.  This is true even for the Lincoplex analysis, as we had many 
ESAT-6 non-responders in our data.  One would expect a correlation between ESAT-6 
stimulated samples and Mantoux readings as both ESAT-6 and PPD test exp
tu
150 
 
                                                                                                             CHAPTER FIVE 
0.01) with the Th1-type cytokines such as IFN- r the BCG results nor the ESAT-6 
results were unexpected, since it is known that BCG induces the Th1 response (Luo et al., 
2003) and ESAT-6 is a protein secreted by the M. tuberculosis complex.  A response to 
ESAT-6 is interpreted to imply that a person has been exposed to M. tuberculosis.  
Accordingly, we found a strong association between the ability to mount a positive 
response to BCG and ESAT-6.  No significant correlation was observed for any of the 
Th2–type cytokines. 
 
No major correlations were found between any of the 18 cytokines and age.  The theory 
behind testing whether a correlation exists between age and certain cytokine production 
levels lies in the fact that the older one becomes the more c ce one has had of being 
exposed to TB.  Therefore one would expect to see an increase in ESAT-6 response as an 
individual gets older.  On the other hand it is hypothesised that the BCG response would 
decrease with age, since all babies are vaccinated with BCG at birth in South Africa, (since 
1975).  This BCG immunity tends to fade over time (Wang et 2002).  We found a weak 
correlation (r = 0.29) with ESAT-6 and age but as mentioned re there were many non-
ponders.  This could be due to the low detection levels of ESAT-6 response, poor 
antigenic properties of ESAT-6 or may indicate that only some of the participants had been 
exposed to M. tuberculosis. 
 
The concentration of all 18 cytokines showed a significant correlation between BCG and 
ESAT-6 stimulated samples.  IFN-γ production was significantly higher in the BCG 
stimulated samples than the ESAT-6 samples, however this might once again be due to the 
low detection of ESAT-6 responders.  IL-8 production was high in both BCG and ESAT-6 
stimulated samples.  IL-8 is a pro-inflammatory cytokine that responds well to any antigen 
stimulation as it might not be T-cell receptor specific and therefore the response might be 
nonspecific.  Interestingly, an extremely strong correlation (r = 0.83) was found between 
BCG and ESAT-6 stimulated samples for IL-1Ra secretion.  According to these results, 
ESAT-6 is far more likely to induce IL-1Ra than IFN-γ.  Due to the strong correlation 
observed between BCG and ESAT-6 stimulated samples this study might indicate that IL-
1Ra is a better cytokine to measure exposure to M. tuberculosi n IFN-γ.  Therefore the 
question arises, is IFN-γ really giving the best read out of an ESAT-6 stimulation assay or 
γ.  Neithe
han
 al., 
befo
s tha
res
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will other cytokines such as IL-1Ra be a better indicator of M. tuberculosis exposure?  This 
needs to be investigated further. 
 
An extremely strong correlation (r = 0.90) was found between BCG and ESAT-6 
stimulated samples with IL-4, but this might be due to the low levels of IL-4, since the 
majority of the measurements lay between 0 and 200 pg/ml.  This might be explained by 
the low detection levels, which is a common problem with Lincoplex measurements of IL-
4 (Siawaya et al., 2008) or low IL-4 production by individuals.  Therefore, it is difficult to 
draw any conclusions from the IL-4 data. 
 
Strong correlations were observed between antigen-specific (BCG and ESAT-6) cytokine 
production levels of some of the 18 cytokines.  The most statistically significant 
correlations were between IFN-γ and GM-CSF for both BCG and ESAT-6 (r = 0.89 and r 
= 0.92 respectively).  For ESAT-6 stimulation, the most significant correlation were 
ll four of these cytokines (IFN-γ, GM-CSF, IP-10 and IL-17) are pro-inflammatory 
ytokines that form part of the Th1 response.  IFN-γ, secreted by dentritic cells, NK cells 
d CD8+ cytotoxic T cells, is known as the major Th1-type cytokine and suppresses Th2 
ell activity (Schoenborn & Wilson, 2007).  Therefore the production of this cytokine 
dicates a T cell-mediated response to an intracellular pathogen such as M. tuberculosis, 
sulting in macrophage activation (Kaufmann et al., 2006).  GM-CSF, secreted by T cells 
imulates monocytes that mature into macrophages which play a crucial role in the 
mune/inflammatory cascade.  IP-10, also known as a chemokine, is induced in several 
ell types including monocytes in response to IFN-γ (Sauty et al., 1999).  IP-10 acts as a 
hemoattractin for macrophages, T cells and NK cells.  IL-17 forms part of a group of 
ytokines called the IL-17 family.  It is involved in inducing and mediating pro-
flammatory responses as well as the production of other cytokines and chemokines such 
between IP-10 and GM-CSF (r = 0.84), IP-10 and IFN-γ (r = 0.91), IL-17 and GM-CSF (r 
= 0.80) and, IL-17 and IFN-γ (r = 0.80). 
 
A
c
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c
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c
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as IFN-γ, GM-CSF and IP-10 (Fig. 5.13).   
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F
D
ig. 5.13  The role of IL-17A, IL-17E and IL-17F in the expression of airway inflammation.  
entritic cell (DC), macrophage (MФ), Growth-related oncogene α (GROα), Epithelial cell-derived 
eutrophil activating protein 78 (ENA-78) (Kawaguchi et al., 2004) 
hese four pro-inflammatory cytokines have a strong mutual correlation after ESAT-6 
imulation which may indicate concerted secretion as a response to exposure to M. 
berculosis. 
e found that the variance in the data could be explained by four major factors.  The 
umulative effect of these factors was the same for both the BCG and ESAT-6 models 
4%).  The first three factors were the same for both BCG and ESAT-6 models.  Based 
n this analysis it became apparent which cytokines are the main contributors to each 
ctor. Factor one, which contains GM-CSF, IFN-γ, IL-13, IL-17, IP-10 and the soluble 
D40 ligand (SCD40L), accounted for about 26% of the variance.  All these cytokines with 
biased cytokines / chemokines 
n
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the exception of IL-13 are pro-inflammatory and are Th1 
that are induced by stimulation with BCG and ESAT-6.  The production of all these 
cytokines except IL-13, indicate a T cell-mediated response to an intracellular pathogen 
such as M. tuberculosis playing a crucial role in the immune/inflammatory cascade as it 
results in macrophage activation.  IL-13 is one of the major Th2-type cytokines that plays 
an important role in mediating allergic inflammation.  Since the Th2 immune response is 
suppressed by the Th1 immune response it was surprising to find IL-13 grouped with other 
Th1-type cytokines.  However, this might be due to very low expression levels of IL-13 
throughout the Lincoplex analysis resulting in a false signal.   
 
Factor two which contains IL-1alpha, MIP-1alpha, RANTES and TNF-alpha accounted 
for about 12% of the variance.  All these cytokines are pro-inflammatory and Th1 biased 
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cytokines / chemokines that are expressed at increasing levels after stimulation with BCG 
and ESAT-6.  All these cytokines are involved in macrophage activation. 
  
Factor three which contains IL-12p70 and IL-4 accounted for about 9% of the variance.  
These two cytokines are very different from each other, as IL-12p70 is a Th1-type pro-
inflammatory cytokine and IL-4 is a Th2-type anti-inflammatory cytokine.  IL-12 is a 
crucial regulator of cell-mediated immune responses and it is secreted by activated B-
lymphocytes and macrophages as a 70-kD glycoprotein (IL-12p70).  The development of 
pro-inflammatory Th1-type CD8+ T cells and NK cells are promoted by IL-12 production.  
bioactive IL-12p70 in dentritic cells (DC) and
It has previously been shown that IL-4 is a powerful enhancer of the production of 
 macrophages.  Human Th2 cells producing 
 acts as a Th2 specific co-inducer of the 
sulting in an inbuilt tendency of human Th2 cells to 
gress to the IFN-γ-producing Th0 / Th1 phenotype upon interaction with DC (Kaliński 
 al., 2000).  DC isolated from the airways and from the gut-associated lymphoid tissues 
has been shown to be IL-12 deficient (Iwasaki & Kelsall, 1999; Stumbles et al., 1998).  The 
grouping of these two cytokines together is therefore concordant with their known 
function. However, this might also be an over-interpretation of what is happening, since 
the IL-12p70 values were very low throughout the Lincoplex analysis. 
 
Different cytokines shaped the fourth factor of the BCG and ESAT-6 models.  Factor four 
contained IL-8 and MCP-1 in the BCG model and accounted for about 7% of the variance.  
Both these cytokines are pro-inflammatory and Th2-type cytokines.  IL-8 forms part of the 
C-X-C chemokine family and acts as a potent activator and chemoattractant of neutrophils 
(Mukaida et al., 1994).  In contrast, MCP-1 forms part of the C-C chemokine family and 
functions as a chemoattractant and activator of lymphocytes and monocytes leading to 
monocyte / macrophage infiltration into tissues (Taub et al., 1995).  Both of these cytokines 
therefore act as chemoattractants that contribute to the influx of monocytes and 
neutrophils after infection / inflammation which can occur during both Th1 and Th2-
biased infections.  This might be why these two cytokines were expressed at noticeably 
higher levels (2-fold) compared to other cytokines detected in the Lincoplex assay.  IL-8 
and MCP-1have interactive effects and are strongly complementary in vivo, which may be a 
reason for these two cytokines appearing together in one factor.  In the ESAT-6 model, 
IL-4 therefore efficiently induce IL-12p70.  It
production of bioactive IL-12p70, re
re
et
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factor four contains IL-10 and IL-7 and accounted for about 7% of the variance.  These 
two cytokines are both B cell-regulating cytokines but different in that IL-10 is an anti-
inflammatory cytokine and IL-7 a pro-inflammatory cytokine.  Based on the factor loading 
results these two cytokines have opposite effects as IL-10 has a factor loading of +0.55 and 
IL-7 has a factor loading of -0.58.  This result might be explained by the opposite functions 
of the two cytokines, or the extremel w expression of IL-7 observed in the Lincoplex 
assay, and cannot be regarded as a reliable result.  
 
In our comparative assessment of IFN  we 
found the results from these two analyses to be highly correlated with each other.  This was 
true for both BCG and ESAT-6 stimulated IFN-γ levels.  This comparative study between 
the ELISA and Lincoplex IFN-γ levels showed that, although ELISA’s are still being 
widely used, the multiplex assay is highly accurate and com ive with ELISA results w  
added advantages like reduced sampl lume and time-saving benefits.  The Lincoplex 
assay was also more sensitive at detecting lower IFN-γ concentrations.  Strong correlations 
ve previously been reported between ELISA and Lincoplex IFN-γ levels measured 
(Siawaya et al., 2008; dupont et al., 2005
 
In conclusion, the multiplex analysis is rapidly becoming the most widely used screening 
tool for the selection of candidate biomarkers associated with specific diseases.  The yield 
of information with the Lincoplex assay compared to the ELISA assay is immense.  We 
were able to simultaneously study 18 cytokines in 340 individuals, leading to a vast amo  
of phenotypic information.  Inclusions of other disciplines, or more specific  
immunogenetic approaches, play a crucial role in unraveling the, yet unknown ab
complex diseases such as TB.  Theref ce cytokines play a major role in immunity to 
tuberculosis (phenotypic information) nctional polymorphisms or haplotype patt  
(genotypic information) in some of these cytokine genes might be vital for protective 
immune responses and may serve as biomarkers of protection or susceptibility to TB 
(Selvaraj et al., 2008). 
 
In future, multiplex methods could be tailor-made to test specific cytokines relevant to  
disease of interest, in this case TB. might lead to a better understanding of the 
pathophysiology of TB and serve as an objective tool to evaluate disease severity and 
y lo
-γ in the ELISA and from the Lincoplex assay,
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susceptibility to M. tuberculosis is multifactorial and complex as it 
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involves many components of the immune system (Raja, 2004).  It is possible that 
manipulation of these specific cytokines may lead to new and more specific therapeutic 
alternatives (Jacob et al., 2003). 
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This study was undertaken to investigate susceptibility to tuberculosis in a South African 
Coloured (SAC) population, by consolidating a number of candidate gene studies and 
xtending these results to include gene-gene interaction analysis and mycobacterial 
 susceptibility of these patients, factors in their 
nvironment, or whether it is due to the virulence of particular strains of M. tuberculosis or 
king the SAC population an ideal population to 
udy disease susceptibility, since functional markers can be identified. 
e
genotypes.   
 
South Africa has one of the highest incidences of TB in the world, reflected by the 
situation in communities such as Ravensmead and Uitsig in the Western Cape, where a 
large number of individuals have had TB episodes on two or more occasions.  It is not 
known whether this is due to the higher
e
all of these. 
 
The SAC population is a unique admixed population with a strong African admixture 
component.  Therefore, the SAC population might have more genetic variability than other 
more homogeneous population groups.  It is known that an admixed population has a 
stronger linkage disequilibrium (LD), ma
st
 
In this study we were able to replicate many previously described associations found in the 
SAC population (see chapter 3).  Although we were unable to reproduce some of the 
previous associations found, the results are still of value.  A result that is not statistically 
significant is often seen as a negative result and therefore not published.  However, both 
positive and negative results from association studies are important. 
 
Our case-control association studies in a SAC population contribute significantly to the TB 
host genetics field, since nine polymorphisms in eight candidate genes (Table 6.1), 
previously indicated to play an important role in TB susceptibility, were investigated in a 
sample size large enough to have sufficient power to detect whether there was an 
association with tuberculosis susceptibility.   
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Genotype Allele
SP-D Met11Thr (rs721917) 3.2
MBL Codon 52 (rs5030737) 3.3
Codon 54 (rs1800450)
Codon 57 (rs1800451)
IFN-γ +874 A/T (rs2430561) 3.4
IFNGR1 1050 T/G (rs11914) 0.022 3.5
5' (GT)  repeat le 118: 0.011 3.8
allele 120: 0.011
Variant
(rs number)
Results in 
Table: 
Significant P-values
Gene
IL-8 +100 C/T (rs2227538) 0.019 3.6
RANTES -403 A/G (rs2107538) 3.7
AMP1 n alleNR
3' UTR (TGTG) deletion 3.9
IL-1Ra 86bp VNTR 0.037 allele 1: 0.019 3.11
allele 2: 0.025
Table 6.1 Summary of all the polymorphisms investigated in the case-control association study in 
the South African Coloured population 
 
 
ur knowledge, that gene-gene interaction analysis was done in the 
bstructure using 209 unlinked 
ndomly selected microsatellites, since substructure may have a confounding effect on 
 
 
 
This is the first time, to o
context of TB host susceptibility.  In this case, a condensed set of 11 variants in these eight 
genes was used (SP-D, MBL, IFN-γ, IFNGR1, IL-8, RANTES, NRAMP1 (SLC11A1), and 
DC-SIGN).  Of the 103 possible interacting pairs, we detected significant interactions 
between eight pairs of variants.  The combined data set consisting of 106 variants yielded a 
very large number of pair-wise interactions.  Of the 318 statistically significant interactions 
(P < 0.05) found, 67 were highly significant (P < 0.01).  Considering the amount of data 
rapidly becoming available from SNP chip studies, similar interaction studies between 
known susceptibility genes and others could well identify new candidates involved in TB 
susceptibility.  This is a multilocus and multi gene approach, consistent with the nature of 
complex-trait diseases, and may provide the paradigm for future genetic studies of TB.  In 
addition to the host genotype conferring susceptibility, the interaction between the 
genotype of the human host and the bacterial strain genotype was also investigated in a 
subset of 229 TB patients, with no significant interactions detected. 
 
This admixed population was also assessed for population su
ra
genetic association studies.  Our results finding no substructure in the population were 
congruent with those with Barreiro et al., (2006), who found no population stratification.  
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However, we now have a better understanding of population stratification and advances in 
bio-informatics and genotyping methods show that more than 25 SNPs are required to 
liably test for population stratification (Hao et al., 2004; Turakulov & Easteal, 2003).  In 
 alleles found in this 
opulation (Tishkoff et al., 2009), novel susceptibility alleles could be identified. 
re
this case, 209 microsatellites were used to strengthen the evidence that no population 
substructure exists in the SAC population  
 
The population structure or ancestral contributions to this admixed population were 
investigated using a large dataset consisting of 959 individuals from the SAC group 
genotyped for nearly 75,000 markers.  This was the first investigation at this high level of 
genetic resolution of a South African population.  Our study showed that the genetic 
background agrees with the historical record and also reveals more interesting detailed 
insights into the events that resulted in the present-day population.  We showed that the 
SAC population group has four major ancestral components: the Khoesan, European, 
African and Asian (Indian), in approximate proportions of 42%, 28%, 21% and 9% 
respectively.  Knowledge of the population structure will be important for association 
studies.  One of the current genome-wide methods to find genetic risk factors for disease is 
that of admixture mapping (see section 6.2).  The SAC would appear to be ideally suited to 
this type of investigation, having ancestral populations with apparently widely different 
rates of TB infection and disease.  Given the high number of private
p
 
Owing to the complexity of the immune system and the multifactorial nature of a complex 
disease such as TB, it has become increasingly evident that unravelling the underlying 
mechanisms indicated by the genetic component may lead to new insights into the 
pathogenesis of TB and the development of new treatment strategies.  Therefore, since 
cytokines play a major role in immunity to tuberculosis (phenotypic information) the 
functional polymorphisms or haplotype patterns (genotypic information) in some of these 
cytokine genes might be vital for protective immune responses and may serve as 
biomarkers of protection or susceptibility to TB (Selvaraj et al., 2008).  We simultaneously 
investigated 18 cytokines in 340 individuals using multiplex analysis, leading to a vast 
amount of phenotypic information.  Host susceptibility to M. tuberculosis is multifactorial 
and complex as it involves many components of the immune system (Raja, 2004).  It is 
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possible that manipulation of these specific cytokines and their balance may lead to new 
and more specific therapeutic alternatives (Jacob et al., 2003). 
 
6.1 Potential limitations of the study 
Owing to the high incidence of latent TB infection in the Ravensmead-Uitsig community, 
many of the control samples used in this study were probably TST skin test positive, 
therefore latently infected.  Consequently, our case-control association study investigated 
ost genetic factors that may predispose individuals to progression to disease.  The 
thout a single major susceptibility locus, which 
neous factor of an infectious agent.  Too stringent 
 
n = 50) might not have been sufficient or have had enough power 
h
possibility exists that a separate set of genes are involved in infection, compared to 
progression to disease.  However, the genes studied here might be involved in primary 
infection. 
 
Some schools of thought suggest that statistical genetics should include corrections for 
multiple testing, however, no corrections were done in the association studies presented 
here.  It is debatable how relevant multiple corrections are, as some argue that these tests 
are too stringent, resulting in the exclusion of true susceptibility variants.  This is arguably 
particularly relevant in a complex disease wi
is further complicated by the extra
requirements may well result in the spurious exclusion of associated loci.  All the variants 
studied here had a prior probability of being associated with TB susceptibility based on 
their function or previous analyses.  Therefore, it is argued that variants studied here were 
not randomly selected and therefore did not require corrections for multiple testing.   
 
Another possible statistical limitation is spurious associations in the combined gene-gene 
interaction dataset consisting of 106 variants and in the gene-trait interaction analysis. 
Since multiple pair-wise interaction tests were done between the different variants it may be 
prone to false positive associations, because a percentage of multiple tests with the same 
dataset will have positive P values just by chance. 
 
The TBM sample size (
to detect an association between TBM susceptibility and the genes investigated.  Although 
a stronger association might have been expected with TBM than pulmonary TB as it is an 
extreme phenotype, our sample size was too small to detect any association. 
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It has been hypothesised that many other inherited DNA features and not only gene 
polymorphisms may also influence susceptibility to a disease.  Epigenetic mechanisms, such 
as DNA methylation and histone acetylation changes, regulate the transcription rate and/or 
tissue-specific expression of certain genes without altering the primary nucleotide sequence 
f the DNA.  M. tuberculosis might interfere with epigenetic regulation to add to the 
omplexity of the disease process.  
hods need to be developed to handle large data sets when investigating 
ene-gene interactions.  Other future directions could include: 
i) Genome-wide association studies  
Genome-wide association studies (GWAS) allow the genotyping of the most frequent 
genetic polymorphisms in the genome without making assumptions about the genomic 
location of the causal variants.  Since most of the genome is surveyed, it eliminates the 
disadvantages of the single polymorphism or candidate gene approach where only a few 
polymorphisms are investigated (Hirschhorn & Daly, 2005).  The completion of the human 
genome sequence, the deposition of SNPs into public databases, the rapid improvements 
in SNP genotyping methods (such as the development of microarray platforms) and the 
International HapMap Project have allowed the genetic association field to progress to this 
study design.  Previous investigations (Daly et al., 2001; Gabriel et al., 2002; Patil et al., 2001) 
and the International HapMap project have shown that most common variation in the 
genome can be represented by approximately 300 000 SNPs (Balding, 2006) in white 
populations.  African and other populations with greater variation and less LD need more 
SNPs (Hirschhorn & Daly, 2005) to ensure coverage of the entire genome. When this 
study design was first suggested, one of the major theoretical stumbling blocks was the 
problem of statistical correction for multiple questions. 
 
GWAS have the potential to identify many false associations and therefore replication or 
validation in independent populations is essential (Burgner et al., 2006).  However, these 
o
c
 
6.2 Future directions 
The significant associations found in this study should be validated in other population 
groups to assess the importance of these polymorphisms in susceptibility to TB.  All pair-
wise gene-gene and gene-trait interactions should also be validated and improved 
computational met
g
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studies are very expensive.  In addition, the best approach to adjust for multiple 
omparisons in these studies has not been determined.  A possible strategy for the 
limination of false-positive results is to use a two-step study design and to adopt strict 
les for declaring significant associations.  A few individuals are genotyped genome-wide 
 the first stage of the study. In the second stage, promising SNPs are genotyped in the 
remainder of the study populatio s where a significant association 
is determined, the results are verified in another population, preferably using another 
genotyping method to exclude technical artefacts.  These studies need a large sample size to 
ensure adequate power.  An additional challenge for GWA studies is that it is currently 
based on the “common disease, common variant” (CDCV) hypothesis, which means that 
rare susceptibility variants may not be detecte  
 
There are currently o other infectious 
diseases, namely Kawasaki disease (Burgner et al., 2009) and chronic hepatitis B (Kamatani 
et al., 2009), has been investigated using GWAS.  The Wellcome Trust Case-Control 
onsortium has initiated GWAS that will consider up to 2000 cases and 2000 controls for 
B and malaria (Burgner et al., 2006; Wellcome Trust Case Control Consortium, 2007). 
) Admixture mapping 
dmixture mapping, a novel approach for disease gene discovery, is an additional 
ethodology for which the resolution is higher than that of linkage analysis, but lower than 
at of association studies (Chakraborty & Weiss, 1988; Stephens et al., 1994).  This 
chnique involves using a population which has arisen from two or more genetically 
ifferent parent populations where the frequency of the disease, and therefore presumably 
f the underlying risk variants as well, is different in the founding populations.  The aim is 
 localise the segments of the genome inherited from a specific ancestral population in the 
ases in order to identify the locus responsible for the phenotype of interest.  The primary 
ols are the genetic markers that occur with significantly different allele frequencies in 
ifferent population groups.  When risk alleles vary across populations, genetically mixed 
dividuals with the disease under investigation are likely to have a higher probability of 
aving inherited the loci near the disease loci from the population at higher risk of the 
isease.  The study design has recently been used successfully in a variety of complex 
diseases, e.g. hypertension (Zhu et al., 2005), multiple sclerosis (Reich et al., 2005) and 
c
e
ru
in
n (Balding, 2006).  In case
d.
no published GWAS in TB, but susceptibility to tw
C
T
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prostate cancer (Freedman et al., 2006) in African Americans.  Preparation for studies in 
admixed populations from Mexico (Bonilla et al., 2005; Martinez-Marignac et al., 2007) and 
Hispanic/Latino populations (Mao et al., 2007; Price et al., 2007) are also underway, but 
none of these studies have involved TB.   
though environmental and social factors are difficult to control for, it does 
pear that the underlying susceptibility is different and thus an approach using an admixed 
f modest effect than 
nkage analysis, and if risk alleles are differentially distributed between ancestral 
ed population studied 
 this thesis. 
rent changes in DNA methylation and histone 
etylation, regulate the transcription rate and/or tissue-specific expression of certain genes 
without altering the primary nucleotide sequence of the DNA.  
 
 
There is an apparent disparity in the rates that European and black individuals are infected 
with TB and progress to disease (Stead et al., 1990).  This is not merely a reflection of 
socio-economic circumstances, but it has been speculated that it is the result of centuries of 
exposure to TB in Europe, which may have resulted in a degree of selection for a more 
resistant population, whereas Sub-Saharan Africa was exposed to the disease only relatively 
recently.  Al
ap
populations from these parent populations could yield useful research. 
 
Admixture mapping may serve as an excellent approach for an initial genome scan owing 
to several advantages when compared to linkage or association studies (Darvasi & Shifman, 
2005).  This technique has a higher statistical power to detect genes o
li
populations, and if the frequencies differ greatly across populations, the power approaches 
that of association mapping (Montana & Pritchard, 2004).  In addition, admixture mapping 
studies are not as affected by allelic heterogeneity as are other study designs (Martinez-
Marignac et al., 2007).  This approach could yield novel susceptibility genes for TB.  An 
admixture mapping study with respect to TB is planned for the admix
in
 
iii) Epigenetics 
A hypothesis that genetic polymorphisms are not the only inherited features of DNA 
which may influence disease susceptibility has been considered for several years (Richards, 
2006).  Epigenetic mechanisms, such as diffe
ac
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DNA methylation plays an important role in the arrangement of some key biological 
histone deacetylation plays an impo
activities such as imprinting and silencing of chromosomal domains (Reik & Walter, 2001; 
Wang & Leung, 2004).  It usually occurs at the cytosine residue in the context of a CpG 
dinucleotide and promoter regions, where it can act as an important modifier of 
transcription.  The relationship between the methylation of the CpG islands and gene 
expression is very complex.  Some studies have reported that the change of methylation 
intensity of the promoter CpG islands is negatively correlated with gene expression levels 
(Futscher et al., 2002; Song et al., 2005), while others have observed no correlation 
(Illingworth et al., 2008; Weber et al., 2007). 
 
Histone acetylation is crucial for gene transcription as histone acetylation sites are required 
for chromatin folding and gene activity. Histone acetyltransferases form part of a family of 
enzymes that are involved in several biological processes.  It has also been shown that 
rtant role in transcription (Shahbazian & Grunstein, 
 be transmitted to subsequent generations, 
y also be influenced by the environment (Richards, 2006).  However, this 
ue to their role in functional 
2007). 
 
The above DNA features have been shown to
but they ma
inheritance is not as stable as DNA-based inheritance and it is not completely elucidated. It 
has been shown that M. tuberculosis may interfere with epigenetic regulation (Pennini et al., 
2006).  Therefore, once the inheritance is understood, it is possible that these epigenetic 
mechanisms may be found to play a role in host susceptibility to TB. 
 
iv) Copy number and rare variants 
The majority of the methods above are based on the CDCV hypothesis which means that 
rare susceptibility variants may not be detected, and are therefore designed to detect 
common genetic markers.  However, a number of sceptics have postulated that this 
hypothesis is not true, and will therefore not lead us to some of the more meaningful 
susceptibility-associated genes (Goldstein, 2009). 
 
DNA copy number variations (CNVs), that can be defined as 1 kb and larger stretches of 
DNA that display copy number differences compared to the normal population, have 
generated remarkable enthusiasm in the science community d
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ons (Walsh et al., 
008).  If this scenario is also true for TB, it will require a more intense search for the rare 
r index of 
spicion if exposed to TB, and prophylactic treatment. 
variation (Iafrate et al., 2004; Scherer et al., 2007).  It was observed that CNV hotspots exist 
(Lee et al., 2008) and that CNV segments were considerably enhanced among sequences 
with low or moderate SNP content (Cutler et al., 2007).  CNVs in individuals have been 
associated with disease or susceptibility to several diseases (Baldini, 2004; Friedman et al., 
2006; Marshall et al., 2008; Stefansson et al., 2008).  It has also been shown that the copy 
number amplification of regions containing the MBL, pfmdr1 and gch1 genes influenced the 
susceptibility to bacterial infection in the zebrafish (Jackson et al., 2007).  Individuals with 
the complex disorder of schizophrenia were recently found to owe their predisposition to 
many individually rare mutations, including rare mutations and duplicati
2
variants governing susceptibility. 
 
6.3 Conclusion 
TB is not only influenced by the bacterium as stated several years ago (Dubos & Dubos, 
1952), but it is a complex disease influenced by immunological, environmental, socio-
economic and host genetic susceptibility factors.  Looking at the history of TB, medical 
solutions alone were not enough to prevent or cure TB, therefore other fields such as 
human genetic susceptibility to TB need to be further investigated. 
 
Even though this research is years from being clinically applied, the era of personalised 
medicine is already upon us, and it may not be long before the admittedly controversial 
benefits of personalised genetics can be extended from conditions such as cardiovascular 
disease, to infectious diseases such as TB.  If individuals can be identified as potentially 
more vulnerable, they may require different vaccination strategies, a highe
su
 
Complex diseases may in all likelihood continue to earn their name and susceptibility could 
prove to be due to the interaction between both common and rare genetic variants in the 
host, variation in the bacterium, and the environment, requiring highly sophisticated 
algorithms to predict susceptibility. 
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